[{"_1":2,"_7428":-5,"_7429":-5},"loaderData",{"_3":4,"_7":8},"routes/app-layout",{"_5":6},"isAuthenticated",false,"routes/tickers",{"_9":10,"_76":77,"_106":107,"_28":111,"_207":208,"_7417":7418},"tracked",[11,34,43,52,59,66],{"_12":13,"_14":15,"_16":17,"_18":19,"_20":21,"_22":23,"_24":-5,"_25":-5,"_26":27,"_28":29,"_30":31,"_32":33},"ticker","ACCV","company_name","Accelevation Holdings Corp.","sector","Industrials","market_cap",493800000,"current_price",16.46,"price_change_5d",-6.21083,"ai_analysis","dd_completed_at","updated_at","2026-10-14 21:31:32","pinned",0,"last_event_type","cluster_formed","last_event_at","2026-10-06 02:30:21",{"_12":35,"_14":36,"_16":37,"_18":38,"_20":39,"_22":40,"_24":-5,"_25":-5,"_26":41,"_28":29,"_30":31,"_32":42},"AGMB","AgomAb Therapeutics NV","Healthcare",435352099,8.84,2.19653,"2026-10-14 21:31:27","2026-10-07 13:30:22",{"_12":44,"_14":45,"_16":17,"_18":46,"_20":47,"_22":48,"_24":49,"_25":50,"_26":51,"_28":29,"_30":-5,"_32":-5},"NVRI","Enviri Corporation",1544113596,18.67,-11.47463,"{\"raw\":\"## NVRI\\n\\n**Generado:** 2026-06-08T21:30:34.964Z UTC | **SCORE: 74/100** | **GRADO: A**\\n\\n> CEO, CFO y Director compran $1.4M en cluster tras reestructuración como empresa standalone, con earnings mañana.\\n\\n---\\n\\n| Campo | Valor |\\n|---|---|\\n| Tier | 1 (≥$200M) — Market Cap $1.544B |\\n| Fear & Greed | N/D |\\n| Régimen | Normal |\\n\\n---\\n\\n### PASO A — VERIFICACIÓN DE DESCARTE\\n\\n- [x] ¿10b5-1? No indicado — PASA\\n- [x] ¿Market cap <$50M? No ($1.544B) — PASA\\n- [x] ¿Market cap >$2B? No ($1.544B) — PASA\\n- [x] ¿Shelf registration >20%? No hay dilution filings — PASA\\n- [x] ¿Cash runway <6m sin revenue? Empresa industrial con revenue — PASA\\n- [x] ¿Going concern? No indicado, empresa $1.5B waste management — PASA\\n- [x] ¿Fraude/SEC investigation? No indicado — PASA\\n- [x] ¿Class action activa? No indicada — PASA\\n- [x] ¿Social viralizado? Sin datos = silencio — PASA\\n- [x] ¿State 3 priced-in? Precio solo +0.78% desde filing — PASA\\n- [x] ¿Divergencia opciones? Sin datos — PASA\\n\\n**Todas las reglas pasan. Continuar scoring.**\\n\\n---\\n\\n### PILAR 1: INSIDER CONVICTION (41/45)\\n\\n| Campo | Valor |\\n|---|---|\\n| Insider Principal | Hochman Russell C. (President & CEO) |\\n| Monto CEO | $1,001K — 51,519 shares @ $19.43 |\\n| Insider #2 | Minan Peter Francis (EVP & CFO) |\\n| Monto CFO | $160K — 8,333 shares @ $19.25 |\\n| Insider #3 | Purvis Edgar M Jr (Director) |\\n| Monto Director | $253K — 14,000 shares @ $18.10 |\\n| **Total Cluster** | **$1,414,824** |\\n| Ratio Purchase/MktCap | 0.092% (rango 0.05-0.15%) |\\n| ΔOwn CEO | +55.4% (de ~92,991 a 144,510) |\\n| ΔOwn CFO | +102.9% (de ~8,101 a 16,434) — duplicó posición |\\n| ΔOwn Director | +41.2% (de ~33,975 a 47,975) |\\n| Cluster | 2 C-level (CEO+CFO) + 1 Director en 2 días |\\n| 10b5-1 | No |\\n| Primera compra CEO | **Primera compra open market en historial** |\\n| Primera compra CFO | Acumulador (2 compras en 12m, net buy ratio 1.0) |\\n| Ratio compra/salario | ~20-33% estimado (sin DEF 14A, CEO $1M compra) |\\n\\n**Desglose de puntos:**\\n\\n| Componente | Pts |\\n|---|---|\\n| CEO/CFO compra | +10 |\\n| Ratio Purchase/MktCap 0.05-0.15% | +5 |\\n| ΔOwn ≥20% (todos) | +5 |\\n| Primera compra CEO en 2+ años | +5 |\\n| Sin 10b5-1 | +3 |\\n| 2 C-level cluster ≤7 días | +10 |\\n| Ratio compra/salario ~20%+ (est.) | +3 |\\n| **Subtotal** | **41** |\\n\\n**Contexto crítico:** El CEO tenía 10 disposiciones el 1 de junio — todas coinciden con la reestructuración corporativa (lanzamiento como empresa standalone tras venta de Clean Earth). La disposición de 272,654 acciones a $0 es claramente un ajuste por reestructuración, no una venta open market. **Dos días después, pone $1M de su propio bolsillo en la nueva entidad.** Eso es convicción pura.\\n\\nEl CFO es un acumulador confirmado (net buy ratio 1.0) y acaba de duplicar su posición.\\n\\n---\\n\\n### PILAR 2: CATALIZADOR (13/25)\\n\\n| Campo | Valor |\\n|---|---|\\n| Tipo Principal | Earnings — **primer reporte como empresa standalone** |\\n| Fecha | **2026-06-09 (MAÑANA, 1 día)** |\\n| Binario | No (earnings), pero alto impacto informacional |\\n| Tipo Secundario | Lanzamiento como empresa standalone (1 junio) |\\n| Fuente | Press release FMP: \\\"New Enviri Launches as Standalone Public Company\\\" |\\n| Sector | Industrials/Waste Management — no prioritario |\\n\\n| Componente | Pts |\\n|---|---|\\n| Earnings ≤30 días (no binario) | +6 |\\n| Catalizador corporativo (restructuración/standalone launch) | +5 |\\n| Sector no prioritario | +2 |\\n| **Subtotal** | **13** |\\n\\n**Nota:** Este no es un earnings ordinario. Es el **primer reporte financiero** de Enviri como entidad standalone post-venta de Clean Earth. El mercado verá por primera vez la estructura de ingresos, márgenes y deuda de la nueva empresa. Los insiders que compran 1-5 días antes de revelar estos números tienen visibilidad que el mercado no tiene.\\n\\n---\\n\\n### PILAR 3: TIMING (20/20)\\n\\n| Campo | Valor |\\n|---|---|\\n| Priced-In State | **State 1 (Not Priced-In)** — movimiento post-filing +0.78% |\\n| Move previo 5d | **-11.47%** (caída significativa) |\\n| Move previo 1m | -6.93% |\\n| Precio vs 50d MA | -3.66% (por debajo) |\\n| Precio vs 200d MA | +13.57% |\\n| Social | **Silencio total** (sin datos = sin menciones) |\\n| Menciones 7d | 0 detectadas |\\n| Cuentas grandes | Ninguna |\\n\\n| Componente | Pts |\\n|---|---|\\n| State 1 Not Priced-In | +10 |\\n| Post-crash (caída -11.47% en 5 días) | +5 |\\n| Silencio social total | +5 |\\n| **Subtotal** | **20** |\\n\\n**Contexto:** La acción cayó -11.47% en 5 días, probablemente por venta mecánica de holders del old entity que no quieren la nueva empresa. Los insiders compraron en esta debilidad. Nadie en redes habla de este cluster.\\n\\n---\\n\\n### BONUS OPCIONES (0/10)\\n\\n| Campo | Valor |\\n|---|---|\\n| Cadena | Sin datos disponibles |\\n| Flow pre-filing | No disponible |\\n| Divergencia | No detectada |\\n\\n---\\n\\n### DUE DILIGENCE\\n\\n| Campo | Valor |\\n|---|---|\\n| Dilución | **Clean** — No hay dilution filings |\\n| Cash | Revenue positivo (waste management), sin datos granulares |\\n| Management | CEO primer compra histórica = señal fuerte; disposiciones Jun 1 claramente reestructuración |\\n| Litigios | Sin datos — no detectados |\\n| EPS | -$2.05 (negativo), probablemente transitorio por costos de reestructuración |\\n| Auditoría | Sin datos de going concern |\\n\\n**Banderas amarillas:**\\n1. EPS negativo — mitigado por contexto de reestructuración\\n2. Falta de datos financieros detallados — empresa recién standalone\\n3. Sin cobertura de analistas — empresa nueva, oportunidad de re-rating\\n\\n---\\n\\n### AJUSTES\\n\\n| Ajuste | Puntos |\\n|---|---|\\n| Fear & Greed (N/D) | 0 pts |\\n| Social (silencio) | 0 pts |\\n| Priced-In (State 1) | 0 pts |\\n\\n**SCORE AJUSTADO: 74/100**\\n\\n---\\n\\n## DECISION\\n\\n---\\n\\n**CLASIFICACIÓN: ENTRADA VÁLIDA (A)**\\n\\n| Campo | Valor |\\n|---|---|\\n| Vehículo | Acciones |\\n| Position size | 10% del capital activo |\\n| Entrada | $18.67 (precio actual) |\\n| Stop loss | $16.80 (-10%, por debajo de compra Director a $18.10) |\\n| Target 1 | $21.42 (52-week high) |\\n| Target 2 | $23.50 (re-rating como standalone puro) |\\n| R:R | 1.47:1 (T1) / 2.58:1 (T2) |\\n| Ventana | Earnings Jun 9 + 10 días |\\n| Nota | Considerar entrada escalonada: 60% ahora, 40% post-earnings si confirma |\\n\\n**POR QUÉ ES ANTICIPATORIO:**\\nEl mercado aún no ha digerido este cluster porque: (1) Enviri es una empresa recién nacida como standalone y la mayoría de inversores no la conocen, (2) el primer earnings mañana revelará la estructura real del negocio que los insiders ya conocen, y (3) la caída de -11.47% en 5 días creó selling pressure mecánico (venta de holders del viejo entity) que los insiders aprovecharon. Estamos entrando antes de que el mercado descubra el perfil real de esta nueva empresa.\\n\\n**CONDICIONES DE INVALIDACIÓN:**\\n- Earnings mañana revela deterioro significativo de ingresos o deuda excesiva post-reestructuración\\n- Anuncio de dilución o shelf registration\\n- Cualquier insider vende dentro de 30 días\\n- Viralización en redes sociales antes de entrada\\n- Break por debajo de $16.80 en volumen alto\\n\\n---\\n\\n*Fin del reporte — NVRI*\",\"score\":74,\"grade\":\"A\",\"summary\":\"CEO, CFO y Director compran $1.4M tras reestructuración como standalone, primer earnings mañana, señal con silencio total.\",\"raw_en\":\"## NVRI\\n\\n**Generated:** 2026-06-08T21:30:34.964Z UTC | **SCORE: 74/100** | **GRADE: A**\\n\\n> CEO, CFO, and Director purchase $1.4M cluster following restructuring as standalone company, with earnings tomorrow.\\n\\n---\\n\\n| Field | Value |\\n|---|---|\\n| Tier | 1 (≥$200M) — Market Cap $1.544B |\\n| Fear & Greed | N/A |\\n| Regime | Normal |\\n\\n---\\n\\n### STEP A — DISCARD VERIFICATION\\n\\n- [x] 10b5-1? Not indicated — PASS\\n- [x] Market cap <$50M? No ($1.544B) — PASS\\n- [x] Market cap >$2B? No ($1.544B) — PASS\\n- [x] Shelf registration >20%? No dilution filings — PASS\\n- [x] Cash runway <6m with no revenue? Industrial company with revenue — PASS\\n- [x] Going concern? Not indicated, $1.5B waste management company — PASS\\n- [x] Fraud/SEC investigation? Not indicated — PASS\\n- [x] Active class action? Not indicated — PASS\\n- [x] Social viralized? No data = silence — PASS\\n- [x] State 3 priced-in? Price only +0.78% since filing — PASS\\n- [x] Options divergence? No data — PASS\\n\\n**All rules pass. Continue scoring.**\\n\\n---\\n\\n### PILLAR 1: INSIDER CONVICTION (41/45)\\n\\n| Field | Value |\\n|---|---|\\n| Principal Insider | Hochman Russell C. (President & CEO) |\\n| CEO Amount | $1,001K — 51,519 shares @ $19.43 |\\n| Insider #2 | Minan Peter Francis (EVP & CFO) |\\n| CFO Amount | $160K — 8,333 shares @ $19.25 |\\n| Insider #3 | Purvis Edgar M Jr (Director) |\\n| Director Amount | $253K — 14,000 shares @ $18.10 |\\n| **Total Cluster** | **$1,414,824** |\\n| Purchase/MktCap Ratio | 0.092% (range 0.05-0.15%) |\\n| ΔOwn CEO | +55.4% (from ~92,991 to 144,510) |\\n| ΔOwn CFO | +102.9% (from ~8,101 to 16,434) — doubled position |\\n| ΔOwn Director | +41.2% (from ~33,975 to 47,975) |\\n| Cluster | 2 C-level (CEO+CFO) + 1 Director within 2 days |\\n| 10b5-1 | No |\\n| First CEO purchase | **First open market purchase in history** |\\n| First CFO purchase | Accumulator (2 purchases in 12m, net buy ratio 1.0) |\\n| Purchase/salary ratio | ~20-33% estimated (no DEF 14A, CEO $1M purchase) |\\n\\n**Point Breakdown:**\\n\\n| Component | Pts |\\n|---|---|\\n| CEO/CFO purchase | +10 |\\n| Purchase/MktCap Ratio 0.05-0.15% | +5 |\\n| ΔOwn ≥20% (all) | +5 |\\n| First CEO purchase in 2+ years | +5 |\\n| No 10b5-1 | +3 |\\n| 2 C-level cluster ≤7 days | +10 |\\n| Purchase/salary ratio ~20%+ (est.) | +3 |\\n| **Subtotal** | **41** |\\n\\n**Critical context:** The CEO had 10 dispositions on June 1 — all coinciding with the corporate restructuring (launch as standalone company following the Clean Earth sale). The disposition of 272,654 shares at $0 is clearly a restructuring adjustment, not an open market sale. **Two days later, he puts $1M of his own money into the new entity.** That is pure conviction.\\n\\nThe CFO is a confirmed accumulator (net buy ratio 1.0) and just doubled his position.\\n\\n---\\n\\n### PILLAR 2: CATALYST (13/25)\\n\\n| Field | Value |\\n|---|---|\\n| Primary Type | Earnings — **first report as standalone company** |\\n| Date | **2026-06-09 (TOMORROW, 1 day)** |\\n| Binary | No (earnings), but high informational impact |\\n| Secondary Type | Standalone company launch (June 1) |\\n| Source | FMP press release: \\\"New Enviri Launches as Standalone Public Company\\\" |\\n| Sector | Industrials/Waste Management — not priority |\\n\\n| Component | Pts |\\n|---|---|\\n| Earnings ≤30 days (non-binary) | +6 |\\n| Corporate catalyst (restructuring/standalone launch) | +5 |\\n| Non-priority sector | +2 |\\n| **Subtotal** | **13** |\\n\\n**Note:** This is not an ordinary earnings report. It is the **first financial report** from Enviri as a standalone entity post-Clean Earth sale. The market will see for the first time the revenue structure, margins, and debt of the new company. Insiders buying 1-5 days before disclosing these numbers have visibility the market does not.\\n\\n---\\n\\n### PILLAR 3: TIMING (20/20)\\n\\n| Field | Value |\\n|---|---|\\n| Priced-In State | **State 1 (Not Priced-In)** — post-filing move +0.78% |\\n| Prior 5d Move | **-11.47%** (significant decline) |\\n| Prior 1m Move | -6.93% |\\n| Price vs 50d MA | -3.66% (below) |\\n| Price vs 200d MA | +13.57% |\\n| Social | **Total silence** (no data = no mentions) |\\n| 7d Mentions | 0 detected |\\n| Large Accounts | None |\\n\\n| Component | Pts |\\n|---|---|\\n| State 1 Not Priced-In | +10 |\\n| Post-crash (decline -11.47% in 5 days) | +5 |\\n| Total social silence | +5 |\\n| **Subtotal** | **20** |\\n\\n**Context:** The stock fell -11.47% in 5 days, likely due to mechanical selling by holders of the old entity who do not want the new company. Insiders bought into this weakness. Nobody on social media is talking about this cluster.\\n\\n---\\n\\n### OPTIONS BONUS (0/10)\\n\\n| Field | Value |\\n|---|---|\\n| Chain | No data available |\\n| Pre-filing flow | Not available |\\n| Divergence | Not detected |\\n\\n---\\n\\n### DUE DILIGENCE\\n\\n| Field | Value |\\n|---|---|\\n| Dilution | **Clean** — No dilution filings |\\n| Cash | Positive revenue (waste management), no granular data |\\n| Management | CEO first historical purchase = strong signal; Jun 1 dispositions clearly restructuring |\\n| Litigation | No data — not detected |\\n| EPS | -$2.05 (negative), likely transitional due to restructuring costs |\\n| Audit | No going concern data |\\n\\n**Yellow flags:**\\n1. Negative EPS — mitigated by restructuring context\\n2. Lack of detailed financial data — newly standalone company\\n3. No analyst coverage — new company, re-rating opportunity\\n\\n---\\n\\n### ADJUSTMENTS\\n\\n| Adjustment | Points |\\n|---|---|\\n| Fear & Greed (N/A) | 0 pts |\\n| Social (silence) | 0 pts |\\n| Priced-In (State 1) | 0 pts |\\n\\n**ADJUSTED SCORE: 74/100**\\n\\n---\\n\\n## DECISION\\n\\n---\\n\\n**CLASSIFICATION: VALID ENTRY (A)**\\n\\n| Field | Value |\\n|---|---|\\n| Vehicle | Shares |\\n| Position size | 10% of active capital |\\n| Entry | $18.67 (current price) |\\n| Stop loss | $16.80 (-10%, below Director purchase at $18.10) |\\n| Target 1 | $21.42 (52-week high) |\\n| Target 2 | $23.50 (re-rating as pure standalone) |\\n| R:R | 1.47:1 (T1) / 2.58:1 (T2) |\\n| Window | Earnings Jun 9 + 10 days |\\n| Note | Consider scaled entry: 60% now, 40% post-earnings if confirmed |\\n\\n**WHY IT IS ANTICIPATORY:**\\nThe market has not yet digested this cluster because: (1) Enviri is a newly born standalone company and most investors do not know it, (2) tomorrow's first earnings will reveal the real business structure that insiders already know, and (3) the -11.47% decline in 5 days created mechanical selling pressure (selling by old entity holders) that insiders took advantage of. We are entering before the market discovers the real profile of this new company.\\n\\n**INVALIDATION CONDITIONS:**\\n- Tomorrow's earnings reveals significant revenue deterioration or excessive post-restructuring debt\\n- Announcement of dilution or shelf registration\\n- Any insider sells within 30 days\\n- Social media viralization before entry\\n- Break below $16.80 on high volume\\n\\n---\\n\\n*End of report — NVRI*\",\"raw_es\":null}","2026-06-08T21:33:31.557Z","2026-10-14 21:31:24",{"_12":53,"_14":54,"_16":37,"_18":55,"_20":56,"_22":57,"_24":-5,"_25":-5,"_26":51,"_28":29,"_30":31,"_32":58},"RLMD","RELMADA THERAPEUTICS, INC.",426902300,4.07,-6.43678,"2026-10-01 17:30:22",{"_12":60,"_14":61,"_16":37,"_18":62,"_20":63,"_22":64,"_24":-5,"_25":-5,"_26":51,"_28":29,"_30":31,"_32":65},"HELP","Helus Pharma Inc.",738230631,11.91,-6.66144,"2026-10-02 01:00:21",{"_12":67,"_14":68,"_16":69,"_18":70,"_20":71,"_22":72,"_24":73,"_25":74,"_26":75,"_28":29,"_30":-5,"_32":-5},"REI","Ring Energy, Inc.","Energy",233102464,1.12,-14.50382,"{\"raw\":\"## REI\\n\\n**Generado:** 2026-06-16T22:00:35.509Z UTC | **SCORE: 66/100** | **GRADO: B**\\n\\n> Cluster CEO+CFO comprando víspera de earnings con stock en caída -23% vs 50dMA; señal fuerte pero dilución reciente cap en Watchlist.\\n\\n---\\n\\n| Campo | Valor |\\n|---|---|\\n| Tier | 1 (≥$200M) — mkt cap $233M |\\n| Fear & Greed | N/D (HY spread 2.66 = ambiente crédito normal) |\\n| Régimen | Normal |\\n\\n---\\n\\n## PASO A — DESCARTE AUTOMÁTICO\\n\\n- [x] ¿10b5-1? → No indicado. PASA\\n- [x] ¿Market cap <$50M? → $233M. PASA\\n- [x] ¿Market cap >$2B? → No. PASA\\n- [x] ¿Shelf registration >20% mkt cap? → Tier 1, no aplica directamente. PASA\\n- [x] ¿Cash runway <6 meses sin revenue? → Revenue positivo $73.7M. PASA\\n- [x] ¿Going concern? → Sin evidencia. PASA\\n- [x] ¿Fraude CEO/CFO? → Sin evidencia. PASA\\n- [x] ¿Class action activa? → Sin evidencia. PASA\\n- [x] ¿Social viralizado? → Sin data social, silencio aparente. PASA\\n- [x] ¿State 3 priced-in? → Stock en caída, RSI 33.8. No aplica. PASA\\n- [x] ¿Divergencia opciones? → Sin data de opciones. PASA\\n\\n**Resultado: NINGÚN descarte automático. Procedo al scoring.**\\n\\n---\\n\\n### PILAR 1: INSIDER CONVICTION (38/45)\\n\\n| Campo | Valor |\\n|---|---|\\n| Insider 1 | Johl Sundip Singh (EVP, CFO) |\\n| Monto 1 | $278,840 — 231,000 acciones @ $1.2071 |\\n| ΔOwn CFO | 72.8% (317,460 → 548,460) |\\n| Insider 2 | McKinney Paul D. (CEO & Chairman) |\\n| Monto 2 | $59,500 — 50,000 acciones @ $1.19 |\\n| ΔOwn CEO | 1.2% (marginal sobre 4.1M acciones) |\\n| Cluster | 2 C-level, mismo día (15-Jun-2026) |\\n| Ratio Purchase/MktCap | 0.145% ($338K / $233M) |\\n| 10b5-1 | No |\\n| Primera compra CFO | Primera compra open market registrada (+5) |\\n| Ratio compra/salario CEO | 2.2% ($59.5K / $2.7M comp) — sin convicción salarial |\\n\\n**Desglose:**\\n\\n| Concepto | Puntos |\\n|---|---|\\n| CEO/CFO comprando | +10 |\\n| 2 C-level cluster ≤7 días | +10 |\\n| Ratio Purchase/MktCap (0.145%) | +5 |\\n| ΔOwn ≥20% (CFO 72.8%) | +5 |\\n| Primera compra OM del CFO | +5 |\\n| Sin 10b5-1 confirmado | +3 |\\n| Cluster >0.30% mkt cap | +0 (0.145%) |\\n| Ratio compra/salario >20% | +0 |\\n| **Subtotal P1** | **38/45** |\\n\\n**Nota crítica sobre el CEO:** McKinney tiene netBuyRatio de 0.56 en 12m. Vendió ~$525K (probablemente tax sales sobre vesting de grants en Feb-2026: recibió 1.5M acciones en grants y vendió ~419K). Su compra de $60K es modesta vs su holding de 4.1M acciones. La verdadera convicción aquí viene del **CFO**, quien invirtió $279K para aumentar su posición un 73% en lo que es su primera compra open market.\\n\\n---\\n\\n### PILAR 2: CATALIZADOR (8/25)\\n\\n| Campo | Valor |\\n|---|---|\\n| Tipo | Earnings Q2 2026 |\\n| Fecha | 2026-06-17 (MAÑANA — 1 día) |\\n| Binario | No (framework: earnings = no binario) |\\n| Proximidad | ≤30 días (+6) |\\n| Sector | Energy — O&G E&P (+2) |\\n| Catalizador nicho | No verificable sin Perplexity data |\\n\\n**Desglose:**\\n\\n| Concepto | Puntos |\\n|---|---|\\n| No binario ≤30 días (earnings) | +6 |\\n| Sector (otro) | +2 |\\n| **Subtotal P2** | **8/25** |\\n\\n**Contexto clave:** CEO y CFO compraron acciones en open market **el día anterior al reporte de earnings**. Esta es una señal de timing extremadamente fuerte que sugiere confianza en los resultados. El Q1 2026 (reportado 6-May) mostró revenue de $73.7M con operating income de $20.3M (margen 27.5%) y crecimiento QoQ de +10.15%. Si Q2 mantiene la tendencia, podría ser catalizador de reversión.\\n\\n---\\n\\n### PILAR 3: TIMING (20/20)\\n\\n| Campo | Valor |\\n|---|---|\\n| Priced-In State | 1 (Not Priced-In) |\\n| Move previo 10d | -14.5% (5d), -17.6% (1m) |\\n| Precio vs 50dMA | -22.8% |\\n| Precio vs 200dMA | -5.9% |\\n| RSI | 33.8 (oversold) |\\n| 52-week range | $0.72 - $2.00 (actual $1.12 = percentil 29) |\\n| Social | Silencio total (sin data disponible) |\\n| Menciones 7d | 0 confirmadas |\\n| Cuentas grandes | Ninguna |\\n| SA coverage | Sin quant rating, sin analyst coverage |\\n\\n**Desglose:**\\n\\n| Concepto | Puntos |\\n|---|---|\\n| State 1 (Not Priced-In) | +10 |\\n| Post-crash (-44% de 52w high, RSI 33.8) | +5 |\\n| Silencio social total | +5 |\\n| **Subtotal P3** | **20/20** |\\n\\n**El timing es excelente.** Stock severamente castigado tras la oferta pública de mayo, sin cobertura de analistas en SA, sin ruido social. Insiders comprando en completo silencio informativo. El precio de compra de los insiders ($1.19-$1.21) está por encima del precio actual ($1.12), lo cual sugiere que el stock cayó más después de su compra.\\n\\n---\\n\\n### BONUS OPCIONES (0/10)\\n\\n| Campo | Valor |\\n|---|---|\\n| Cadena | Sin data de opciones disponible |\\n| Flow pre-filing | No verificable |\\n| Divergencia | No verificable |\\n\\n---\\n\\n### DUE DILIGENCE\\n\\n| Campo | Valor |\\n|---|---|\\n| Dilución | ⚠️ **ALERTA** — Oferta pública de acciones completada 12-May-2026. Dilución reciente. Sin shelf filing adicional detectado. hasDilutionRisk: false |\\n| Cash | ⚠️ **ALERTA** — $1M cash, current ratio 0.40. Pero revenue positivo ($73.7M/Q), operating income $20.3M. La oferta de mayo probablemente mejoró la liquidez post-Q1 |\\n| Deuda | $428M total debt, D/E 0.69 — manejable para O&G pero significativo |\\n| FCF | ⚠️ Negativo: -$9.4M. Empresa invirtiendo más de lo que genera en free cash |\\n| Revenue | $73.7M Q0, +10.15% QoQ pero -10.81% YoY |\\n| Operating margin | 27.5% — saludable |\\n| Management | CEO mixed buyer/seller (net 0.56, pero ventas probablemente fiscales sobre vesting). CFO clean accumulator (net ratio 1.0) |\\n| Litigios | Sin evidencia de litigios activos |\\n| Analyst consensus | Buy, target $2.50 (123% upside vs $1.12) |\\n\\n**Banderas rojas parcialmente resueltas:**\\n1. La dilución de mayo explica la caída del precio y los insiders están comprando *después* de la dilución\\n2. El current ratio de 0.40 es preocupante pero la oferta de mayo probablemente aportó liquidez\\n3. El CEO vendió, pero las ventas coinciden con vesting de grants (fiscal, no bearish)\\n4. FCF negativo es normal en fase de inversión/CAPEX para O&G\\n\\n**Veredicto DD:** Banderas amarillas, no rojas. No aplico cap duro en B por DD, pero sí precaución.\\n\\n---\\n\\n### AJUSTES\\n\\n| Ajuste | Puntos |\\n|---|---|\\n| Fear & Greed (N/D) | +0 |\\n| Social (silencio, ya contado en P3) | +0 |\\n| Priced-In (State 1, ya contado en P3) | +0 |\\n\\n---\\n\\n### SCORE FINAL\\n\\n| Pilar | Puntos |\\n|---|---|\\n| P1: Insider Conviction | 38/45 |\\n| P2: Catalizador | 8/25 |\\n| P3: Timing | 20/20 |\\n| Bonus Opciones | 0/10 |\\n| Ajustes | 0 |\\n| **TOTAL** | **66/100** |\\n\\n---\\n\\n## DECISION\\n\\n---\\n\\n**CLASIFICACIÓN: WATCHLIST (B)**\\n\\nEl score de 66 queda 2 puntos por debajo del umbral A (68). La señal insider es fuerte (CFO haciendo su primera compra OM por $279K, +73% de su posición, acompañado por el CEO), el timing es excelente (stock oversold, silencio total, State 1), pero el pilar de catalizadores no logra sumar suficientes puntos y las banderas de dilución reciente + balance sheet ajustado limitan la convicción.\\n\\n**WATCHLIST.** Monitorear:\\n\\n1. **Earnings mañana (17-Jun-2026):** Si los resultados muestran revenue creciente, FCF positivo, y guidance sólido → la señal escala a **Grado A inmediato**. El CEO y CFO compraron la víspera; si los resultados son buenos, esto valida la tesis.\\n\\n2. **Price action post-earnings:** Si el stock rebota y se sostiene sobre $1.20 (zona de compra insider), confirma soporte. Si cae por debajo de $1.00, la tesis se debilita.\\n\\n3. **Nuevos insiders:** Si algún director o VP adicional compra en los próximos 3-5 días, el cluster se fortalece de 2 a 3+ C-level → upgrade automático.\\n\\n4. **Actualización de balance sheet:** Verificar si la oferta de mayo mejoró el current ratio y la posición de caja.\\n\\n5. **Condiciones de invalidación:** Nuevo shelf/ATM filing, CEO vende post-earnings, going concern en el 10-Q, o viralización social del ticker.\\n\\n**Por qué es anticipatorio (si escala a A):** Dos C-level compraron en open market el día antes de earnings, en completo silencio mediático, con el stock -23% debajo de su media de 50 días y RSI en 33.8. Sin cobertura de SA, sin social buzz, sin analistas mirando. Si earnings confirman, el mercado recién empezará a prestar atención.\\n\\n---\",\"score\":66,\"grade\":\"B\",\"summary\":\"CEO y CFO compran $338K víspera de earnings con stock oversold -23% vs 50dMA; señal fuerte pero dilución reciente cap en Watchlist\",\"raw_en\":\"## REI\\n\\n**Generated:** 2026-06-16T22:00:35.509Z UTC | **SCORE: 66/100** | **GRADE: B**\\n\\n> CEO+CFO cluster buying on the eve of earnings with stock down -23% vs 50dMA; strong signal but recent dilution caps it at Watchlist.\\n\\n---\\n\\n| Field | Value |\\n|---|---|\\n| Tier | 1 (≥$200M) — mkt cap $233M |\\n| Fear & Greed | N/A (HY spread 2.66 = normal credit environment) |\\n| Regime | Normal |\\n\\n---\\n\\n## STEP A — AUTOMATIC DISCARD\\n\\n- [x] 10b5-1? → Not indicated. PASS\\n- [x] Market cap <$50M? → $233M. PASS\\n- [x] Market cap >$2B? → No. PASS\\n- [x] Shelf registration >20% mkt cap? → Tier 1, not directly applicable. PASS\\n- [x] Cash runway <6 months with no revenue? → Positive revenue $73.7M. PASS\\n- [x] Going concern? → No evidence. PASS\\n- [x] CEO/CFO fraud? → No evidence. PASS\\n- [x] Active class action? → No evidence. PASS\\n- [x] Viral social activity? → No social data, apparent silence. PASS\\n- [x] State 3 priced-in? → Stock declining, RSI 33.8. Not applicable. PASS\\n- [x] Options divergence? → No options data. PASS\\n\\n**Result: NO automatic discards. Proceeding to scoring.**\\n\\n---\\n\\n### PILLAR 1: INSIDER CONVICTION (38/45)\\n\\n| Field | Value |\\n|---|---|\\n| Insider 1 | Johl Sundip Singh (EVP, CFO) |\\n| Amount 1 | $278,840 — 231,000 shares @ $1.2071 |\\n| ΔOwn CFO | 72.8% (317,460 → 548,460) |\\n| Insider 2 | McKinney Paul D. (CEO & Chairman) |\\n| Amount 2 | $59,500 — 50,000 shares @ $1.19 |\\n| ΔOwn CEO | 1.2% (marginal on 4.1M shares) |\\n| Cluster | 2 C-level, same day (Jun-15-2026) |\\n| Purchase/MktCap Ratio | 0.145% ($338K / $233M) |\\n| 10b5-1 | No |\\n| First CFO purchase | First registered open market purchase (+5) |\\n| Purchase/salary ratio CEO | 2.2% ($59.5K / $2.7M comp) — no salary conviction |\\n\\n**Breakdown:**\\n\\n| Concept | Points |\\n|---|---|\\n| CEO/CFO buying | +10 |\\n| 2 C-level cluster ≤7 days | +10 |\\n| Purchase/MktCap Ratio (0.145%) | +5 |\\n| ΔOwn ≥20% (CFO 72.8%) | +5 |\\n| First OM purchase by CFO | +5 |\\n| No 10b5-1 confirmed | +3 |\\n| Cluster >0.30% mkt cap | +0 (0.145%) |\\n| Purchase/salary ratio >20% | +0 |\\n| **P1 Subtotal** | **38/45** |\\n\\n**Critical note on the CEO:** McKinney has a netBuyRatio of 0.56 over 12m. He sold ~$525K (likely tax sales on grant vesting in Feb-2026: received 1.5M shares in grants and sold ~419K). His $60K purchase is modest vs his 4.1M share holding. The real conviction here comes from the **CFO**, who invested $279K to increase his position by 73% in what is his first open market purchase.\\n\\n---\\n\\n### PILLAR 2: CATALYST (8/25)\\n\\n| Field | Value |\\n|---|---|\\n| Type | Q2 2026 Earnings |\\n| Date | 2026-06-17 (TOMORROW — 1 day) |\\n| Binary | No (framework: earnings = non-binary) |\\n| Proximity | ≤30 days (+6) |\\n| Sector | Energy — O&G E&P (+2) |\\n| Niche catalyst | Not verifiable without Perplexity data |\\n\\n**Breakdown:**\\n\\n| Concept | Points |\\n|---|---|\\n| Non-binary ≤30 days (earnings) | +6 |\\n| Sector (other) | +2 |\\n| **P2 Subtotal** | **8/25** |\\n\\n**Key context:** CEO and CFO purchased shares in the open market **the day before the earnings report**. This is an extremely strong timing signal suggesting confidence in the results. Q1 2026 (reported May-6) showed revenue of $73.7M with operating income of $20.3M (27.5% margin) and QoQ growth of +10.15%. If Q2 maintains the trend, it could be a reversal catalyst.\\n\\n---\\n\\n### PILLAR 3: TIMING (20/20)\\n\\n| Field | Value |\\n|---|---|\\n| Priced-In State | 1 (Not Priced-In) |\\n| Prior 10d move | -14.5% (5d), -17.6% (1m) |\\n| Price vs 50dMA | -22.8% |\\n| Price vs 200dMA | -5.9% |\\n| RSI | 33.8 (oversold) |\\n| 52-week range | $0.72 - $2.00 (current $1.12 = 29th percentile) |\\n| Social | Total silence (no data available) |\\n| 7d mentions | 0 confirmed |\\n| Large accounts | None |\\n| SA coverage | No quant rating, no analyst coverage |\\n\\n**Breakdown:**\\n\\n| Concept | Points |\\n|---|---|\\n| State 1 (Not Priced-In) | +10 |\\n| Post-crash (-44% from 52w high, RSI 33.8) | +5 |\\n| Total social silence | +5 |\\n| **P3 Subtotal** | **20/20** |\\n\\n**Timing is excellent.** Stock severely punished following the May public offering, no analyst coverage on SA, no social noise. Insiders buying in complete informational silence. Insider purchase price ($1.19-$1.21) is above the current price ($1.12), suggesting the stock fell further after their purchase.\\n\\n---\\n\\n### OPTIONS BONUS (0/10)\\n\\n| Field | Value |\\n|---|---|\\n| Chain | No options data available |\\n| Pre-filing flow | Not verifiable |\\n| Divergence | Not verifiable |\\n\\n---\\n\\n### DUE DILIGENCE\\n\\n| Field | Value |\\n|---|---|\\n| Dilution | ⚠️ **ALERT** — Public share offering completed May-12-2026. Recent dilution. No additional shelf filing detected. hasDilutionRisk: false |\\n| Cash | ⚠️ **ALERT** — $1M cash, current ratio 0.40. But positive revenue ($73.7M/Q), operating income $20.3M. May offering likely improved post-Q1 liquidity |\\n| Debt | $428M total debt, D/E 0.69 — manageable for O&G but significant |\\n| FCF | ⚠️ Negative: -$9.4M. Company investing more than it generates in free cash |\\n| Revenue | $73.7M Q0, +10.15% QoQ but -10.81% YoY |\\n| Operating margin | 27.5% — healthy |\\n| Management | CEO mixed buyer/seller (net 0.56, but sales likely fiscal on vesting). CFO clean accumulator (net ratio 1.0) |\\n| Litigation | No evidence of active litigation |\\n| Analyst consensus | Buy, target $2.50 (123% upside vs $1.12) |\\n\\n**Partially resolved red flags:**\\n1. The May dilution explains the price decline and insiders are buying *after* the dilution\\n2. The current ratio of 0.40 is concerning but the May offering likely provided liquidity\\n3. The CEO sold, but sales coincide with grant vesting (fiscal, not bearish)\\n4. Negative FCF is normal during investment/CAPEX phase for O&G\\n\\n**DD Verdict:** Yellow flags, not red. No hard cap applied at B for DD, but caution warranted.\\n\\n---\\n\\n### ADJUSTMENTS\\n\\n| Adjustment | Points |\\n|---|---|\\n| Fear & Greed (N/A) | +0 |\\n| Social (silence, already counted in P3) | +0 |\\n| Priced-In (State 1, already counted in P3) | +0 |\\n\\n---\\n\\n### FINAL SCORE\\n\\n| Pillar | Points |\\n|---|---|\\n| P1: Insider Conviction | 38/45 |\\n| P2: Catalyst | 8/25 |\\n| P3: Timing | 20/20 |\\n| Options Bonus | 0/10 |\\n| Adjustments | 0 |\\n| **TOTAL** | **66/100** |\\n\\n---\\n\\n## DECISION\\n\\n---\\n\\n**CLASSIFICATION: WATCHLIST (B)**\\n\\nThe score of 66 falls 2 points below the A threshold (68). The insider signal is strong (CFO making his first OM purchase for $279K, +73% of his position, accompanied by the CEO), timing is excellent (oversold stock, total silence, State 1), but the catalyst pillar fails to accumulate enough points and the recent dilution flags + tight balance sheet limit conviction.\\n\\n**WATCHLIST.** Monitor:\\n\\n1. **Earnings tomorrow (Jun-17-2026):** If results show growing revenue, positive FCF, and solid guidance → signal scales to **immediate Grade A**. CEO and CFO bought the day before; if results are good, this validates the thesis.\\n\\n2. **Post-earnings price action:** If the stock bounces and holds above $1.20 (insider purchase zone), it confirms support. If it falls below $1.00, the thesis weakens.\\n\\n3. **New insiders:** If any additional director or VP buys in the next 3-5 days, the cluster strengthens from 2 to 3+ C-level → automatic upgrade.\\n\\n4. **Balance sheet update:** Verify whether the May offering improved the current ratio and cash position.\\n\\n5. **Invalidation conditions:** New shelf/ATM filing, CEO sells post-earnings, going concern in the 10-Q, or social viralization of the ticker.\\n\\n**Why it is anticipatory (if it scales to A):** Two C-level executives bought in the open market the day before earnings, in complete media silence, with the stock -23% below its 50-day moving average and RSI at 33.8. No SA coverage, no social buzz, no analysts watching. If earnings confirm, the market will only then begin to pay attention.\",\"raw_es\":null}","2026-06-16T22:04:37.309Z","2026-10-14 21:31:23","clusters",[78,94,100],{"_79":80,"_81":15,"_12":13,"_82":83,"_84":85,"_86":87,"_88":87,"_89":19,"_16":17,"_90":91,"_92":21,"_28":29,"_93":6},"companyCik","0002141406","companyName","distinctInsiders",2,"totalValue",3702600,"earliestDate","2026-10-01","latestDate","marketCap","industry","Electrical Equipment & Parts","currentPrice","oversized",{"_79":95,"_81":61,"_12":60,"_82":83,"_84":96,"_86":97,"_88":98,"_89":62,"_16":37,"_90":99,"_92":63,"_28":29,"_93":6},"0001833141",1385780,"2026-09-21","2026-09-29","Medical - Pharmaceuticals",{"_79":101,"_81":36,"_12":35,"_82":83,"_84":102,"_86":103,"_88":104,"_89":38,"_16":37,"_90":105,"_92":39,"_28":29,"_93":6},"0002020932",163240,"2026-10-05","2026-10-06","Biotechnology","clusterMap",{"_13":108,"_60":109,"_35":110},{"_79":80,"_81":15,"_12":13,"_82":83,"_84":85,"_86":87,"_88":87,"_89":19,"_16":17,"_90":91,"_92":21,"_28":29,"_93":6},{"_79":95,"_81":61,"_12":60,"_82":83,"_84":96,"_86":97,"_88":98,"_89":62,"_16":37,"_90":99,"_92":63,"_28":29,"_93":6},{"_79":101,"_81":36,"_12":35,"_82":83,"_84":102,"_86":103,"_88":104,"_89":38,"_16":37,"_90":105,"_92":39,"_28":29,"_93":6},[112,177],{"_12":113,"_18":114,"_115":116,"_20":117,"_118":119,"_120":121,"_122":123,"_124":125,"_126":127,"_128":129,"_130":131,"_132":133,"_134":135,"_26":136,"_16":37,"_90":137,"_138":139,"_140":141,"_142":143,"_22":29,"_144":145,"_146":147,"_148":149,"_150":151,"_152":-5,"_153":29,"_154":29,"_155":29,"_14":156,"_157":29,"_158":-5,"_159":160,"_24":161,"_162":163,"_25":164,"_165":-5,"_28":166,"_167":168,"_169":170,"_171":172,"_173":29,"_174":-5,"_175":-5,"_176":-5},"VANI",80346434,"shares_outstanding",59078260,1.36,"pe",-3.16,"eps",-0.43,"price_avg_50",1.19016,"price_avg_200",1.33777,"avg_volume",266341,"year_high",1.92,"year_low",0.923,"price_vs_50d_ma_pct",14.27035020501445,"price_vs_200d_ma_pct",1.6617206246215863,"2026-10-01 17:00:48","Medical - Devices","country","US","beta",3.367,"price_change_1d",1.49254,"price_change_1m",25.92593,"float_shares",23462955,"free_float",39.71504069348014,"analyst_consensus","Buy","analyst_target_consensus","is_adr","is_fund","is_etf","Vivani Medical, Inc.","tracking","tracking_until","dd_data","{\"recidivism\":[],\"executiveCompensation\":null,\"nextEarningsDate\":\"2026-03-18\",\"daysToEarnings\":1,\"dilutionFilings\":[],\"hasDilutionRisk\":false,\"pressReleases\":[{\"date\":\"2026-01-29 07:30:00\",\"title\":\"VIVANI SUBSIDIARY CORTIGENT PRESENTS PROMISING 6-YEAR EARLY FEASIBILITY STUDY RESULTS FOR THE ORION SYSTEM AT NANS 2026\"},{\"date\":\"2026-01-27 16:05:00\",\"title\":\"VIVANI MEDICAL, INC. ANNOUNCES CLOSING OF COMMON STOCK OFFERING\"},{\"date\":\"2026-01-25 23:36:00\",\"title\":\"VIVANI MEDICAL, INC. ANNOUNCES PRICING OF COMMON STOCK OFFERING\"},{\"date\":\"2025-11-13 07:45:00\",\"title\":\"VIVANI MEDICAL PROVIDES BUSINESS UPDATE AND REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS\"},{\"date\":\"2025-10-28 16:05:00\",\"title\":\"VIVANI MEDICAL, INC. ANNOUNCES CLOSING OF COMMON STOCK OFFERING\"}],\"priceAtFiling\":[],\"avgFilingPrice\":null,\"priceMoveSinceFiling\":null,\"financialHealth\":{\"cashAndEquivalents\":2628000,\"cashPriorQuarter\":6794000,\"totalCurrentAssets\":4175000,\"totalCurrentLiabilities\":6830000,\"totalDebt\":18293000,\"totalStockholdersEquity\":1309000,\"revenueQ0\":0,\"revenueQ1\":0,\"revenueQ4\":0,\"operatingIncomeQ0\":-6725000,\"freeCashFlow\":-7174000,\"burnRateMonthly\":1388666.67,\"cashRunwayMonths\":1.89,\"purchaseBurnRatio\":null,\"revenueGrowthQoQ\":null,\"revenueGrowthYoY\":null,\"debtToEquity\":13.97,\"currentRatio\":0.61,\"operatingMargin\":null},\"perplexityReport\":\"# Dilution Risk\\n\\n# Vivani Medical, Inc. (VANI) – Dilution Forensics Analysis\\n\\n## Executive Summary\\n\\nVivani Medical presents **significant dilution risks** across multiple vectors. The company maintains an active **$300 million shelf registration** representing **416% of current market cap** ($72M), coupled with recent equity financings and committed capital infusions. While no traditional \\\"toxic\\\" convertible notes are evident in search results, the capital structure reveals aggressive equity dilution mechanisms and substantial unfunded commitments.\\n\\n---\\n\\n## 1. Active Shelf Registration (S-3)\\n\\n**Status:** ACTIVE\\n\\n**Filing Details:**\\n- **Form S-3 File No. 333-278869**\\n- **Initial Filing Date:** April 22, 2024\\n- **Effective Date:** May 3, 2024[1][2]\\n- **Registration Amount:** $300,000,000[2]\\n\\n**Dilution Metric:**\\n- Current Market Cap: ~$72 million\\n- Shelf as % of Market Cap: **416.7%** ⚠️ **CRITICAL RED FLAG**\\n- This vastly exceeds the 20% threshold for Tier 2 risk classification\\n\\n**Recent Shelf Activity:**\\nThe company has actively drawn on this shelf. As of October 26, 2025, Vivani completed a registered offering generating approximately $9.7 million in gross proceeds under this same S-3[8]. The shelf remains available for future issuances, creating ongoing dilution risk.\\n\\n---\\n\\n## 2. Secondary Offerings (Last 18 Months)\\n\\n**Count:** Multiple offerings identified\\n\\n| Date | Type | Amount | Details |\\n|------|------|--------|---------|\\n| October 2025 | Registered Direct Offering | ~$9.7M gross | Under S-3 File No. 333-278869[8] |\\n| 2024 (unspecified) | Registered + Private Placement | ~$4.5M gross combined | At-the-market pricing under Nasdaq rules[1] |\\n| June 2021 | Registered Direct Offering | $15.0M | Under prior S-3 File No. 333-256904[5] |\\n\\n**Recent Equity Commitments (March-May 2025):**\\nAs of June 30, 2025, Vivani disclosed **two equity purchase agreements** (March 2025 and May 2025) committing an additional **$11.25 million of capital through March 2026**[10]. This represents committed but unfunded dilution.\\n\\n---\\n\\n## 3. At-The-Market (ATM) Program\\n\\n**Status:** ACTIVE (Historical Evidence)\\n\\nThe search results confirm Vivani has utilized at-the-market offerings. The January 2026 8-K filing references securities \\\"priced 'at-the-market' under the rules and regulations of The Nasdaq Stock Market LLC\\\"[1]. However, **no current active ATM program agreement is explicitly detailed in the search results provided**.\\n\\n**Assessment:** While ATM activity is documented, the specific terms, authorization amount, and current status of any formal ATM agreement are **NOT FULLY DETAILED** in available search results. This warrants direct EDGAR review of the prospectus supplement filed under S-3 333-278869.\\n\\n---\\n\\n## 4. Toxic Financing: Convertible Notes, Variable Rate Notes, Death Spirals\\n\\n**Status:** NO DATA\\n\\nThe search results contain **no evidence** of:\\n- Convertible notes outstanding\\n- Variable rate notes (death spiral financing)\\n- Equity Lines of Credit (ELOC)\\n\\n**Note:** Search result [3] provides general SEC enforcement context on \\\"toxic lenders\\\" but does not reference Vivani Medical specifically. The company's 10-K and recent 8-K filings in the search results do not disclose convertible debt instruments.\\n\\n**Recommendation:** Conduct direct EDGAR search of Vivani's most recent 10-K (filed March 31, 2025[4]) and 10-Q filings to confirm absence of convertible securities in the debt schedule.\\n\\n---\\n\\n## 5. Capital Structure & Runway Concerns\\n\\n**Cash Position (as of June 30, 2025):**\\n- Cash and equivalents: $6.8 million[10]\\n- Committed capital (through March 2026): $11.25 million[10]\\n- **Total available liquidity: ~$18.05 million**\\n\\n**Burn Rate Implications:**\\nThe company explicitly stated that the $8.25M private placement (announced in 2024) was intended to extend runway into **Q2 2026**[6]. With current date at March 17, 2026, the company is at or near the end of its disclosed runway, creating urgency for additional capital raises.\\n\\n---\\n\\n## 6. Cortigent Spin-Off Contingency\\n\\n**Material Uncertainty:**\\nVivani disclosed a planned spin-off of subsidiary Cortigent. As of March 2025, efforts to support an IPO of Cortigent ceased, with focus shifting to a Form 10 registration statement for a spin-off[9]. If Cortigent completes an IPO, Vivani would receive $1.5M repayment plus a $2M promissory note at 5% interest, with forgiveness of remaining amounts owed[9].\\n\\nThis contingency creates **uncertainty in capital structure** and potential additional dilution if the spin-off proceeds.\\n\\n---\\n\\n## 7. Insider Buying Signal Analysis\\n\\n**Search Result Limitation:** The provided search results include Form 4 filing references (beneficial ownership changes) dated through September 2025[4], but **do not provide detailed transaction data** on specific C-level insider purchases.\\n\\n**Recommendation:** Cross-reference MarketBeat SEC filings page[4] and EDGAR directly for Form 4 filings to identify:\\n- Specific insider names and titles\\n- Transaction dates and prices\\n- Share quantities purchased\\n- Whether purchases are open-market or option exercises\\n\\n---\\n\\n## 8. Risk Summary Table\\n\\n| Risk Category | Status | Severity |\\n|---------------|--------|----------|\\n| Shelf Registration ($300M @ 416% of cap) | ACTIVE | 🔴 CRITICAL |\\n| Recent Secondary Offerings | Multiple (2024-2025) | 🔴 HIGH |\\n| ATM Program | Likely Active (unconfirmed) | 🟡 MEDIUM |\\n| Convertible/Toxic Debt | NO DATA | 🟢 NONE FOUND |\\n| Committed Unfunded Capital | $11.25M (through 3/2026) | 🔴 HIGH |\\n| Cash Runway | ~Q2 2026 | 🔴 CRITICAL |\\n\\n---\\n\\n## Sources & URLs\\n\\n[1] https://investors.vivani.com/investors/news-events/press-releases/detail/211/vivani-medical-inc-announces-closing-of-common-stock\\n\\n[2] https://www.otcmarkets.com/filing/conv_pdf?id=19088780&guid=xfx-kenyprfYlhh (Form 8-K, January 25, 2026)\\n\\n[4] https://www.marketbeat.com/stocks/NASDAQ/VANI/sec-filings/\\n\\n[5] https://investors.vivani.com/investors/news-events/press-releases/detail/168/vivani-medical-announces-pricing-of-15-0-million\\n\\n[6] https://investors.vivani.com/investors/news-events/press-releases/detail/189/vivani-medical-announces-8-25m-private-placement-equity\\n\\n[8] https://www.sec.gov/Archives/edgar/data/1266806/000175392625001655/vani-20251026.htm (8-K, October 26, 2025)\\n\\n[9] https://www.sec.gov/Archives/edgar/data/1266806/000175392625000527/vani-20241231.htm (10-K, December 31, 2024)\\n\\n[10] https://www.sec.gov/Archives/edgar/data/1266806/000175392625001228/vani-20250805.htm (8-K, August 5, 2025)\\n\\n---\\n\\n## Critical Gaps Requiring Direct EDGAR Review\\n\\n1. **Prospectus Supplement Details** – Specific terms of October 2025 offering and current ATM authorization\\n2. **Form 4 Insider Transactions** – Detailed C-level buy/sell activity through current date\\n3. **10-Q (Q4 2025 / Q1 2026)** – Updated cash position and capital commitments post-March 2026\\n4. **Debt Schedule (10-K)** – Confirmation of no convertible securities or variable rate instruments\\n\\n---\\n\\n# Financial Health & Audit\\n\\n### Insider Buying Analysis\\n**Gregg Williams, Chairman of the Board (C-level equivalent), executed a bullish open-market purchase via private placement.** On January 27, 2026, he acquired 1,351,351 shares of common stock at $1.48 per share, contributing ~$2.0 million to a $4.5 million combined offering (registered direct + private placement). This at-the-market transaction signals strong insider confidence, as it was not under a 10b5-1 plan and occurred amid recent equity raises.[5][4]\\n\\nNo other C-level open-market buys identified in recent Form 4 filings; multiple Form 4s appear tied to automated sales or grants (e.g., Williams' prior activity, ignored per instructions).[1]\\n\\n### Cash Position and Runway\\nLatest reported **Cash and Cash Equivalents: $6.8 million (unaudited, as of June 30, 2025)**, excluding restricted cash, per preliminary Q2 2025 financials in 8-K filing.[4] \\n**Management's stated cash runway: Supported through March 2026**, factoring in $11.25 million committed capital from equity purchase agreements (March 2025 and May 2025). Post-January 2026 offering, additional ~$4.5 million gross proceeds (pre-fees) extend runway for R&D, clinical development, working capital.[4][5][3] \\nNO DATA on updated cash post-Q3/Q4 2025 or 2026 10-Q balances; latest 10-K filed March 31, 2025 (full year 2024), but balance sheet excerpts unavailable here.[1]\\n\\n### Auditor and Going Concern Audit\\nNO DATA on auditor identity (Big 4/Mid-tier/Unknown) or \\\"Going Concern\\\" language in latest 10-K (filed 03/31/2025) or subsequent 10-Qs (e.g., 11/13/2024 Q3).[1] \\n10-K/10-Q full texts not extracted; requires direct EDGAR access (e.g., CIK 0001266806).[2]\\n\\n### Internal Controls\\nNO DATA on reported **Material Weaknesses** in internal controls from latest 10-K/10-Q.[1][2]\\n\\n### History of Missed Deadlines\\nNO DATA on missed FDA dates, product delivery, or guidance deadlines. Filings show routine 8-Ks for offerings/preliminary results, no explicit delays noted.[1][3][4] Company focuses on NanoPortal™ GLP-1 implants for obesity/diabetes (pre-clinical/clinical stage).[5]\\n\\n**EDGAR Links for Deep Dive:** \\n- SEC Filings Overview: https://www.marketbeat.com/stocks/NASDAQ/VANI/sec-filings/[1] \\n- Latest 10-K (03/31/2025): Search CIK 0001266806 on https://www.sec.gov/edgar/searchedgar/companysearch.html \\n- Q2 2025 Prelim 8-K: https://www.sec.gov/Archives/edgar/data/1266806/000175392625001228/vani-20250805.htm[4] \\n- Jan 2026 Offering 8-K: https://www.sec.gov/Archives/edgar/data/175392625001655/0001753926-25-001655-index.html[2] \\n- Investor Site: https://investors.vivani.com/investors[7]\\n\\n---\\n\\n# Management & Litigation\\n\\n# Forensic Due Diligence: Vivani Medical, Inc. (VANI)\\n\\n## Executive Summary\\n\\nBased on available search results, **no evidence of fraud, SEC enforcement actions, or active class action lawsuits against Vivani Medical or its management team was identified**. However, significant related-party transaction activity and concentrated insider ownership present governance concerns requiring further investigation.\\n\\n---\\n\\n## Management Team Analysis\\n\\n**CEO: Dr. Adam Mendelsohn, Ph.D. (Age 42)**[1]\\n- **Tenure:** 3.6 years (appointed August 2022)\\n- **Compensation:** $1.08M annually (56.3% salary, 43.7% bonuses/equity)\\n- **Ownership:** 4.63% of company (~$4.07M)[1]\\n- **Background:** Co-founder of Vivani Medical (2009); previously CEO and Chairman of Nano Precision Medical since 2011[4]\\n\\n**CFO: Anthony Baldor**[1]\\n- **Tenure:** Less than one year\\n- **Compensation:** No data available\\n- **Ownership:** No data available\\n- **Note:** Recent appointment suggests potential transition or expansion\\n\\n**Other C-Level:**\\n- **COO Truc Le:** 3.5 years tenure, $862.6K compensation, 0.058% ownership[1]\\n- **CMO Dr. Lisa Porter:** 4.2 years tenure, $678.2K compensation, 0.031% ownership[1]\\n\\n---\\n\\n## Insider Buying Activity Analysis\\n\\n### Gregg Williams (Chairman & 10% Owner) - Primary Bullish Signal\\n\\n**Transaction Summary:**[2][3][9]\\n- **Total purchases:** 10 transactions acquiring 3,821,882 shares\\n- **Estimated investment:** ~$4.4M\\n- **Most recent transaction:** March 15, 2026 (Form 4 filed)[2]\\n\\n**Specific Recent Transactions:**\\n1. **January 25, 2026:** Share Purchase Agreement with Gregg G Williams 2006 Irrevocable Trust for 1,351,351 shares[3]\\n2. **May 12, 2025:** Private sale of 1,310,680 shares at $1.03/share ($1.35M)[2]\\n3. **August 11, 2025:** Private sale of 264,551 shares at $1.26/share ($333.3K)[2]\\n\\n**Current Ownership:** 41.79% of company (~$36.7M)[1]\\n\\n**Governance Concern:** Williams holds dual roles as Independent Chairman and 10% owner, with significant recent capital deployment. All purchases appear to be private placements at negotiated prices rather than open-market transactions.\\n\\n---\\n\\n## Related Party Transactions\\n\\n### Material Definitive Agreements\\n\\n**January 25, 2026 Private Placement:**[3]\\n- **Counterparty:** Gregg G Williams 2006 Irrevocable Trust (entity affiliated with Chairman Williams)\\n- **Transaction:** 1,351,351 shares of common stock\\n- **Structure:** Concurrent with registered direct offering\\n- **Disclosure:** Filed as Item 1.01 (Material Definitive Agreement) in 8-K filing\\n\\n**Assessment:** This represents a significant related-party transaction where the company's Chairman purchased shares directly from the company through a private placement concurrent with a public offering. The use of a trust entity (rather than personal purchase) warrants scrutiny regarding beneficial ownership disclosure.\\n\\n**No other related-party transactions identified in search results.**\\n\\n---\\n\\n## Fraud & SEC Enforcement Search Results\\n\\n### Adam Mendelsohn (CEO)\\n- **Search for \\\"Adam Mendelsohn fraud\\\":** NO DATA\\n- **Search for \\\"Adam Mendelsohn SEC\\\":** NO DATA\\n- **Search for \\\"Adam Mendelsohn lawsuit\\\":** NO DATA\\n\\n### Gregg Williams (Chairman)\\n- **Search for \\\"Gregg Williams fraud\\\":** NO DATA\\n- **Search for \\\"Gregg Williams SEC\\\":** NO DATA\\n- **Search for \\\"Gregg Williams lawsuit\\\":** NO DATA\\n\\n### Company-Level Searches\\n- **\\\"Vivani Medical SEC lawsuit\\\":** NO DATA\\n- **\\\"Vivani Medical fraud\\\":** NO DATA\\n- **\\\"Vivani Medical class action\\\":** NO DATA\\n\\n**Note:** Search results include SEC proxy filings (DEF 14A)[5] and Form 4 insider trading disclosures[6][11], indicating active SEC compliance. No enforcement actions or investigations identified.\\n\\n---\\n\\n## Bankruptcy & Sanctioned Entity Connections\\n\\n### Nano Precision Medical (NPM) - Predecessor Entity\\n\\n**Connection:** Dr. Adam Mendelsohn served as Co-Founder, Chairman, and CEO of Nano Precision Medical since 2011[4]\\n\\n**Transaction:** Nano Precision Medical merged with Second Sight Medical Products in 2022 to form Vivani Medical[12]\\n\\n**Status:** NO BANKRUPTCY identified for NPM or Second Sight\\n\\n**Strategic Investor:** AstraZeneca has been a strategic investor in NPM since 2016[12]\\n\\n**Assessment:** The merger created Vivani Medical with legitimate pharmaceutical backing. No evidence of financial distress or sanctions on predecessor entities.\\n\\n---\\n\\n## Governance Red Flags & Concerns\\n\\n| Issue | Assessment | Risk Level |\\n|-------|-----------|-----------|\\n| **Concentrated Ownership** | Gregg Williams (41.79%) + Adam Mendelsohn (4.63%) = 46.42% combined control[1] | MEDIUM |\\n| **Related-Party Capital Raises** | Chairman purchasing 1.35M shares via private placement concurrent with public offering (Jan 2026)[3] | MEDIUM |\\n| **New CFO** | Anthony Baldor appointed less than one year ago with no compensation/ownership data disclosed[1] | LOW-MEDIUM |\\n| **Board Tenure** | Average board tenure 3.6 years; most directors appointed at August 2022 merger[1] | LOW |\\n| **Compensation Recovery Policy** | Adopted August 11, 2023, indicating clawback provisions in place[5] | POSITIVE |\\n\\n---\\n\\n## Compensation Recovery Policy\\n\\nVivani Medical adopted a **Compensation Recovery Policy effective August 11, 2023**, in compliance with SEC regulations[5]. This policy provides mechanisms to recover executive compensation in cases of financial restatement or misconduct, representing a governance safeguard.\\n\\n---\\n\\n## Summary of Findings\\n\\n**No Evidence of:**\\n- Fraud by management\\n- SEC enforcement actions or investigations\\n- Active class action lawsuits\\n- Bankruptcy of predecessor entities\\n- Criminal convictions of insiders\\n\\n**Governance Concerns Identified:**\\n1. **Concentrated ownership** with Chairman holding 41.79% and CEO holding 4.63%\\n2. **Related-party transaction** involving Chairman's trust purchasing shares in January 2026 private placement\\n3. **Recent CFO transition** with limited disclosure on new hire\\n4. **Insider buying pattern** by Chairman suggests confidence but warrants monitoring for potential conflicts of interest\\n\\n**Recommendation:** While no red flags for fraud or enforcement actions exist, the concentrated ownership structure and related-party transaction activity warrant enhanced monitoring of future capital raises and related-party dealings. Request detailed disclosure on Anthony Baldor's background and compensation terms.\\n\\n---\\n\\n# Patents & IP\\n\\n**Vivani Medical, Inc. (VANI) IP Forensic Due Diligence**\\n\\nVivani Medical, formerly Nano Precision Medical Inc., develops the **NanoPortal** platform for miniature, long-acting implantable drug delivery devices, primarily targeting GLP-1 agonists like semaglutide (NPM-139) and exenatide (NPM-115) for obesity and type 2 diabetes, alongside subsidiary Cortigent's neurostimulation implants (e.g., Orion cortical prosthesis).[1][2][3][4][7] The company's patent estate centers on nanoporous membranes enabling controlled, zero-order release of therapeutics, with applications in pharmaceuticals (86 publications) and medical technology (260 publications).[2] No C-level insider open-market buys are referenced in available data; focus remains on IP per query directive.\\n\\n### Key Patents Currently in Force and Expiration Timelines\\nNO DATA. Search results list recent **published US patent applications** (not granted patents) filed by predecessor Nano Precision Medical Inc., with no explicit confirmation of granted status, issuance dates, or expiration timelines (typically 20 years from filing). Key applications include:\\n- **US-20250288527-A1** (\\\"Devices and Methods to Improve Bioavailability of Therapeutic Agents\\\"): Published Sep 18, 2025; filed May 30, 2023. Covers implantable capsule with nanoporous membrane, reservoir, therapeutic agent, and anti-inflammatory for sustained release.[2]\\n- **US-20230022463-A1** (\\\"Implantable Medical Devices for Extended Release of Therapeutic Agents\\\"): Published Jan 26, 2023; filed Sep 16, 2022.[2]\\n- **US-20220008345-A1** (\\\"Methods to Control the Rate of Release of Therapeutic Agents from Implantable Devices\\\"): Published Jan 13, 2022; filed Jul 22, 2021.[2]\\n- **US-20210401735-A1** (\\\"Drug Delivery Device\\\"): Published Dec 30, 2021; filed Sep 7, 2021. Describes nanoporous membranes matched to molecular diameter for zero-order release (pore >5x Stokes' diameter).[2]\\n- Older applications like **US-20210246271-A1** (\\\"Polymeric Stabilizing Formulations\\\"): Published Aug 12, 2021; filed Apr 27, 2021.[2]\\n\\nCortigent (Vivani subsidiary) holds an **extensive intellectual property estate** covering the Orion visual cortical prosthesis (FDA Breakthrough Device Designation), built on Argus II retinal prosthesis technology (previously FDA-approved for retinitis pigmentosa), but no specific patent numbers, grant status, or expirations provided.[5][7][8][14] Citations to competitors like Roche (12), Novartis (5) indicate defensive patent landscape in drug delivery and neurostimulation.[2] Strategy targets post-expiration reformulation of GLP-1 drugs (e.g., semaglutide) via NanoPortal.[11]\\n\\nSources: https://free-competitor-patent-data.minesoft.com/showfile.php?s=Rlkyay8xRTBhTUxwc3krS2NPcDZJQ1ov [2]\\n\\n### Active Patent Disputes (Plaintiff or Defendant)\\nNO DATA. No court records, litigation, or disputes identified in USPTO, court databases, or results. Vivani's 10-K (filed Mar 31, 2025) and subsequent filings reference general risks but no ongoing IP conflicts.[4]\\n\\n### Recent Patent Approvals (Potential Catalysts)\\nNO DATA. No granted patents or approvals in results; all are published applications (2021-2025). Potential catalysts are clinical/regulatory:\\n- **NPM-139 (semaglutide implant)**: Preclinical feasibility shows ~20% weight loss over 6+ months (single dose), prioritizing for 2026 clinical start pending clearance; leverages $29B+ semaglutide market (Ozempic/Wegovy).[1][4]\\n- **LIBERATE-1 (NPM-115 exenatide implant)**: Phase 1 completed 2025; first-in-human NanoPortal validation, no serious AEs, 9-week release profile supports 6-month durability.[1][4]\\n- **Cortigent Orion**: 6-year Early Feasibility Study (completed 2025) shows safety/reliability for blindness restoration; pivotal trial planning in 2026.[5][7][8][14]\\n\\nSources: https://www.drugdeliverybusiness.com/vivani-initiate-semaglutide-implant-study-2026/ [1]; https://investors.vivani.com/investors/news-events/press-releases/detail/198/vivani-medical-announces-rapid-advancement-of-npm-139-a [4]; https://investors.vivani.com/investors/news-events/press-releases/detail/212/vivani-subsidiary-cortigent-presents-promising-6-year-early [7]; https://www.globenewswire.com/news-release/2026/01/29/3228474/0/en/Vivani-Subsidiary-Cortigent-Presents-Promising-6-Year-Early-Feasibility-Study-Results-for-the-Orion-System-at-NANS-2026.html [14]\\n\\n---\\n\\n# Analyst Consensus\\n\\n**Vivani Medical, Inc. (VANI) has limited Wall Street analyst coverage from 1-3 firms, with a generally bullish consensus featuring price targets implying 225-250% upside from the current $1.23 price, amplifying the bullish signal from recent C-level insider open-market buys amid maximum information asymmetry.**[1][2][9]\\n\\n### SeekingAlpha Quant Rating\\nNO DATA.\\n\\n### Wall Street Consensus\\nAnalyst counts vary slightly across sources: 2 analysts (3 Buy ratings, 0 Hold, 0 Sell)[1]; 1 analyst (Strong Buy)[2][3]; or 3 analysts in the last 12 months (consensus \\\"Hold\\\" or \\\"Reduce,\\\" but with Buy ratings predominant)[9]. Overall sentiment skews bullish, with no Sell ratings noted and Strong Buy from select firms like HC Wainwright & Co.[1][2][3][9]\\n\\n### Number of Analysts Covering\\n1-3 analysts provide active coverage, per aggregator data; this low breadth (far below typical healthcare peers) signals **maximum information asymmetry**, a positive amplifier for the C-level insider buying signal as external scrutiny remains minimal.[1][2][3][9]\\n\\n### Average / Max / Min Price Target and Implied Upside\\n- **Average/Median**: $4.00 (241.9% upside from $1.17; 225% from $1.23)[1][2][6]\\n- **Max**: $7.00 (498% upside from $1.17; ~469% from $1.23) by Ashok Kumar, ThinkEquity[1]\\n- **Min**: $4.00 (242% upside from $1.17; 225% from $1.23) by Yi Chen, HC Wainwright[1][2]\\nUpside calculated conservatively from query's $1.23 current price; targets unchanged since mid-2025 reiterations.[1][2]\\n\\n| Source | Low Target | Avg/Median | High Target | Implied Upside (from ~$1.23) |\\n|--------|------------|------------|-------------|------------------------------|\\n| TickerNerd[1] | $4.00 | $4.00 | $7.00 | 225-469% |\\n| StockAnalysis[2] | $4.00 | $4.00 | $4.00 | 225% |\\n| Public.com[3] | N/A | $4.00 | N/A | 225% |\\n| Zacks[6] | $4.00 | $4.00 | $4.00 | 225% |\\n| MarketBeat[9] | $4.00 | $4.00 | N/A | 225%+ |\\n\\n### Most Recent Upgrade or Downgrade\\nMost recent actions are **Buy reiterations**, not upgrades/downgrades:\\n- Sep 2, 2025: HC Wainwright (Yi Chen) **Reiterates Buy**, $4.00[1]\\n- May 19, 2025: HC Wainwright **Reiterates Strong Buy**, $4.00[2]\\nNo upgrades/downgrades near unknown filing date; 1 recent downgrade noted over past 90 days (unspecified, minor amid Buy dominance)[9]. No evidence of information leaks.\\n\\n### Recent Analyst Initiations\\n- Nov 7, 2024: HC Wainwright **Initiates Buy**, $3.00 (later raised/reiterated to $4.00)[1]\\n- Dec 5, 2022: ThinkEquity **Initiates Buy**, $7.00[1]\\nNo 2025-2026 initiations; coverage stagnant.[1]\\n\\nThis sparse, bullish coverage (e.g., https://tickernerd.com/stock/vani-forecast/[1]; https://stockanalysis.com/stocks/vani/forecast/[2]; https://www.marketbeat.com/stocks/NASDAQ/VANI/forecast/[9]) underscores insider-driven asymmetry, as zero additional firms have piled in despite positive semaglutide implant catalysts (Phase 1 H1 2026).[1] Recent insider buys align with reiterated targets, warranting forensic focus on C-level conviction.[11]\\n\\n---\\n\\n# SeekingAlpha Analyst Deep Dive\\n\\n**Seeking Alpha Coverage: Low (0 articles found)**\\n\\nNo analysis articles from SeekingAlpha were identified in the search results for VANI (Vivani Medical, Inc.), despite targeted queries like \\\"site:seekingalpha.com VANI analysis\\\" and \\\"seekingalpha Vivani Medical, Inc. stock analysis\\\". All results point to third-party forecast sites (e.g., Intellectia AI[1], Public.com[2], StockScan[3]).\\n\\n**Coverage density**: 0 articles in the last 6 months (low coverage = **high information asymmetry**, creating opportunities for mispricing).\\n\\n**SA Author Consensus**: N/A (no SA articles).\\n\\n**Contrarian Signal**: **Strong**. C-level insider open-market buys signal **bullish conviction** amid zero SA coverage. This is a classic information asymmetry setup where insiders act on non-public insights while public analysis lags. Absence of SA bearish takes amplifies the bullish insider signal.\\n\\n**Key External Analyst Signals (non-SA, for context)**:\\n- Public.com: 1 analyst **Strong Buy**, $4 PT (NPM-139 weight loss potential)[2].\\n- TickerNerd: 2 analysts, median $4 PT (+242% upside), **Buy** ratings[5].\\n- MarketBeat: 3 analysts **Hold** consensus, $4 PT (+148% upside)[6].\\n- Mixed technicals: Some bearish short-term (e.g., Intellectia Strong Sell[1]), but long-term bullish forecasts dominate (e.g., StockScan $6 avg 2026[3]).\\n\\n**Forensic Takeaway**: Zero SA coverage + C-level buys = **prime forensic DD target**. Insiders buying at $1.23 with $72M mkt cap suggests undervaluation ahead of catalysts like H1 2026 Phase 1 semaglutide implant trial[5]. Monitor for SA articles post-insider filing.\\n\\n---\\n\\n# Sentiment & Articles\\n\\n### Forensic Due Diligence on $VANI (Vivani Medical, Inc.)\\n\\n**Vivani Medical ($VANI), a ~$72M market cap healthcare microcap, shows exceptionally strong insider buying led by Director and 10% owner Gregg Williams, with 17 open-market purchases totaling ~17.5M shares for ~$22M over the past 6 months—no insider sales reported—contrasting sparse media coverage and creating potential information asymmetry.** Insiders own ~62% of shares, with Williams controlling ~32.7M shares post-purchases.[1][3][4][5]\\n\\n#### Recent Articles from SA, Motley Fool, Barron's, Bloomberg, etc.\\nNO DATA. Search results yield no articles from Seeking Alpha, Motley Fool, Barron's, or Bloomberg on $VANI. Coverage limited to insider trading trackers (MarketBeat, StockTitan, QuiverQuant, Fintel, TipRanks, Simply Wall St).[1][2][3][4][5][6][7][10]\\n\\n#### Dominant Narrative\\n**No narrative.** Absence of financial media coverage indicates $VANI flies under the radar, with focus solely on bullish insider accumulation rather than company fundamentals or catalysts.[1][2][3][4]\\n\\n#### Target Insiders Who Bought (C-level Focus; Ignoring 10b5-1 Sales)\\n- **Gregg Williams (Director, 10% Owner; not C-level but primary buyer):** Recent open-market purchases include 1,575,231 shares on March 15, 2026 at $1.07 (~$1.685M); prior buys: 1,737,765 shares on Jan 15 at $1.14 (~$1.98M), 1,473,214 shares on Jan 15 at $1.12 (~$1.65M via private sale under 2025 agreement), 264,551 shares on Jan 15 at $1.26 (~$333K), and others totaling 17.5M shares for ~$22M across 16 trades in 6 months. Post-March buy, owns 31.36M shares (5.29% ownership increase).[1][2][3][6][7]\\n- **C-level buys:** Aaron Mendelsohn (Director, possibly overlapping exec role) bought 20,000 shares (~$24.6K). No other explicit C-level (CEO/CFO/COO) open-market buys highlighted; insiders overall bought 8M+ shares for ~$9.7M in last 24 months.[3][7]\\n- **Bullish signal strength:** 17 buys, 0 sales in 6 months; 46-62% insider ownership signals alignment. Williams' trades are private/open-market (not 10b5-1 flagged).[1][3][5][7]\\n\\n#### Red Flags in Articles\\nNO DATA. No mentions of dilution, going concern warnings, fraud, or management issues across sources. Institutional interest noted (e.g., State Street +12.5%, Citadel new position), but no negatives.[2]\\n\\n#### Catalyst Asymmetry (Market Awareness of Insider-Buy Catalysts)\\nNO DATA. No articles reference specific catalysts (e.g., trials, FDA, partnerships) tied to Williams' buys. Private sales under 2025 agreements suggest non-public execution, implying insiders act ahead of public knowledge—high asymmetry as media silent.[1][2]\\n\\n#### Contrarian Signal\\n**Strong contrarian setup.** Zero media narrative + no short-seller reports equals low visibility/bearish neglect, yet relentless insider buying (17 purchases, $22M) screams conviction. Analyst consensus \\\"Hold\\\" at $4 target (3x current $1.23), but microcap status amplifies insider edge.[2][3][4]\\n\\n#### Short-Seller Reports or Activist Campaigns\\nNO DATA. No mentions of short reports, activists, or campaigns; focus exclusively on insider accumulation.[3][5]\\n\\n**Overall Sentiment Landscape:** **Bullish insider dominance amid media void.** Williams' multi-million buys (e.g., $1.7M March 15) at discounts to $4 target signal major confidence in Vivani's implantable device pipeline, unpriced by Street. Ideal asymmetry for contrarian play—monitor Q1 2026 catalysts.[1][2][3][5][10]\\n\\n---\\n\\n# Options & Flow Intelligence\\n\\n# Forensic Due Diligence: $VANI (Vivani Medical, Inc.)\\n\\n## Executive Summary\\n\\n**Vivani Medical exhibits a highly concentrated insider accumulation pattern centered on director and 10% owner Gregg Williams, with sustained open-market purchases totaling approximately $20.3M over six months.** However, the search results provided contain **no data on unusual options activity, dark pool prints, implied volatility metrics, or institutional positioning** necessary for comprehensive flow analysis.\\n\\n---\\n\\n## Insider Buying Analysis: C-Level & Director Activity\\n\\n### Primary Accumulator: Gregg Williams (Director, 10% Owner)\\n\\n**Sustained Accumulation Pattern:**\\n\\nGregg Williams has executed **14 open-market purchases totaling 15,941,057 shares for approximately $20,316,665** over the past six months[5]. This represents aggressive, consistent capital deployment:\\n\\n- **March 15, 2026**: 1,575,231 shares @ $1.07 = $1,685,497[2]\\n- **February 15, 2026**: 1,601,941 shares @ $1.03 = $1,649,999[5]\\n- **January 27, 2026**: 1,351,351 shares @ $1.48 = $2,001,999[2]\\n- **January 15, 2026**: 1,473,214 shares @ $1.12 + 264,551 shares @ $1.26 = $1,649,999[4]\\n- **November 15, 2025**: 1,737,764 shares @ $1.26 = $1,983,333[3]\\n- **October 27, 2025**: 3,703,703 shares @ $1.62 = $5,999,999[3]\\n\\n**Ownership Impact:** Williams' holdings increased from approximately 30.8M shares to 31.4M shares (5.29% increase as of March 15)[2], maintaining his position as the largest individual shareholder with 40.8% of insider-owned shares.\\n\\n### Secondary Accumulator: Aaron Mendelsohn (Director)\\n\\nAaron Mendelsohn purchased 20,000 shares for approximately $24,600[5], representing minimal activity compared to Williams.\\n\\n### Other C-Level Activity\\n\\n**Donald Dwyer (Chief Business Officer)** made two small purchases totaling 5,000 shares for approximately $5,110 in April 2025[7]. No recent C-level officer purchases are documented in the search results.\\n\\n---\\n\\n## Ownership Structure & Insider Concentration\\n\\n**Insider ownership stands at 46.40%-62.46% of outstanding shares** (sources vary on methodology)[1][7], with the top three shareholders controlling 53% of the company[6]:\\n\\n- **Gregg Williams**: 32,714,660 shares (10% owner, director)\\n- **Alfred E. Mann Living Trust**: 16,672,840 shares (10% owner)\\n- **Joachim Eberhard Bolck**: 7,870,382 shares (10% owner)\\n\\nThis concentration indicates **maximum upside/downside exposure for insiders**, aligning incentives with shareholder value creation[6].\\n\\n---\\n\\n## Timing Analysis: Form 4 Filings vs. Open-Market Purchases\\n\\n**Critical Finding:** The search results do not specify the exact Form 4 filing dates for Williams' purchases. However, the data reveals:\\n\\n- **January 15, 2026 purchases** were disclosed via Form 4 filing but tied to a **March 26, 2025 share purchase agreement**[4], indicating these were **pre-arranged private sales**, not spontaneous open-market accumulation.\\n- **Open-market purchases** (January 27, February 15, March 15, 2026) appear to be **separate from the private sale transactions** and represent genuine market-based accumulation.\\n\\n**No evidence of front-running ahead of material announcements is apparent from the available data**, as the purchases appear methodical and consistent rather than clustered around specific catalysts.\\n\\n---\\n\\n## Unusual Options Activity, Dark Pool Prints & Institutional Positioning\\n\\n**NO DATA** on the following critical metrics:\\n\\n- **Unusual options activity** (sweeps, block trades, unusual volume)\\n- **Put/Call ratio** for VANI\\n- **Implied volatility context** (historical IV comparison)\\n- **Dark pool prints** or large block trades\\n- **Open interest buildup** at specific strikes\\n- **Whale entries** (13D/13G filings >5% ownership)\\n\\nThe search results focus exclusively on insider Form 4 filings and do not include options flow analysis, dark pool data, or institutional positioning reports.\\n\\n---\\n\\n## Sentiment & Market Context\\n\\n**Positive Indicators:**\\n\\n- **Zero insider selling in the past 12 months**[5][7]: All 30 insider transactions were purchases, indicating unified bullish conviction.\\n- **Insider Sentiment Score**: The company maintains positive insider accumulation metrics, though specific score not disclosed in results[1].\\n- **Analyst Consensus**: Hold rating with $4.00 average price target[2], implying 225% upside from current $1.23 price.\\n- **Market Cap**: ~$72M-$86M (sources vary), suggesting micro-cap liquidity constraints[2].\\n\\n**Risk Factors:**\\n\\n- **Negative P/E ratio** indicates current unprofitability[2].\\n- **Micro-cap status** creates liquidity risk and potential manipulation vulnerability.\\n- **High insider concentration** (46-62% ownership) creates governance risk if insiders face liquidity pressures.\\n\\n---\\n\\n## Conclusion\\n\\nVivani Medical exhibits **strong insider conviction through sustained, multi-million-dollar open-market accumulation by director Gregg Williams**, with zero offsetting insider sales. However, **comprehensive flow analysis is impossible without options activity data, dark pool prints, and institutional positioning metrics**, which are absent from the provided search results. To complete this forensic analysis, additional searches targeting options flow platforms (Unusual Whales, Flow Alerts, etc.) and dark pool data providers would be required.\",\"socialReport\":\"# Social Noise Level\\n\\nRUIDO SOCIAL: [Silencio selectivo] \\nMenciones 7d: [10] \\nCuentas grandes lo mencionaron: [No] \\nVEREDICTO TIMING: [VENTANA ABIERTA]\\n\\n---\\n\\n# Niche Catalyst Hunting\\n\\nCATALIZADOR DETECTADO EN X: Sí — Presentación de resultados de viabilidad a 6 años para el implante visual Orion en NANS 2026, mostrando mejoras en pruebas visuales, funcionalidad sostenida y planes para un ensayo pivotal. Esto podría explicar la confianza insider en avances clínicos futuros.\\n\\nFuente del catalizador: @DataRetailer — https://x.com/DataRetailer/status/2016947118821273739\\n\\nTipo: trial / data\\n\\nCATALIZADOR DETECTADO EN X: Sí — Oferta de acciones comunes en enero 2026 para recaudar ~$4.5M, potencialmente para financiar desarrollo (aunque implica riesgo de dilución).\\n\\nFuente del catalizador: @notdumbmoney — https://x.com/notdumbmoney/status/2016553624881549728\\n\\nTipo: offering\\n\\nCATALIZADOR DETECTADO EN X: No (ninguna mención de banderas rojas como fraude o scam; no hay resultados relevantes).\\n\\nFuente del catalizador: N/A\\n\\nTipo: N/A\\n\\n---\\n\\n# Sentiment & Narrative\\n\\nSENTIMIENTO: Bullish incipiente \\nShort sellers activos: No \\nNarrativa dominante: Recent insider buying by a director (over $1.6M in shares) signaling confidence in future catalysts, with mentions of stock price gains and insider accumulation trends. \\nRed flags detectados: ninguno\\n\\n---\\n\\n# Options Flow on X\\n\\nFLOW EN X: Post-filing \\nDetalles: Una alerta de una cuenta de trading (@SwingOptionsPro) mencionando una posición de opciones de $6M para octubre 2025 en $VANI, en el contexto de compras de insiders. Posteado el 16 de marzo de 2026, con hashtag #OptionsFlow. No se detectaron otras menciones directas de flow de opciones para $VANI en las últimas 72 horas. \\nTiming vs filing: después\",\"seekingAlphaReport\":null,\"seekingAlphaData\":null,\"perplexityReport_en\":null,\"perplexityReport_es\":null,\"socialReport_en\":\"# Social Noise Level\\n\\nSOCIAL NOISE: [Selective silence] \\n7d Mentions: [10] \\nLarge accounts mentioned it: [No] \\nTIMING VERDICT: [OPEN WINDOW]\\n\\n---\\n\\n# Niche Catalyst Hunting\\n\\nCATALYST DETECTED ON X: Yes — Presentation of 6-year viability results for the Orion visual implant at NANS 2026, showing improvements in visual tests, sustained functionality, and plans for a pivotal trial. This could explain insider confidence in future clinical advances.\\n\\nCatalyst source: @DataRetailer — https://x.com/DataRetailer/status/2016947118821273739\\n\\nType: trial / data\\n\\nCATALYST DETECTED ON X: Yes — Common stock offering in January 2026 to raise ~$4.5M, potentially to fund development (although it implies dilution risk).\\n\\nCatalyst source: @notdumbmoney — https://x.com/notdumbmoney/status/2016553624881549728\\n\\nType: offering\\n\\nCATALYST DETECTED ON X: No (no mentions of red flags such as fraud or scam; no relevant results).\\n\\nCatalyst source: N/A\\n\\nType: N/A\\n\\n---\\n\\n# Sentiment & Narrative\\n\\nSENTIMENT: Incipient bullish \\nActive short sellers: No \\nDominant narrative: Recent insider buying by a director (over $1.6M in shares) signaling confidence in future catalysts, with mentions of stock price gains and insider accumulation trends. \\nRed flags detected: none\\n\\n---\\n\\n# Options Flow on X\\n\\nFLOW ON X: Post-filing \\nDetails: An alert from a trading account (@SwingOptionsPro) mentioning a $6M options position for October 2025 on $VANI, in the context of insider purchases. Posted on March 16, 2026, with hashtag #OptionsFlow. No other direct mentions of options flow for $VANI were detected in the last 72 hours. \\nTiming vs filing: after\",\"socialReport_es\":null,\"seekingAlphaReport_en\":null,\"seekingAlphaReport_es\":null}","{\"raw\":\"## VANI\\n\\n**Generado:** 2026-03-17T17:23:15.733Z UTC | **SCORE: 0/100** | **GRADO: D**\\n\\n> Descartado por shelf registration 416% del market cap + cash runway de 1.89 meses sin revenue, riesgo terminal.\\n\\n---\\n\\n| Campo | Valor |\\n|---|---|\\n| Tier | 2 ($50-200M) — $72M |\\n| Fear & Greed | NO DATA |\\n| Régimen | Cautela extrema |\\n\\n---\\n\\n### PASO A — VERIFICACIÓN DE REGLAS DE DESCARTE AUTOMÁTICO\\n\\n- [x] ¿Compra bajo plan 10b5-1? → **No** (pasa)\\n- [x] ¿Market cap <$50M? → **No, $72M** (pasa)\\n- [x] ¿Market cap >$2B? → **No** (pasa)\\n- [x] **¿Shelf registration >20% mkt cap en Tier 2? → ⛔ SÍ. $300M shelf = 416% del market cap. DESCARTAR.**\\n- [x] **¿Cash runway <6 meses sin revenue? → ⛔ SÍ. 1.89 meses de runway, $0 revenue. DESCARTAR.**\\n- [x] ¿Going concern del auditor? → **NO DATA confirmado**, pero con 1.89 meses de cash y current ratio 0.61, going concern es virtualmente seguro en el próximo filing (earnings MAÑANA 18-Mar).\\n- [x] ¿CEO/CFO con historial de fraude? → **No** (pasa)\\n- [x] ¿Class action activa? → **No** (pasa)\\n- [x] ¿Social viralizado? → **No** (pasa)\\n- [x] ¿State 3 priced-in? → **No** (pasa)\\n- [x] ¿Divergencia opciones? → **No data** (pasa por defecto)\\n\\n### ⛔ RESULTADO: DOS REGLAS DE DESCARTE AUTOMÁTICO ACTIVADAS\\n\\n**Regla 1 — Shelf Registration letal:** $300M de shelf sobre $72M de market cap = 416%. El umbral de descarte es 20%. Estamos 20x por encima del límite. La empresa ha utilizado activamente este shelf (Oct 2025: ~$9.7M; Ene 2026: ~$4.5M). Cada offering diluye masivamente.\\n\\n**Regla 2 — Cash Runway terminal:** $2.6M en caja (Q3 2025 reportado), burn rate de ~$1.4M/mes, runway de 1.89 meses. **Revenue: $0.** La empresa está esencialmente en colapso de liquidez. Management declaró runway hasta marzo 2026 — estamos en marzo 17, 2026. Se agotó.\\n\\n---\\n\\n### ANÁLISIS COMPLEMENTARIO (para documentación, no altera la decisión)\\n\\n### PILAR 1: INSIDER (análisis informativo — no scoreable)\\n\\n| Campo | Valor |\\n|---|---|\\n| Insider | Gregg Williams (Chairman/Director/10% Owner) |\\n| Cargo | **NO es C-level** (no es CEO/CFO/COO/President) |\\n| Monto total 6 meses | ~$20.3M en 14 transacciones |\\n| Naturaleza de compras | **Mayoritariamente private placements bajo acuerdos pre-arreglados** (Share Purchase Agreements de Mar/May 2025), NO open-market espontáneas |\\n| Último | Mar 15, 2026: 1.575M shares @ $1.07 (~$1.685M) |\\n| Ownership post-compra | 41.79% de la empresa |\\n| C-level comprando | **NO.** Solo 1 director (Williams) + micro-compra de Aaron Mendelsohn (Director, $24.6K) |\\n| Cluster C-level | **NO.** Cero CEO/CFO/COO comprando |\\n| 10b5-1 | No confirmado |\\n\\n**Problemas críticos con la señal insider:**\\n\\n1. **No es C-level.** Williams es Chairman/Director con 10%+ ownership. El protocolo prioriza CEO/CFO/President. Ni Mendelsohn (CEO) ni Baldor (CFO nuevo) compraron.\\n2. **Private placements, no open-market.** Las compras de Williams son bajo acuerdos pre-negociados con la empresa. Esto es fundamentalmente distinto a un C-level que va al mercado abierto y compra con su propio dinero a precio de mercado. En los private placements, el insider negocia precio y términos directos.\\n3. **Williams es simultáneamente el mayor financista de la empresa.** Su \\\"compra\\\" es más capital infusion que señal de convicción — la empresa necesita su dinero para sobrevivir.\\n4. **Conflicto de intereses:** Un 10% owner inyectando capital a una empresa sin cash es auto-rescate, no señal de mercado anticipatoria.\\n\\n### PILAR 2: CATALIZADOR (análisis informativo)\\n\\n| Campo | Valor |\\n|---|---|\\n| Tipo 1 | Earnings — Q4 2025 / FY 2025 |\\n| Fecha | **MAÑANA — 18-Mar-2026** |\\n| Binario | No (earnings de empresa pre-revenue) |\\n| Tipo 2 | NPM-139 semaglutide implant — clinical start 2026 |\\n| Fecha | Indefinida (H1 2026 target) |\\n| Tipo 3 | Cortigent Orion pivotal trial planning |\\n| Fecha | 2026 (sin fecha específica) |\\n\\n**Nota:** El earnings de mañana es una **trampa**, no un catalizador. Con 1.89 meses de runway y $0 revenue, el earnings probablemente revelará: (a) going concern del auditor, (b) necesidad de capital raise inmediato, (c) dilución inminente. Comprar antes de este earnings es jugar ruleta rusa financiera.\\n\\n### PILAR 3: TIMING (análisis informativo)\\n\\n| Campo | Valor |\\n|---|---|\\n| RSI | 32.14 (oversold) |\\n| vs 50d MA | -4.49% |\\n| vs 200d MA | -9.21% |\\n| vs 52-week high | -36.2% ($1.92 high) |\\n| vs 52-week low | +35.4% ($0.905 low) |\\n| Beta | 3.363 (extremadamente volátil) |\\n| Social | Silencio selectivo (~10 menciones 7d) |\\n\\n### DUE DILIGENCE — BANDERAS ROJAS ACUMULADAS\\n\\n| Bandera Roja | Severidad | Detalle |\\n|---|---|---|\\n| **Shelf $300M (416% mkt cap)** | 🔴 CRÍTICO | Capacidad de dilución masiva activa |\\n| **Cash runway 1.89 meses** | 🔴 CRÍTICO | Insolvencia inminente sin nueva emisión |\\n| **$0 Revenue** | 🔴 CRÍTICO | Pre-revenue, pre-clinical para NPM-139 |\\n| **Current ratio 0.61** | 🔴 ALTO | Pasivos corrientes > Activos corrientes |\\n| **D/E ratio 13.97x** | 🔴 ALTO | Altamente apalancada |\\n| **2 offerings en 3 meses** | 🔴 ALTO | Oct 2025 + Ene 2026 |\\n| **CFO nuevo sin historial** | 🟡 MEDIO | Anthony Baldor, <1 año, sin data |\\n| **Earnings mañana** | 🟡 MEDIO | Potencial going concern disclosure |\\n| **Insider = Director, no C-level** | 🟡 MEDIO | Señal más débil que CEO/CFO |\\n| **Private placements, no open-market** | 🟡 MEDIO | Naturaleza de compras cuestionable |\\n\\n---\\n\\n## DECISION\\n\\n---\\n\\n**CLASIFICACIÓN: DESCARTAR (GRADO D)**\\n\\n### Razones de descarte (en orden de prioridad):\\n\\n**1. Shelf Registration letal (416% del market cap):** Una empresa Tier 2 con un shelf de $300M sobre $72M de capitalización tiene capacidad de diluir a los accionistas 4x. Ya lo está haciendo activamente (2 offerings en los últimos 5 meses). Regla dura del protocolo: Tier 2 con shelf >20% = DESCARTAR.\\n\\n**2. Cash runway terminal (1.89 meses, $0 revenue):** Con $2.6M en caja y quemando $1.4M/mes, Vivani está funcionalmente insolvente. No tiene revenue. El runway declarado por management era hasta marzo 2026 — estamos ahí. Otra dilución es inevitable e inminente. Regla dura: cash runway <6 meses sin revenue = DESCARTAR.\\n\\n**3. La señal insider no es lo que parece:** Gregg Williams no es un C-level comprando en mercado abierto con convicción. Es un 10%+ owner haciendo private placements pre-acordados para mantener viva a una empresa que depende de su capital. Es un rescate, no una señal anticipatoria.\\n\\n**4. Earnings mañana con riesgo de going concern:** Comprar hoy es exponerse a un filing que probablemente contenga lenguaje de going concern, disclosure de necesidad de capital adicional, y posiblemente un nuevo offering anunciado.\\n\\n### ¿Qué cambiaría esto?\\n\\nNada razonable en el corto plazo. Para que VANI sea investible necesitaría:\\n- Revenue real (NPM-139 está en pre-clínico)\\n- Cash runway >12 meses sin depender de dilución\\n- Reducción significativa del shelf activo\\n- Compras genuinas de open-market por CEO o CFO\\n- Eliminación del going concern risk\\n\\n**Timeline realista para reevaluación:** 12-18 meses mínimo, post data clínica de NPM-139.\\n\\n---\\n\\n*Esta señal no tiene las 2 confluencias principales requeridas (insider C-level genuino + catalizador claro). Tiene múltiples banderas rojas fatales que la descalifican automáticamente. No operar bajo ninguna circunstancia.*\\n\\n---\",\"score\":12,\"grade\":\"D\",\"summary\":\"Descartado: shelf 416% del mkt cap, cash runway 1.89 meses sin revenue, insider es director no C-level, dilución inminente.\",\"raw_en\":\"## VANI\\n\\n**Generated:** 2026-03-17T17:23:15.733Z UTC | **SCORE: 0/100** | **GRADE: D**\\n\\n> Discarded due to shelf registration at 416% of market cap + cash runway of 1.89 months with no revenue, terminal risk.\\n\\n---\\n\\n| Field | Value |\\n|---|---|\\n| Tier | 2 ($50-200M) — $72M |\\n| Fear & Greed | NO DATA |\\n| Regime | Extreme caution |\\n\\n---\\n\\n### STEP A — AUTOMATIC DISCARD RULE VERIFICATION\\n\\n- [x] Purchases under 10b5-1 plan? → **No** (passes)\\n- [x] Market cap <$50M? → **No, $72M** (passes)\\n- [x] Market cap >$2B? → **No** (passes)\\n- [x] **Shelf registration >20% mkt cap in Tier 2? → ⛔ YES. $300M shelf = 416% of market cap. DISCARD.**\\n- [x] **Cash runway <6 months with no revenue? → ⛔ YES. 1.89 months of runway, $0 revenue. DISCARD.**\\n- [x] Auditor going concern? → **NO DATA confirmed**, but with 1.89 months of cash and a current ratio of 0.61, going concern is virtually certain in the next filing (earnings TOMORROW 18-Mar).\\n- [x] CEO/CFO with history of fraud? → **No** (passes)\\n- [x] Active class action? → **No** (passes)\\n- [x] Social media viral? → **No** (passes)\\n- [x] State 3 priced-in? → **No** (passes)\\n- [x] Options divergence? → **No data** (passes by default)\\n\\n### ⛔ RESULT: TWO AUTOMATIC DISCARD RULES TRIGGERED\\n\\n**Rule 1 — Lethal Shelf Registration:** $300M shelf against $72M market cap = 416%. The discard threshold is 20%. We are 20x above the limit. The company has actively used this shelf (Oct 2025: ~$9.7M; Jan 2026: ~$4.5M). Each offering causes massive dilution.\\n\\n**Rule 2 — Terminal Cash Runway:** $2.6M in cash (Q3 2025 reported), burn rate of ~$1.4M/month, runway of 1.89 months. **Revenue: $0.** The company is essentially in a liquidity collapse. Management declared runway through March 2026 — we are on March 17, 2026. It has run out.\\n\\n---\\n\\n### SUPPLEMENTARY ANALYSIS (for documentation purposes, does not alter the decision)\\n\\n### PILLAR 1: INSIDER (informational analysis — not scoreable)\\n\\n| Field | Value |\\n|---|---|\\n| Insider | Gregg Williams (Chairman/Director/10% Owner) |\\n| Role | **NOT C-level** (not CEO/CFO/COO/President) |\\n| Total amount 6 months | ~$20.3M across 14 transactions |\\n| Nature of purchases | **Primarily private placements under pre-arranged agreements** (Share Purchase Agreements from Mar/May 2025), NOT spontaneous open-market purchases |\\n| Most recent | Mar 15, 2026: 1.575M shares @ $1.07 (~$1.685M) |\\n| Post-purchase ownership | 41.79% of the company |\\n| C-level buying | **NO.** Only 1 director (Williams) + micro-purchase by Aaron Mendelsohn (Director, $24.6K) |\\n| C-level cluster | **NO.** Zero CEO/CFO/COO buying |\\n| 10b5-1 | Not confirmed |\\n\\n**Critical issues with the insider signal:**\\n\\n1. **Not C-level.** Williams is Chairman/Director with 10%+ ownership. The protocol prioritizes CEO/CFO/President. Neither Mendelsohn (CEO) nor Baldor (new CFO) purchased.\\n2. **Private placements, not open-market.** Williams's purchases are under pre-negotiated agreements with the company. This is fundamentally different from a C-level going to the open market and buying with their own money at market price. In private placements, the insider negotiates price and terms directly.\\n3. **Williams is simultaneously the company's primary financier.** His \\\"purchase\\\" is more of a capital infusion than a conviction signal — the company needs his money to survive.\\n4. **Conflict of interest:** A 10%+ owner injecting capital into a cash-strapped company is a self-rescue, not an anticipatory market signal.\\n\\n### PILLAR 2: CATALYST (informational analysis)\\n\\n| Field | Value |\\n|---|---|\\n| Type 1 | Earnings — Q4 2025 / FY 2025 |\\n| Date | **TOMORROW — 18-Mar-2026** |\\n| Binary | No (pre-revenue company earnings) |\\n| Type 2 | NPM-139 semaglutide implant — clinical start 2026 |\\n| Date | Indefinite (H1 2026 target) |\\n| Type 3 | Cortigent Orion pivotal trial planning |\\n| Date | 2026 (no specific date) |\\n\\n**Note:** Tomorrow's earnings is a **trap**, not a catalyst. With 1.89 months of runway and $0 revenue, the earnings will likely reveal: (a) auditor going concern, (b) immediate need for a capital raise, (c) imminent dilution. Buying ahead of these earnings is playing financial Russian roulette.\\n\\n### PILLAR 3: TIMING (informational analysis)\\n\\n| Field | Value |\\n|---|---|\\n| RSI | 32.14 (oversold) |\\n| vs 50d MA | -4.49% |\\n| vs 200d MA | -9.21% |\\n| vs 52-week high | -36.2% ($1.92 high) |\\n| vs 52-week low | +35.4% ($0.905 low) |\\n| Beta | 3.363 (extremely volatile) |\\n| Social | Selective silence (~10 mentions 7d) |\\n\\n### DUE DILIGENCE — ACCUMULATED RED FLAGS\\n\\n| Red Flag | Severity | Detail |\\n|---|---|---|\\n| **$300M Shelf (416% mkt cap)** | 🔴 CRITICAL | Active massive dilution capacity |\\n| **Cash runway 1.89 months** | 🔴 CRITICAL | Imminent insolvency without new issuance |\\n| **$0 Revenue** | 🔴 CRITICAL | Pre-revenue, pre-clinical for NPM-139 |\\n| **Current ratio 0.61** | 🔴 HIGH | Current liabilities > Current assets |\\n| **D/E ratio 13.97x** | 🔴 HIGH | Highly leveraged |\\n| **2 offerings in 3 months** | 🔴 HIGH | Oct 2025 + Jan 2026 |\\n| **New CFO with no track record** | 🟡 MEDIUM | Anthony Baldor, <1 year, no data |\\n| **Earnings tomorrow** | 🟡 MEDIUM | Potential going concern disclosure |\\n| **Insider = Director, not C-level** | 🟡 MEDIUM | Weaker signal than CEO/CFO |\\n| **Private placements, not open-market** | 🟡 MEDIUM | Questionable nature of purchases |\\n\\n---\\n\\n## DECISION\\n\\n---\\n\\n**CLASSIFICATION: DISCARD (GRADE D)**\\n\\n### Reasons for discard (in order of priority):\\n\\n**1. Lethal Shelf Registration (416% of market cap):** A Tier 2 company with a $300M shelf against $72M in capitalization has the capacity to dilute shareholders 4x. It is already doing so actively (2 offerings in the last 5 months). Hard protocol rule: Tier 2 with shelf >20% = DISCARD.\\n\\n**2. Terminal cash runway (1.89 months, $0 revenue):** With $2.6M in cash and burning $1.4M/month, Vivani is functionally insolvent. It has no revenue. The runway declared by management was through March 2026 — we are there. Further dilution is inevitable and imminent. Hard rule: cash runway <6 months with no revenue = DISCARD.\\n\\n**3. The insider signal is not what it appears:** Gregg Williams is not a C-level buying on the open market out of conviction. He is a 10%+ owner making pre-arranged private placements to keep alive a company that depends on his capital. It is a rescue, not an anticipatory signal.\\n\\n**4. Earnings tomorrow with going concern risk:** Buying today means exposure to a filing that will likely contain going concern language, disclosure of the need for additional capital, and possibly a new offering announcement.\\n\\n### What would change this?\\n\\nNothing reasonable in the short term. For VANI to be investable it would need:\\n- Real revenue (NPM-139 is in pre-clinical stage)\\n- Cash runway >12 months without relying on dilution\\n- Significant reduction of the active shelf\\n- Genuine open-market purchases by the CEO or CFO\\n- Elimination of going concern risk\\n\\n**Realistic timeline for reassessment:** 12-18 months minimum, post NPM-139 clinical data.\\n\\n---\\n\\n*This signal does not have the 2 required primary confluences (genuine C-level insider + clear catalyst). It has multiple fatal red flags that automatically disqualify it. Do not trade under any circumstances.*\",\"raw_es\":null}","macro_data","{\"snapshotDate\":\"2026-03-17\",\"fearGreedValue\":null,\"fearGreedLabel\":null,\"hySpreadOas\":3.28,\"m2YoyPct\":4.28631,\"hygPrice\":79.45,\"hygPriceAvg50\":80.7142,\"hygPriceAvg200\":80.514,\"jnkPrice\":95.65,\"jnkPriceAvg50\":97.2808,\"jnkPriceAvg200\":97.0486}","2026-03-17T17:27:27.513Z","created_at",1,"dd_status","queued","image_url","https://images.financialmodelingprep.com/symbol/VANI.png","rsi",32.14840328929081,"is_otc","grade_d_since","last_dd_price","next_earnings_date",{"_12":178,"_18":179,"_115":180,"_20":181,"_118":182,"_120":183,"_122":184,"_124":185,"_126":186,"_128":187,"_130":188,"_132":189,"_134":190,"_26":191,"_16":17,"_90":192,"_138":139,"_140":193,"_142":194,"_22":195,"_144":196,"_146":197,"_148":198,"_150":151,"_152":-5,"_153":29,"_154":29,"_155":29,"_14":199,"_157":29,"_158":-5,"_159":200,"_24":201,"_162":202,"_25":203,"_165":-5,"_28":166,"_167":204,"_169":205,"_171":206,"_173":29,"_174":-5,"_175":-5,"_176":-5},"ROCK",1162707280,29660900,39.2,12.06,3.25,41.501,54.0058,318279,75.08,37.3,-5.544444712175598,-27.415203552211054,"2026-10-01 14:25:45","Construction",1.356,0.43556,-1.25945,0.79712008,29290168,98.7501,"Gibraltar Industries, Inc.","{\"recidivism\":[{\"reporterCik\":\"0001685928\",\"insiderName\":\"Lovechio Joseph A\",\"buys12m\":7,\"sells12m\":2,\"netBuyRatio\":0.78,\"totalBuyValue12m\":34615,\"totalSellValue12m\":56692,\"isAccumulator\":true,\"priorPurchasesDB\":0,\"buySpanDays\":324,\"lastBuyDate\":\"2026-05-20\",\"transactions\":[{\"transactionDate\":\"2026-05-20\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":1000,\"price\":34.615},{\"transactionDate\":\"2026-03-31\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":284.72,\"price\":0},{\"transactionDate\":\"2026-03-06\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":765.49,\"price\":0},{\"transactionDate\":\"2026-03-02\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":4840,\"price\":0},{\"transactionDate\":\"2026-03-03\",\"acquistionOrDisposition\":\"D\",\"securitiesTransacted\":379,\"price\":43.83},{\"transactionDate\":\"2025-12-31\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":200.08,\"price\":0},{\"transactionDate\":\"2025-09-30\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":213.8,\"price\":0},{\"transactionDate\":\"2025-08-19\",\"acquistionOrDisposition\":\"D\",\"securitiesTransacted\":637,\"price\":62.92},{\"transactionDate\":\"2025-06-30\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":200.22,\"price\":0}]},{\"reporterCik\":\"0001914788\",\"insiderName\":\"Bolanowski Katherine\",\"buys12m\":8,\"sells12m\":3,\"netBuyRatio\":0.73,\"totalBuyValue12m\":49886,\"totalSellValue12m\":158118,\"isAccumulator\":true,\"priorPurchasesDB\":0,\"buySpanDays\":325,\"lastBuyDate\":\"2026-05-21\",\"transactions\":[{\"transactionDate\":\"2026-05-21\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":144,\"price\":35.66},{\"transactionDate\":\"2026-05-21\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":1256,\"price\":35.63},{\"transactionDate\":\"2026-03-31\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":239.71,\"price\":0},{\"transactionDate\":\"2026-03-06\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":437.86,\"price\":0},{\"transactionDate\":\"2026-03-04\",\"acquistionOrDisposition\":\"D\",\"securitiesTransacted\":2601,\"price\":43.05},{\"transactionDate\":\"2026-03-02\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":3410,\"price\":0},{\"transactionDate\":\"2026-03-03\",\"acquistionOrDisposition\":\"D\",\"securitiesTransacted\":286,\"price\":43.83},{\"transactionDate\":\"2026-03-01\",\"acquistionOrDisposition\":\"D\",\"securitiesTransacted\":739,\"price\":45.48},{\"transactionDate\":\"2025-12-31\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":171.67,\"price\":0},{\"transactionDate\":\"2025-09-30\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":183.44,\"price\":0},{\"transactionDate\":\"2025-06-30\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":171.79,\"price\":0}]},{\"reporterCik\":\"0001675953\",\"insiderName\":\"Bosway William T\",\"buys12m\":7,\"sells12m\":3,\"netBuyRatio\":0.7,\"totalBuyValue12m\":1011796,\"totalSellValue12m\":1645366,\"isAccumulator\":true,\"priorPurchasesDB\":0,\"buySpanDays\":85,\"lastBuyDate\":\"2026-05-26\",\"transactions\":[{\"transactionDate\":\"2026-05-26\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":19735,\"price\":37.4377},{\"transactionDate\":\"2026-05-07\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":181,\"price\":0},{\"transactionDate\":\"2026-03-31\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":512.21,\"price\":0},{\"transactionDate\":\"2026-03-13\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":1000,\"price\":41.37},{\"transactionDate\":\"2026-03-10\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":1500,\"price\":39.525},{\"transactionDate\":\"2026-03-09\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":4500,\"price\":38.29},{\"transactionDate\":\"2026-03-04\",\"acquistionOrDisposition\":\"D\",\"securitiesTransacted\":30026,\"price\":43.05},{\"transactionDate\":\"2026-03-02\",\"acquistionOrDisposition\":\"A\",\"securitiesTransacted\":27801,\"price\":0},{\"transactionDate\":\"2026-03-03\",\"acquistionOrDisposition\":\"D\",\"securitiesTransacted\":1955,\"price\":43.83},{\"transactionDate\":\"2026-03-01\",\"acquistionOrDisposition\":\"D\",\"securitiesTransacted\":5872,\"price\":45.48}]}],\"executiveCompensation\":[{\"insiderName\":\"Lovechio Joseph A\",\"year\":2025,\"totalComp\":49357,\"purchaseValue\":34615,\"compPct\":70.13},{\"insiderName\":\"Bolanowski Katherine\",\"year\":2025,\"totalComp\":85484,\"purchaseValue\":44751.280000000006,\"compPct\":52.35},{\"insiderName\":\"Bolanowski Katherine\",\"year\":2025,\"totalComp\":85484,\"purchaseValue\":5135.039999999999,\"compPct\":6.01},{\"insiderName\":\"Bosway William T\",\"year\":2025,\"totalComp\":49357,\"purchaseValue\":738833.0095,\"compPct\":1496.92}],\"nextEarningsDate\":\"2026-05-28\",\"daysToEarnings\":1,\"dilutionFilings\":[],\"hasDilutionRisk\":false,\"pressReleases\":[{\"date\":\"2026-05-21 17:25:00\",\"title\":\"BLACK ROCK COFFEE BAR ALERT: BRAGAR EAGEL & SQUIRE, P.C. IS INVESTIGATING BLACK ROCK COFFEE BAR, INC. ON BEHALF OF BLACK ROCK STOCKHOLDERS AND ENCOURAGES INVESTORS TO CONTACT THE FIRM\"},{\"date\":\"2026-05-15 20:00:00\",\"title\":\"BLACK ROCK COFFEE BAR, INC. INVESTOR ALERT: KIRBY MCINERNEY LLP ANNOUNCES INVESTIGATION INTO POTENTIAL SECURITIES FRAUD\"},{\"date\":\"2026-05-08 07:30:00\",\"title\":\"GIBRALTAR TO ATTEND MAY INVESTOR CONFERENCES\"},{\"date\":\"2026-05-07 07:30:00\",\"title\":\"GIBRALTAR REPORTS FIRST QUARTER 2026 RESULTS\"},{\"date\":\"2026-04-23 07:30:00\",\"title\":\"GIBRALTAR TO ANNOUNCE FIRST QUARTER 2026 FINANCIAL RESULTS ON MAY 7\"}],\"priceAtFiling\":[{\"date\":\"2026-05-20\",\"close\":35.15},{\"date\":\"2026-05-21\",\"close\":35.54},{\"date\":\"2026-05-26\",\"close\":37.48}],\"avgFilingPrice\":36.06,\"priceMoveSinceFiling\":8.72,\"financialHealth\":{\"cashAndEquivalents\":20347000,\"cashPriorQuarter\":115724000,\"totalCurrentAssets\":699705000,\"totalCurrentLiabilities\":497341000,\"totalDebt\":1374199000,\"totalStockholdersEquity\":880632000,\"revenueQ0\":356287000,\"revenueQ1\":225030000,\"revenueQ4\":309517000,\"operatingIncomeQ0\":-4456000,\"freeCashFlow\":-47164000,\"burnRateMonthly\":31792333.33,\"cashRunwayMonths\":0.64,\"purchaseBurnRatio\":0.03,\"revenueGrowthQoQ\":58.33,\"revenueGrowthYoY\":15.11,\"debtToEquity\":1.56,\"currentRatio\":1.41,\"operatingMargin\":-1.25},\"perplexityReport\":\"# Dilution Risk\\n\\nNo data available for this block.\\n\\n---\\n\\n# Financial Health & Audit\\n\\nNo data available for this block.\\n\\n---\\n\\n# Management & Litigation\\n\\nNo data available for this block.\\n\\n---\\n\\n# Patents & IP\\n\\nNo data available for this block.\\n\\n---\\n\\n# Analyst Consensus\\n\\nNo data available for this block.\\n\\n---\\n\\n# SeekingAlpha Analyst Deep Dive\\n\\nNo data available for this block.\\n\\n---\\n\\n# Sentiment & Articles\\n\\nNo data available for this block.\\n\\n---\\n\\n# Options & Flow Intelligence\\n\\nNo data available for this block.\",\"socialReport\":\"# Social Noise Level\\n\\nNo data available for this block.\\n\\n---\\n\\n# Niche Catalyst Hunting\\n\\nNo data available for this block.\\n\\n---\\n\\n# Sentiment & Narrative\\n\\nNo data available for this block.\\n\\n---\\n\\n# Options Flow on X\\n\\nNo data available for this block.\",\"seekingAlphaReport\":null,\"seekingAlphaData\":null,\"perplexityReport_en\":null,\"perplexityReport_es\":\"# Riesgo de Dilución\\n\\nNo hay datos disponibles para este bloque.\\n\\n---\\n\\n# Salud Financiera y Auditoría\\n\\nNo hay datos disponibles para este bloque.\\n\\n---\\n\\n# Gestión y Litigios\\n\\nNo hay datos disponibles para este bloque.\\n\\n---\\n\\n# Patentes y Propiedad Intelectual\\n\\nNo hay datos disponibles para este bloque.\\n\\n---\\n\\n# Consenso de Analistas\\n\\nNo hay datos disponibles para este bloque.\\n\\n---\\n\\n# Análisis Profundo de Analistas de SeekingAlpha\\n\\nNo hay datos disponibles para este bloque.\\n\\n---\\n\\n# Sentimiento y Artículos\\n\\nNo hay datos disponibles para este bloque.\\n\\n---\\n\\n# Inteligencia de Opciones y Flujo\\n\\nNo hay datos disponibles para este bloque.\",\"socialReport_en\":null,\"socialReport_es\":\"# Nivel de Ruido Social\\n\\nNo hay datos disponibles para este bloque.\\n\\n---\\n\\n# Búsqueda de Catalizadores de Nicho\\n\\nNo hay datos disponibles para este bloque.\\n\\n---\\n\\n# Sentimiento y Narrativa\\n\\nNo hay datos disponibles para este bloque.\\n\\n---\\n\\n# Flujo de Opciones en X\\n\\nNo hay datos disponibles para este bloque.\",\"seekingAlphaReport_en\":null,\"seekingAlphaReport_es\":null}","{\"raw\":\"## ROCK\\n\\n**Generado:** 2026-05-27T16:31:11.762Z UTC | **SCORE: 64/100** | **GRADO: B**\\n\\n> Cluster fuerte CEO+CFO comprando $823K cerca de mínimos de 52 semanas pero sin catalizador binario claro a la vista.\\n\\n---\\n\\n| Campo | Valor |\\n|---|---|\\n| Tier | 1 (≥$200M) — Market cap $1.16B |\\n| Fear & Greed | N/D |\\n| Régimen | Cautela (stock -48% desde máximos, RSI 34) |\\n\\n---\\n\\n### PASO A — DESCARTE AUTOMÁTICO\\n\\n- [x] No 10b5-1 (compras discrecionales a precio de mercado)\\n- [x] Market cap $1.16B — dentro de rango $50M-$2B\\n- [x] Sin shelf registration / dilución\\n- [x] Cash runway limitado PERO con revenue ($356M/Q) — no aplica regla\\n- [x] Sin going concern\\n- [x] Sin historial de fraude (press releases de \\\"Black Rock Coffee Bar\\\" NO son Gibraltar)\\n- [x] Sin class action contra ROCK\\n- [x] Sin social viralizado\\n- [x] State 1 claro (stock en mínimos)\\n- [x] Sin divergencia opciones\\n\\n**→ Todas las reglas pasan. Continúo.**\\n\\n---\\n\\n### PILAR 1: INSIDER CONVICTION (36/45)\\n\\n| Campo | Valor |\\n|---|---|\\n| Insider #1 | **Bosway William T (President & CEO)** |\\n| Monto | $738,833 — 19,735 acciones a ~$37.44 |\\n| Insider #2 | **Lovechio Joseph A (VP & CFO)** |\\n| Monto | $34,615 — 1,000 acciones a $34.62 |\\n| Insider #3 | **Bolanowski Katherine (GC, VP, Secretary)** |\\n| Monto | $49,886 — 1,400 acciones en 2 tramos a ~$35.64 |\\n| Total cluster | **$823,334** |\\n| Ratio Purchase/MktCap | 0.071% (rango 0.05-0.15%) |\\n| ΔOwn CEO | +8.6% (19,735 sobre 230,585 previos) |\\n| ΔOwn CFO | +8.1% (1,000 sobre 12,390 previos) |\\n| Cluster | **2 C-level (CEO + CFO) + VP en ≤7 días** |\\n| 10b5-1 | **No** — compras a mercado abierto a diferentes precios |\\n| Primera compra CFO | Primera compra open-market en los últimos 12+ meses (previas eran grants a $0) |\\n| Ratio compra/salario CEO | >100% del comp reportado (extraordinario) |\\n\\n**Desglose puntos:**\\n\\n| Concepto | Pts |\\n|---|---|\\n| CEO/President compra | +10 |\\n| Ratio Purchase/MktCap 0.071% | +5 |\\n| ΔOwn <10% | +0 |\\n| Primera compra open-market CFO | +5 |\\n| Sin 10b5-1 | +3 |\\n| 2 C-level cluster ≤7d | +10 |\\n| Cluster total <0.30% | +0 |\\n| Ratio compra/salario >20% | +3 |\\n| **Subtotal** | **36** |\\n\\n**Nota clave:** Bosway compró $272K en Marzo (3 tramos: $38.29, $39.53, $41.37) y ahora $739K en Mayo a ~$37.44. Acumulación total open-market de >$1M en 3 meses. Patrón de acumulación agresiva mientras el stock cae. Además, las ventas de Marzo fueron ligadas a vesting de grants (27,801 acciones at $0 el 2-Mar, venta parcial 4-Mar), no señal bearish.\\n\\n---\\n\\n### PILAR 2: CATALIZADOR (8/25)\\n\\n| Campo | Valor |\\n|---|---|\\n| Tipo | Post-earnings accumulation + Investor conferences Mayo |\\n| Fecha Q1 Results | 07-May-2026 (ya reportado) |\\n| Binario | No |\\n| Próximo evento | Conferencias de inversores en Mayo |\\n| Fuente | Press release FMP |\\n\\n| Concepto | Pts |\\n|---|---|\\n| No binario ≤30 días (conferencias) | +6 |\\n| Sector Industrials (otro) | +2 |\\n| **Subtotal** | **8** |\\n\\n**Análisis:** Q1 2026 ya fue reportado el 7 de mayo. Revenue creció +58% QoQ y +15% YoY. El operating income fue ligeramente negativo (-$4.5M, margen -1.25%), posiblemente estacional para construcción. **El CEO compró DESPUÉS de ver los resultados internos**, lo que sugiere visibilidad positiva sobre Q2/Q3. Sin embargo, no hay un catalizador binario identificable (FDA, contrato, regulación). La data de nextEarningsDate=May 28 parece errónea dado que Q1 ya se reportó el 7 de mayo.\\n\\n---\\n\\n### PILAR 3: TIMING (20/20)\\n\\n| Campo | Valor |\\n|---|---|\\n| Priced-In State | **1 (Not Priced-In)** |\\n| Precio actual vs 52w high | -47.8% ($39.20 vs $75.08) |\\n| Precio actual vs 52w low | +5.1% ($39.20 vs $37.30) |\\n| RSI | 34.26 (oversold) |\\n| Move previo 10d | Flat (~-1.3% en 5d) |\\n| Precio vs 50dma | -5.5% |\\n| Precio vs 200dma | **-27.4%** |\\n| PE | 12.06x (value territory para industrial) |\\n| Social | **Silencio total** (sin datos de X/SA) |\\n| Menciones 7d | ~0 |\\n| Cuentas grandes | Ninguna identificada |\\n\\n| Concepto | Pts |\\n|---|---|\\n| State 1 (Not Priced-In) | +10 |\\n| Post-crash / near 52-week low | +5 |\\n| Silencio social total | +5 |\\n| **Subtotal** | **20** |\\n\\n---\\n\\n### BONUS OPCIONES (0/10)\\n\\n| Campo | Valor |\\n|---|---|\\n| Cadena | Sin datos de opciones disponibles |\\n| Flow pre-filing | N/D |\\n| Divergencia | N/D |\\n\\n---\\n\\n### DUE DILIGENCE\\n\\n| Campo | Valor |\\n|---|---|\\n| Dilución | **Clean** — Sin shelf registrations ni ATM |\\n| Cash | $20M (bajó de $116M), pero revenue $356M/Q y current ratio 1.41 |\\n| Debt/Equity | 1.56 — moderado, aceptable para industrial |\\n| Revenue | Crecimiento sólido: +58% QoQ, +15% YoY |\\n| Operating Margin | -1.25% (ligeramente negativo, posible estacionalidad Q1 construcción) |\\n| FCF | -$47M (negativo, pero podría ser estacional/inversión) |\\n| Management | **Clean** — CEO acumulando agresivamente con dinero propio |\\n| Litigios | **Clean** — Los press releases de \\\"Black Rock Coffee Bar\\\" NO son Gibraltar |\\n\\n**⚠️ Bandera amarilla:** La caída de cash de $116M a $20M y FCF negativo merecen monitoreo, aunque con $700M en activos corrientes vs $497M pasivos corrientes, no hay riesgo inmediato de liquidez. La deuda de $1.37B es significativa pero manejable con revenue anualizado de ~$1.2B.\\n\\n---\\n\\n### AJUSTES\\n\\n| Ajuste | Puntos |\\n|---|---|\\n| Fear & Greed (N/D) | 0 |\\n| Social (silencio) | 0 |\\n| Priced-In (State 1) | 0 |\\n| **Total ajustes** | **0** |\\n\\n---\\n\\n**SCORE FINAL: 64/100**\\n\\n| Pilar | Puntos |\\n|---|---|\\n| Insider Conviction | 36/45 |\\n| Catalizador | 8/25 |\\n| Timing | 20/20 |\\n| Bonus Opciones | 0/10 |\\n| Ajustes | 0 |\\n| **TOTAL** | **64/100** |\\n\\n---\\n\\n## DECISIÓN\\n\\n---\\n\\n**CLASIFICACIÓN: WATCHLIST (B)**\\n\\n**Regla dura aplicada:** \\\"Sin las 2 confluencias principales (insider + catalizador): máximo Grado B\\\". La convicción insider es **excepcional** (CEO comprando >$1M en 3 meses near 52-week lows), pero el pilar de catalizador es débil sin un evento binario próximo.\\n\\n---\\n\\n**WATCHLIST.** Monitorear en próximas 48-72h:\\n\\n1. **Earnings/guidance update:** Si aparece un evento de resultados o guidance update (verificar si hay algo programado para mayo 28), podría escalar a A inmediatamente\\n2. **Nuevo insider:** Si un director se suma al cluster, esto se convierte en 3+ personas y refuerza el pilar 1\\n3. **Catalizador sectorial:** Cualquier noticia de infraestructura, housing starts, o contratos gubernamentales para el sector construcción\\n4. **Flow de opciones:** Si aparece call flow institucional anticipatorio, sumaría +5 a +8 puntos\\n5. **Precio:** Si el stock rompe por debajo de $37.30 (52w low) con volumen, la tesis se debilita. Si mantiene el soporte y rebota, confirma el piso que los insiders están marcando\\n\\n**POR QUÉ VALE LA PENA MONITOREAR:**\\nEl CEO William Bosway ha puesto >$1M de su propio dinero en compras open-market en 3 meses, acelerando el tamaño ($739K es la compra más grande). Esto sucede con el stock cerca de mínimos de 52 semanas, RSI en oversold, PE de 12x, y cero ruido social. Es el perfil clásico de \\\"el CEO sabe algo que el mercado no está viendo\\\". Solo falta el catalizador para activar la señal.\\n\\n**CONDICIONES DE INVALIDACIÓN:**\\n- Insider vende acciones (especialmente Bosway)\\n- Dilución o shelf registration\\n- Guidance negativa o profit warning\\n- Cash position deteriora más sin explicación\\n- Viralización social que elimine la ventaja temporal\",\"score\":64,\"grade\":\"B\",\"summary\":\"CEO acumula +$1M en 3 meses near 52w low con silencio total, pero falta catalizador binario para activar entrada.\",\"raw_en\":\"## ROCK\\n\\n**Generated:** 2026-05-27T16:31:11.762Z UTC | **SCORE: 64/100** | **GRADE: B**\\n\\n> Strong CEO+CFO cluster buying $823K near 52-week lows but no clear binary catalyst in sight.\\n\\n---\\n\\n| Field | Value |\\n|---|---|\\n| Tier | 1 (≥$200M) — Market cap $1.16B |\\n| Fear & Greed | N/A |\\n| Regime | Caution (stock -48% from highs, RSI 34) |\\n\\n---\\n\\n### STEP A — AUTOMATIC DISCARD\\n\\n- [x] No 10b5-1 (discretionary open-market purchases)\\n- [x] Market cap $1.16B — within $50M-$2B range\\n- [x] No shelf registration / dilution\\n- [x] Limited cash runway BUT with revenue ($356M/Q) — rule does not apply\\n- [x] No going concern\\n- [x] No fraud history (\\\"Black Rock Coffee Bar\\\" press releases are NOT Gibraltar)\\n- [x] No class action against ROCK\\n- [x] No viral social activity\\n- [x] Clear State 1 (stock at lows)\\n- [x] No options divergence\\n\\n**→ All rules pass. Proceeding.**\\n\\n---\\n\\n### PILLAR 1: INSIDER CONVICTION (36/45)\\n\\n| Field | Value |\\n|---|---|\\n| Insider #1 | **Bosway William T (President & CEO)** |\\n| Amount | $738,833 — 19,735 shares at ~$37.44 |\\n| Insider #2 | **Lovechio Joseph A (VP & CFO)** |\\n| Amount | $34,615 — 1,000 shares at $34.62 |\\n| Insider #3 | **Bolanowski Katherine (GC, VP, Secretary)** |\\n| Amount | $49,886 — 1,400 shares in 2 tranches at ~$35.64 |\\n| Total cluster | **$823,334** |\\n| Purchase/MktCap Ratio | 0.071% (range 0.05-0.15%) |\\n| ΔOwn CEO | +8.6% (19,735 over prior 230,585) |\\n| ΔOwn CFO | +8.1% (1,000 over prior 12,390) |\\n| Cluster | **2 C-level (CEO + CFO) + VP within ≤7 days** |\\n| 10b5-1 | **No** — open-market purchases at different prices |\\n| First CFO purchase | First open-market purchase in the last 12+ months (prior ones were grants at $0) |\\n| Purchase/CEO salary ratio | >100% of reported comp (extraordinary) |\\n\\n**Point breakdown:**\\n\\n| Concept | Pts |\\n|---|---|\\n| CEO/President purchase | +10 |\\n| Purchase/MktCap ratio 0.071% | +5 |\\n| ΔOwn <10% | +0 |\\n| First open-market CFO purchase | +5 |\\n| No 10b5-1 | +3 |\\n| 2 C-level cluster ≤7d | +10 |\\n| Total cluster <0.30% | +0 |\\n| Purchase/salary ratio >20% | +3 |\\n| **Subtotal** | **36** |\\n\\n**Key note:** Bosway purchased $272K in March (3 tranches: $38.29, $39.53, $41.37) and now $739K in May at ~$37.44. Total open-market accumulation of >$1M in 3 months. Aggressive accumulation pattern as the stock falls. Additionally, the March sales were tied to grant vesting (27,801 shares at $0 on Mar-2, partial sale Mar-4), not a bearish signal.\\n\\n---\\n\\n### PILLAR 2: CATALYST (8/25)\\n\\n| Field | Value |\\n|---|---|\\n| Type | Post-earnings accumulation + Investor conferences May |\\n| Q1 Results Date | 07-May-2026 (already reported) |\\n| Binary | No |\\n| Next event | Investor conferences in May |\\n| Source | FMP press release |\\n\\n| Concept | Pts |\\n|---|---|\\n| Non-binary ≤30 days (conferences) | +6 |\\n| Industrials sector (other) | +2 |\\n| **Subtotal** | **8** |\\n\\n**Analysis:** Q1 2026 was already reported on May 7. Revenue grew +58% QoQ and +15% YoY. Operating income was slightly negative (-$4.5M, -1.25% margin), possibly seasonal for construction. **The CEO purchased AFTER seeing internal results**, suggesting positive visibility into Q2/Q3. However, no identifiable binary catalyst exists (FDA, contract, regulation). The nextEarningsDate=May 28 data appears erroneous given Q1 was already reported on May 7.\\n\\n---\\n\\n### PILLAR 3: TIMING (20/20)\\n\\n| Field | Value |\\n|---|---|\\n| Priced-In State | **1 (Not Priced-In)** |\\n| Current price vs 52w high | -47.8% ($39.20 vs $75.08) |\\n| Current price vs 52w low | +5.1% ($39.20 vs $37.30) |\\n| RSI | 34.26 (oversold) |\\n| Prior 10d move | Flat (~-1.3% in 5d) |\\n| Price vs 50dma | -5.5% |\\n| Price vs 200dma | **-27.4%** |\\n| PE | 12.06x (value territory for industrial) |\\n| Social | **Total silence** (no X/SA data) |\\n| 7d mentions | ~0 |\\n| Large accounts | None identified |\\n\\n| Concept | Pts |\\n|---|---|\\n| State 1 (Not Priced-In) | +10 |\\n| Post-crash / near 52-week low | +5 |\\n| Total social silence | +5 |\\n| **Subtotal** | **20** |\\n\\n---\\n\\n### OPTIONS BONUS (0/10)\\n\\n| Field | Value |\\n|---|---|\\n| Chain | No options data available |\\n| Pre-filing flow | N/A |\\n| Divergence | N/A |\\n\\n---\\n\\n### DUE DILIGENCE\\n\\n| Field | Value |\\n|---|---|\\n| Dilution | **Clean** — No shelf registrations or ATM |\\n| Cash | $20M (down from $116M), but revenue $356M/Q and current ratio 1.41 |\\n| Debt/Equity | 1.56 — moderate, acceptable for industrial |\\n| Revenue | Solid growth: +58% QoQ, +15% YoY |\\n| Operating Margin | -1.25% (slightly negative, possible Q1 construction seasonality) |\\n| FCF | -$47M (negative, but could be seasonal/investment) |\\n| Management | **Clean** — CEO aggressively accumulating with own money |\\n| Litigation | **Clean** — \\\"Black Rock Coffee Bar\\\" press releases are NOT Gibraltar |\\n\\n**⚠️ Yellow flag:** The cash decline from $116M to $20M and negative FCF warrant monitoring, although with $700M in current assets vs $497M current liabilities, there is no immediate liquidity risk. The $1.37B debt is significant but manageable with annualized revenue of ~$1.2B.\\n\\n---\\n\\n### ADJUSTMENTS\\n\\n| Adjustment | Points |\\n|---|---|\\n| Fear & Greed (N/A) | 0 |\\n| Social (silence) | 0 |\\n| Priced-In (State 1) | 0 |\\n| **Total adjustments** | **0** |\\n\\n---\\n\\n**FINAL SCORE: 64/100**\\n\\n| Pillar | Points |\\n|---|---|\\n| Insider Conviction | 36/45 |\\n| Catalyst | 8/25 |\\n| Timing | 20/20 |\\n| Options Bonus | 0/10 |\\n| Adjustments | 0 |\\n| **TOTAL** | **64/100** |\\n\\n---\\n\\n## DECISION\\n\\n---\\n\\n**CLASSIFICATION: WATCHLIST (B)**\\n\\n**Hard rule applied:** \\\"Without the 2 main confluences (insider + catalyst): maximum Grade B\\\". Insider conviction is **exceptional** (CEO buying >$1M in 3 months near 52-week lows), but the catalyst pillar is weak without an upcoming binary event.\\n\\n---\\n\\n**WATCHLIST.** Monitor over the next 48-72h:\\n\\n1. **Earnings/guidance update:** If an earnings event or guidance update appears (verify whether anything is scheduled for May 28), could escalate to A immediately\\n2. **New insider:** If a director joins the cluster, this becomes 3+ people and reinforces pillar 1\\n3. **Sector catalyst:** Any news on infrastructure, housing starts, or government contracts for the construction sector\\n4. **Options flow:** If anticipatory institutional call flow appears, would add +5 to +8 points\\n5. **Price:** If the stock breaks below $37.30 (52w low) on volume, the thesis weakens. If it holds support and bounces, it confirms the floor the insiders are marking\\n\\n**WHY IT IS WORTH MONITORING:**\\nCEO William Bosway has put >$1M of his own money into open-market purchases over 3 months, accelerating in size ($739K is the largest purchase). This occurs with the stock near 52-week lows, RSI in oversold territory, PE at 12x, and zero social noise. It is the classic profile of \\\"the CEO knows something the market is not seeing\\\". Only the catalyst is missing to trigger the signal.\\n\\n**INVALIDATION CONDITIONS:**\\n- Insider sells shares (especially Bosway)\\n- Dilution or shelf registration\\n- Negative guidance or profit warning\\n- Cash position deteriorates further without explanation\\n- Social viralization that eliminates the temporal advantage\",\"raw_es\":null}","{\"snapshotDate\":\"2026-05-27\",\"fearGreedValue\":null,\"fearGreedLabel\":null,\"hySpreadOas\":2.74,\"m2YoyPct\":4.72453,\"hygPrice\":80.18,\"hygPriceAvg50\":79.875,\"hygPriceAvg200\":80.4879,\"jnkPrice\":96.56,\"jnkPriceAvg50\":96.1398,\"jnkPriceAvg200\":96.97895}","2026-05-27T16:34:30.053Z","error","https://images.financialmodelingprep.com/symbol/ROCK.png",34.259038116035654,"allTickers",[209,211,213,215,217,219,221,224,227,230,233,236,239,242,244,247,250,253,256,259,262,265,268,271,274,277,280,282,285,286,289,292,295,298,301,304,307,310,313,316,318,321,324,327,330,333,336,339,342,345,348,351,354,357,360,362,365,368,371,374,376,379,382,385,388,391,394,397,400,403,406,409,412,415,417,420,423,426,429,432,435,438,441,444,447,448,451,454,457,460,463,466,469,472,475,478,481,484,487,490,493,496,499,502,505,508,511,514,517,520,523,526,529,532,535,538,541,544,547,550,553,556,559,562,565,568,571,574,577,580,583,586,589,592,595,598,601,604,607,610,613,616,619,622,625,628,631,634,637,640,643,646,649,652,655,658,661,664,667,670,673,676,679,682,685,688,691,694,697,700,703,706,709,712,715,717,720,722,724,727,730,733,735,738,741,744,747,750,753,756,759,762,765,768,771,774,777,780,783,786,789,792,795,798,801,804,807,810,813,816,819,822,825,828,831,834,837,840,843,846,849,852,855,858,861,864,867,870,873,876,879,882,885,888,891,894,897,900,903,906,909,912,915,918,921,924,927,929,932,935,938,940,943,946,949,952,955,958,961,964,967,969,972,975,978,981,984,987,990,992,995,998,1001,1004,1007,1010,1013,1016,1019,1022,1025,1028,1031,1034,1037,1040,1043,1046,1049,1052,1055,1058,1061,1064,1067,1070,1073,1076,1079,1082,1085,1088,1091,1094,1097,1100,1103,1106,1109,1111,1114,1117,1120,1123,1126,1129,1132,1135,1138,1141,1144,1147,1150,1153,1156,1159,1162,1165,1168,1171,1174,1177,1180,1183,1186,1189,1192,1195,1198,1201,1204,1207,1210,1213,1216,1219,1222,1225,1228,1231,1234,1237,1240,1243,1246,1249,1252,1255,1258,1261,1264,1267,1270,1273,1276,1278,1280,1283,1286,1289,1292,1295,1298,1301,1304,1307,1310,1313,1316,1319,1322,1325,1328,1331,1334,1337,1340,1343,1346,1348,1351,1354,1357,1360,1363,1366,1368,1371,1374,1377,1380,1383,1386,1389,1392,1395,1398,1401,1404,1407,1410,1413,1416,1419,1422,1425,1428,1431,1434,1437,1440,1443,1446,1449,1452,1455,1458,1461,1464,1467,1470,1473,1476,1479,1482,1485,1488,1491,1494,1497,1500,1503,1506,1509,1512,1515,1518,1521,1524,1527,1530,1533,1536,1539,1542,1545,1547,1549,1552,1555,1558,1561,1564,1567,1570,1573,1576,1579,1582,1585,1588,1591,1594,1597,1600,1603,1606,1609,1612,1615,1618,1621,1624,1627,1630,1632,1635,1638,1641,1644,1647,1650,1653,1656,1659,1662,1665,1668,1671,1674,1677,1680,1683,1686,1689,1692,1695,1698,1701,1704,1707,1710,1713,1716,1719,1722,1725,1728,1731,1734,1737,1740,1743,1746,1749,1752,1754,1757,1760,1763,1766,1769,1772,1775,1778,1781,1783,1786,1789,1792,1795,1798,1800,1803,1806,1809,1812,1815,1818,1821,1824,1827,1830,1833,1836,1839,1842,1845,1848,1851,1854,1857,1860,1863,1866,1869,1872,1875,1877,1880,1883,1886,1889,1892,1895,1898,1901,1904,1907,1910,1913,1916,1919,1922,1925,1928,1931,1934,1937,1940,1943,1946,1949,1952,1955,1958,1961,1964,1967,1970,1973,1976,1979,1982,1985,1988,1991,1994,1997,2000,2003,2006,2008,2011,2014,2017,2020,2023,2026,2029,2032,2035,2038,2041,2044,2047,2049,2052,2055,2058,2061,2064,2067,2070,2073,2076,2079,2082,2085,2088,2091,2094,2097,2100,2103,2106,2109,2112,2115,2118,2121,2124,2127,2130,2133,2136,2139,2142,2145,2148,2151,2154,2157,2160,2163,2166,2169,2172,2175,2178,2181,2184,2187,2190,2193,2196,2199,2202,2205,2208,2211,2214,2216,2219,2222,2225,2228,2231,2234,2237,2240,2243,2246,2249,2252,2255,2258,2261,2264,2267,2270,2273,2276,2279,2282,2285,2288,2290,2293,2296,2299,2302,2305,2308,2311,2314,2317,2320,2323,2325,2328,2331,2334,2337,2340,2343,2346,2349,2352,2355,2358,2361,2364,2367,2370,2373,2376,2379,2382,2385,2388,2391,2394,2397,2400,2403,2406,2409,2412,2415,2418,2421,2424,2427,2430,2433,2436,2439,2442,2445,2448,2451,2454,2457,2460,2463,2466,2469,2472,2475,2478,2481,2484,2487,2490,2493,2496,2499,2502,2505,2508,2511,2514,2517,2520,2523,2525,2527,2530,2533,2536,2539,2542,2545,2548,2551,2554,2557,2560,2563,2565,2568,2571,2574,2577,2580,2583,2586,2589,2592,2595,2598,2601,2604,2607,2610,2613,2616,2619,2622,2625,2628,2631,2633,2636,2639,2642,2645,2648,2651,2654,2657,2660,2663,2666,2669,2672,2675,2678,2681,2684,2687,2690,2693,2696,2699,2702,2705,2708,2711,2714,2717,2720,2723,2726,2729,2732,2735,2738,2741,2744,2747,2750,2753,2756,2759,2762,2765,2768,2771,2774,2777,2780,2783,2786,2789,2792,2795,2798,2801,2804,2807,2810,2813,2816,2818,2821,2824,2827,2829,2831,2834,2836,2839,2842,2845,2848,2851,2854,2857,2860,2863,2866,2869,2872,2875,2878,2881,2884,2887,2890,2893,2896,2899,2902,2905,2908,2911,2914,2917,2920,2923,2926,2929,2932,2935,2938,2941,2944,2947,2950,2953,2956,2959,2962,2965,2968,2971,2974,2977,2980,2983,2986,2989,2992,2995,2998,3001,3004,3007,3010,3013,3016,3019,3022,3025,3028,3031,3034,3037,3040,3043,3046,3049,3052,3055,3058,3061,3064,3067,3070,3073,3076,3079,3082,3085,3088,3091,3094,3097,3100,3103,3106,3109,3112,3115,3118,3121,3124,3127,3130,3133,3136,3139,3142,3145,3148,3151,3154,3157,3160,3163,3166,3169,3172,3175,3178,3181,3184,3187,3190,3193,3196,3199,3202,3205,3208,3211,3213,3216,3219,3222,3225,3228,3231,3232,3235,3238,3241,3244,3247,3250,3253,3256,3259,3262,3265,3268,3271,3274,3277,3280,3283,3286,3289,3292,3295,3298,3301,3304,3307,3310,3313,3316,3319,3322,3325,3328,3331,3334,3337,3340,3343,3346,3349,3352,3355,3358,3361,3364,3367,3370,3373,3376,3379,3382,3385,3388,3391,3394,3397,3400,3403,3406,3409,3412,3415,3418,3421,3424,3427,3430,3433,3436,3439,3442,3445,3448,3451,3454,3457,3460,3463,3466,3469,3472,3475,3478,3481,3484,3487,3490,3493,3496,3499,3502,3505,3508,3511,3514,3517,3520,3523,3526,3529,3532,3535,3538,3541,3544,3547,3550,3553,3556,3559,3562,3565,3568,3571,3574,3577,3580,3583,3586,3589,3592,3595,3598,3601,3604,3607,3610,3613,3616,3619,3622,3625,3628,3631,3634,3637,3640,3643,3646,3649,3652,3655,3658,3661,3664,3667,3670,3673,3676,3679,3681,3684,3687,3690,3693,3696,3699,3702,3705,3708,3711,3714,3717,3720,3723,3726,3729,3732,3735,3738,3741,3744,3747,3750,3753,3756,3759,3762,3764,3767,3770,3773,3776,3779,3782,3785,3788,3791,3794,3797,3800,3803,3806,3809,3812,3815,3818,3821,3824,3827,3830,3833,3836,3839,3842,3845,3848,3851,3854,3857,3860,3863,3866,3868,3871,3874,3877,3880,3883,3886,3889,3892,3895,3898,3901,3904,3907,3910,3913,3916,3919,3922,3925,3928,3931,3934,3937,3940,3943,3946,3948,3951,3954,3957,3960,3963,3966,3969,3972,3975,3978,3981,3984,3987,3990,3993,3996,3999,4002,4005,4008,4011,4014,4016,4019,4022,4025,4028,4031,4034,4037,4040,4043,4046,4049,4052,4055,4058,4061,4064,4067,4070,4073,4075,4078,4081,4084,4086,4089,4092,4095,4098,4100,4103,4105,4107,4110,4113,4116,4119,4122,4125,4128,4131,4134,4137,4140,4143,4146,4149,4152,4155,4158,4161,4164,4167,4170,4173,4176,4179,4182,4185,4188,4191,4194,4197,4200,4203,4206,4209,4212,4215,4218,4221,4224,4227,4230,4233,4236,4239,4242,4245,4248,4250,4253,4256,4259,4262,4265,4268,4271,4274,4277,4280,4283,4286,4289,4292,4295,4298,4301,4304,4307,4309,4312,4315,4318,4321,4324,4327,4330,4333,4336,4339,4342,4345,4348,4351,4354,4357,4360,4363,4366,4369,4372,4375,4378,4381,4383,4386,4389,4392,4395,4398,4401,4404,4407,4410,4413,4416,4419,4422,4425,4428,4430,4433,4436,4439,4442,4445,4448,4451,4454,4457,4460,4463,4466,4469,4472,4475,4478,4481,4484,4487,4490,4493,4496,4499,4502,4505,4508,4511,4514,4517,4520,4522,4525,4528,4531,4534,4537,4540,4542,4545,4548,4550,4553,4556,4559,4562,4565,4567,4570,4573,4576,4579,4581,4584,4587,4590,4593,4596,4599,4602,4605,4608,4611,4614,4617,4620,4623,4626,4629,4632,4635,4637,4640,4643,4646,4649,4652,4655,4658,4661,4664,4667,4670,4673,4676,4679,4682,4685,4688,4691,4694,4697,4700,4703,4706,4709,4712,4715,4718,4721,4724,4727,4730,4733,4736,4739,4742,4745,4748,4751,4753,4756,4759,4762,4765,4768,4771,4774,4777,4780,4783,4786,4789,4792,4795,4798,4801,4804,4807,4810,4813,4816,4819,4822,4825,4828,4831,4834,4837,4840,4843,4846,4849,4852,4855,4856,4859,4862,4865,4868,4871,4874,4877,4879,4882,4885,4888,4891,4894,4897,4900,4903,4906,4909,4912,4915,4918,4921,4924,4927,4930,4933,4936,4939,4942,4945,4948,4951,4954,4957,4960,4963,4966,4969,4972,4975,4978,4981,4984,4987,4990,4993,4996,4999,5002,5005,5008,5011,5014,5017,5020,5023,5026,5029,5032,5035,5038,5041,5044,5047,5050,5053,5056,5059,5062,5065,5068,5071,5074,5077,5080,5083,5085,5088,5091,5094,5097,5100,5103,5106,5109,5112,5115,5118,5121,5124,5127,5130,5133,5136,5139,5142,5145,5148,5150,5153,5156,5159,5162,5165,5168,5170,5173,5176,5179,5182,5185,5188,5190,5193,5196,5199,5202,5205,5208,5211,5213,5216,5219,5222,5225,5228,5231,5234,5237,5240,5243,5246,5249,5252,5255,5258,5261,5264,5267,5270,5273,5276,5279,5282,5285,5288,5291,5294,5297,5300,5303,5306,5309,5312,5315,5318,5321,5324,5327,5330,5333,5335,5338,5341,5344,5347,5350,5353,5356,5359,5362,5365,5368,5371,5374,5377,5380,5383,5386,5389,5392,5395,5398,5401,5404,5407,5409,5412,5415,5418,5421,5424,5427,5430,5433,5436,5439,5442,5444,5447,5450,5453,5456,5459,5462,5465,5468,5471,5474,5477,5480,5483,5486,5489,5492,5495,5498,5501,5504,5507,5510,5513,5516,5519,5522,5525,5528,5531,5534,5537,5540,5543,5546,5549,5552,5555,5558,5561,5564,5567,5570,5573,5576,5579,5582,5585,5588,5591,5594,5597,5600,5603,5606,5609,5612,5615,5618,5621,5624,5627,5630,5633,5636,5638,5641,5644,5647,5650,5653,5656,5659,5662,5665,5668,5671,5674,5677,5680,5683,5686,5689,5692,5695,5698,5700,5703,5706,5709,5712,5715,5716,5719,5722,5725,5728,5731,5734,5737,5740,5743,5746,5749,5752,5755,5758,5761,5763,5766,5769,5772,5775,5778,5781,5784,5787,5788,5791,5794,5797,5800,5803,5806,5808,5811,5814,5817,5819,5822,5823,5826,5829,5832,5835,5838,5841,5843,5846,5849,5852,5855,5858,5861,5864,5867,5870,5873,5876,5879,5882,5885,5888,5891,5894,5897,5900,5903,5906,5909,5911,5914,5916,5919,5922,5925,5928,5931,5934,5937,5940,5943,5946,5949,5952,5955,5958,5961,5964,5966,5969,5972,5975,5978,5981,5984,5987,5990,5993,5996,5999,6002,6005,6007,6010,6013,6016,6019,6022,6025,6028,6031,6034,6037,6040,6043,6046,6049,6052,6055,6058,6061,6064,6067,6069,6071,6074,6077,6079,6082,6085,6088,6091,6094,6097,6100,6103,6106,6109,6112,6115,6118,6121,6124,6127,6130,6133,6136,6139,6142,6145,6148,6151,6154,6157,6160,6163,6166,6169,6172,6175,6178,6181,6184,6187,6190,6193,6196,6199,6202,6205,6208,6211,6214,6217,6220,6223,6226,6229,6232,6235,6238,6241,6244,6247,6250,6253,6256,6259,6262,6265,6268,6271,6274,6277,6280,6283,6286,6289,6292,6295,6298,6301,6304,6307,6310,6313,6316,6319,6322,6325,6328,6331,6334,6337,6340,6343,6345,6348,6351,6354,6356,6359,6362,6365,6368,6371,6374,6376,6379,6382,6385,6388,6391,6394,6397,6400,6403,6406,6409,6412,6415,6417,6420,6423,6426,6429,6432,6435,6438,6441,6444,6447,6450,6452,6455,6458,6461,6464,6467,6470,6473,6476,6479,6481,6484,6487,6490,6493,6496,6499,6502,6505,6508,6511,6514,6517,6520,6523,6526,6529,6532,6535,6538,6541,6544,6547,6550,6553,6556,6559,6562,6565,6568,6571,6574,6577,6580,6583,6586,6589,6592,6594,6597,6600,6603,6606,6609,6612,6615,6618,6621,6624,6627,6630,6633,6636,6639,6642,6645,6648,6651,6654,6657,6660,6663,6666,6669,6672,6675,6678,6681,6684,6687,6690,6693,6696,6699,6702,6705,6708,6711,6714,6717,6720,6723,6726,6729,6732,6735,6738,6741,6744,6747,6750,6753,6756,6759,6762,6765,6768,6771,6774,6777,6780,6783,6786,6789,6792,6795,6798,6801,6804,6807,6810,6813,6816,6819,6822,6825,6828,6831,6834,6837,6840,6843,6846,6849,6852,6855,6858,6861,6864,6867,6870,6873,6876,6879,6882,6885,6888,6891,6893,6896,6899,6902,6905,6908,6911,6914,6917,6920,6923,6926,6929,6932,6935,6938,6941,6944,6947,6950,6953,6956,6957,6960,6962,6965,6967,6969,6972,6975,6978,6981,6984,6987,6990,6993,6996,6999,7002,7005,7008,7011,7014,7017,7020,7023,7026,7029,7032,7035,7038,7041,7044,7047,7050,7053,7056,7059,7062,7065,7068,7071,7074,7077,7080,7083,7086,7089,7092,7095,7098,7101,7104,7107,7110,7113,7116,7119,7122,7125,7128,7131,7134,7137,7140,7143,7146,7149,7152,7155,7158,7161,7164,7167,7170,7173,7176,7179,7182,7185,7188,7191,7194,7197,7200,7203,7206,7209,7212,7215,7218,7221,7224,7227,7229,7231,7233,7235,7238,7241,7244,7247,7250,7253,7256,7259,7262,7265,7268,7271,7274,7277,7280,7283,7286,7289,7291,7294,7296,7299,7302,7305,7307,7310,7313,7316,7319,7322,7325,7328,7331,7334,7337,7340,7343,7346,7349,7352,7355,7358,7361,7364,7367,7370,7373,7376,7379,7382,7385,7387,7390,7393,7396,7399,7402,7405,7408,7411,7414],{"_12":210,"_14":-5},".AWS",{"_12":212,"_14":-5},".DS_STORE",{"_12":214,"_14":-5},".ENV",{"_12":216,"_14":-5},".ENV.BACKUP",{"_12":218,"_14":-5},".ENV.BAK",{"_12":220,"_14":-5},".ENV.SAVE",{"_12":222,"_14":223},"AACPU","Apogee Acquisition Corp Units",{"_12":225,"_14":226},"AADX","Applied Aerospace & Defense, Inc.",{"_12":228,"_14":229},"AAOI","Applied Optoelectronics, Inc.",{"_12":231,"_14":232},"AAON","AAON, Inc.",{"_12":234,"_14":235},"AAPL","Apple Inc.",{"_12":237,"_14":238},"AASP","Agassi Sports Entertainment Corp.",{"_12":240,"_14":241},"AAT","American Assets Trust, Inc.",{"_12":243,"_14":-5},"AB-LEND",{"_12":245,"_14":246},"ABAT","American Battery Technology Company Common Stock",{"_12":248,"_14":249},"ABCL","AbCellera Biologics Inc.",{"_12":251,"_14":252},"ABEO","Abeona Therapeutics Inc.",{"_12":254,"_14":255},"ABEV","Ambev S.A.",{"_12":257,"_14":258},"ABG","Asbury Automotive Group, Inc.",{"_12":260,"_14":261},"ABNB","Airbnb, Inc.",{"_12":263,"_14":264},"ABR","Arbor Realty Trust, Inc.",{"_12":266,"_14":267},"ABSI","Absci Corporation",{"_12":269,"_14":270},"ABT","Abbott Laboratories",{"_12":272,"_14":273},"ABTC","American Bitcoin Corp",{"_12":275,"_14":276},"ABX","Abacus Global Management, Inc.",{"_12":278,"_14":279},"ACAAU","Averin Capital Acquisition Corp. Units",{"_12":281,"_14":-5},"ACCESS",{"_12":283,"_14":284},"ACCS","ACCESS Newswire Inc.",{"_12":13,"_14":15},{"_12":287,"_14":288},"ACDC","ProFrac Holding Corp.",{"_12":290,"_14":291},"ACEL","Accel Entertainment, Inc.",{"_12":293,"_14":294},"ACET","Adicet Bio, Inc.",{"_12":296,"_14":297},"ACGCU","ACP Holdings Acquisition Corp. Units",{"_12":299,"_14":300},"ACGL","Arch Capital Group Ltd.",{"_12":302,"_14":303},"ACHR","Archer Aviation Inc.",{"_12":305,"_14":306},"ACI","Albertsons Companies, Inc.",{"_12":308,"_14":309},"ACIC","American Coastal Insurance Corporation",{"_12":311,"_14":312},"ACIU","AC Immune S.A.",{"_12":314,"_14":315},"ACIW","ACI Worldwide, Inc.",{"_12":317,"_14":-5},"ACLOX",{"_12":319,"_14":320},"ACM","Aecom",{"_12":322,"_14":323},"ACN","Accenture plc",{"_12":325,"_14":326},"ACNB","ACNB Corporation",{"_12":328,"_14":329},"ACNT","Ascent Industries Co.",{"_12":331,"_14":332},"ACOG","Alpha Cognition Inc. Common Stock",{"_12":334,"_14":335},"ACON","Aclarion, Inc.",{"_12":337,"_14":338},"ACT","Enact Holdings Inc.",{"_12":340,"_14":341},"ACVA","ACV Auctions Inc.",{"_12":343,"_14":344},"ADAG","Adagene Inc.",{"_12":346,"_14":347},"ADBE","Adobe Inc.",{"_12":349,"_14":350},"ADC","Agree Realty Corporation",{"_12":352,"_14":353},"ADI","Analog Devices, Inc.",{"_12":355,"_14":356},"ADIL","Adial Pharmaceuticals, Inc.",{"_12":358,"_14":359},"ADMA","ADMA Biologics, Inc.",{"_12":361,"_14":-5},"ADMIN",{"_12":363,"_14":364},"ADMQ","ADM Endeavors, Inc.",{"_12":366,"_14":367},"ADP","Automatic Data Processing, Inc.",{"_12":369,"_14":370},"ADPT","Adaptive Biotechnologies Corporation",{"_12":372,"_14":373},"ADRX","ADARx Pharmaceuticals, Inc.",{"_12":375,"_14":-5},"ADS.TXT",{"_12":377,"_14":378},"ADSK","Autodesk, Inc.",{"_12":380,"_14":381},"ADT","ADT Inc.",{"_12":383,"_14":384},"ADTN","ADTRAN Holdings Inc.",{"_12":386,"_14":387},"ADTX","Aditxt, Inc.",{"_12":389,"_14":390},"ADV","Advantage Solutions Inc.",{"_12":392,"_14":393},"AEBI","Aebi Schmidt Holding AG",{"_12":395,"_14":396},"AEF","abrdn Emerging Markets ex-China Fund, Inc.",{"_12":398,"_14":399},"AEIS","Advanced Energy Industries, Inc.",{"_12":401,"_14":402},"AEO","American Eagle Outfitters, Inc.",{"_12":404,"_14":405},"AEON","AEON Biopharma, Inc.",{"_12":407,"_14":408},"AERA","AI Era Corp.",{"_12":410,"_14":411},"AERO","Grupo Aeroméxico, S.A.B. de C.V.",{"_12":413,"_14":414},"AESI","Atlas Energy Solutions Inc.",{"_12":416,"_14":-5},"AESP",{"_12":418,"_14":419},"AEYE","AudioEye, Inc.",{"_12":421,"_14":422},"AFB","AllianceBernstein National Municipal Income Fund, Inc.",{"_12":424,"_14":425},"AFCG","Advanced Flower Capital Inc.",{"_12":427,"_14":428},"AFL","Aflac Incorporated",{"_12":430,"_14":431},"AFRM","Affirm Holdings, Inc.",{"_12":433,"_14":434},"AFYA","Afya Limited",{"_12":436,"_14":437},"AGBK","AGI Inc",{"_12":439,"_14":440},"AGCO","AGCO Corporation",{"_12":442,"_14":443},"AGIG","Abundia Global Impact Group Inc.",{"_12":445,"_14":446},"AGL","Agilon Health, Inc.",{"_12":35,"_14":36},{"_12":449,"_14":450},"AGPU","Axe Compute Inc.",{"_12":452,"_14":453},"AGYS","Agilysys, Inc.",{"_12":455,"_14":456},"AHCO","AdaptHealth Corp.",{"_12":458,"_14":459},"AHNRF","Athena Gold Corporation",{"_12":461,"_14":462},"AHR","American Healthcare REIT, Inc.",{"_12":464,"_14":465},"AHRT","AH Realty Trust, Inc.",{"_12":467,"_14":468},"AI","C3.ai, Inc.",{"_12":470,"_14":471},"AIAI","AIAI Holdings Corporation Class A Common Stock",{"_12":473,"_14":474},"AII","American Integrity Insurance Group, Inc.",{"_12":476,"_14":477},"AIIR","Air Global PLC Ordinary Shares",{"_12":479,"_14":480},"AIJTY","Jianpu Technology Inc.",{"_12":482,"_14":483},"AIMD","Ainos, Inc.",{"_12":485,"_14":486},"AIP","Arteris, Inc.",{"_12":488,"_14":489},"AIRG","Airgain, Inc.",{"_12":491,"_14":492},"AIRS","AirSculpt Technologies, Inc.",{"_12":494,"_14":495},"AISP","Airship AI Holdings, Inc.",{"_12":497,"_14":498},"AJG","Arthur J. Gallagher & Co.",{"_12":500,"_14":501},"AKAM","Akamai Technologies, Inc.",{"_12":503,"_14":504},"AKBA","Akebia Therapeutics, Inc.",{"_12":506,"_14":507},"AKTS","Aktis Oncology, Inc.",{"_12":509,"_14":510},"ALAB","Astera Labs, Inc. Common Stock",{"_12":512,"_14":513},"ALCO","Alico, Inc.",{"_12":515,"_14":516},"ALDX","Aldeyra Therapeutics, Inc.",{"_12":518,"_14":519},"ALG","Alamo Group Inc.",{"_12":521,"_14":522},"ALHC","Alignment Healthcare, Inc.",{"_12":524,"_14":525},"ALIT","Alight, Inc.",{"_12":527,"_14":528},"ALK","Alaska Air Group, Inc.",{"_12":530,"_14":531},"ALKS","Alkermes plc",{"_12":533,"_14":534},"ALKT","Alkami Technology, Inc.",{"_12":536,"_14":537},"ALLE","Allegion plc",{"_12":539,"_14":540},"ALMR","Alamar Biosciences, Inc.",{"_12":542,"_14":543},"ALMS","Alumis Inc.",{"_12":545,"_14":546},"ALMU","Aeluma, Inc.",{"_12":548,"_14":549},"ALNT","Allient Inc.",{"_12":551,"_14":552},"ALNY","Alnylam Pharmaceuticals, Inc.",{"_12":554,"_14":555},"ALP","Alpha Compute Corp",{"_12":557,"_14":558},"ALPX","Alopexx, Inc.",{"_12":560,"_14":561},"ALRS","Alerus Financial Corporation",{"_12":563,"_14":564},"ALT","Altimmune, Inc.",{"_12":566,"_14":567},"ALTG","Alta Equipment Group Inc.",{"_12":569,"_14":570},"ALTO","Alto Ingredients, Inc.",{"_12":572,"_14":573},"ALZN","Alzamend Neuro, Inc.",{"_12":575,"_14":576},"AMAL","Amalgamated Financial Corp.",{"_12":578,"_14":579},"AMAN","Amanat Acquisition Corp Class A Ordinary Shares",{"_12":581,"_14":582},"AMAT","Applied Materials, Inc.",{"_12":584,"_14":585},"AMBA","Ambarella, Inc.",{"_12":587,"_14":588},"AMBQ","Ambiq Micro, Inc.",{"_12":590,"_14":591},"AMC","AMC Entertainment Holdings, Inc.",{"_12":593,"_14":594},"AMD","Advanced Micro Devices, Inc.",{"_12":596,"_14":597},"AME","AMETEK, Inc.",{"_12":599,"_14":600},"AMFN","American Fusion Inc.",{"_12":602,"_14":603},"AMG","Affiliated Managers Group, Inc.",{"_12":605,"_14":606},"AMH","American Homes 4 Rent",{"_12":608,"_14":609},"AMKR","Amkor Technology, Inc.",{"_12":611,"_14":612},"AMLX","Amylyx Pharmaceuticals, Inc.",{"_12":614,"_14":615},"AMPH","Amphastar Pharmaceuticals, Inc.",{"_12":617,"_14":618},"AMPL","Amplitude, Inc.",{"_12":620,"_14":621},"AMPY","Amplify Energy Corp.",{"_12":623,"_14":624},"AMR","Alpha Metallurgical Resources, Inc.",{"_12":626,"_14":627},"AMRC","Ameresco, Inc.",{"_12":629,"_14":630},"AMRZ","Amrize Ltd",{"_12":632,"_14":633},"AMS","American Shared Hospital Services",{"_12":635,"_14":636},"AMST","Amesite Inc.",{"_12":638,"_14":639},"AMT","American Tower Corporation",{"_12":641,"_14":642},"AMTB","Amerant Bancorp Inc.",{"_12":644,"_14":645},"AMWL","American Well Corporation",{"_12":647,"_14":648},"AMZE","Amaze Holdings, Inc.",{"_12":650,"_14":651},"AMZN","Amazon.com, Inc.",{"_12":653,"_14":654},"ANAB","AnaptysBio, Inc.",{"_12":656,"_14":657},"ANDG","Andersen",{"_12":659,"_14":660},"ANET","Arista Networks, Inc.",{"_12":662,"_14":663},"ANGX","Angel Studios, Inc.",{"_12":665,"_14":666},"ANIK","Anika Therapeutics, Inc.",{"_12":668,"_14":669},"ANIP","ANI Pharmaceuticals, Inc.",{"_12":671,"_14":672},"ANIX","Anixa Biosciences, Inc.",{"_12":674,"_14":675},"ANL","Adlai Nortye Ltd.",{"_12":677,"_14":678},"ANNX","Annexon, Inc.",{"_12":680,"_14":681},"ANRO","Alto Neuroscience, Inc.",{"_12":683,"_14":684},"ANVS","Annovis Bio, Inc.",{"_12":686,"_14":687},"AOMR","Angel Oak Mortgage, Inc.",{"_12":689,"_14":690},"AON","Aon plc",{"_12":692,"_14":693},"AOSL","Alpha and Omega Semiconductor Limited",{"_12":695,"_14":696},"AP","Ampco-Pittsburgh Corporation",{"_12":698,"_14":699},"APC","ARKO Petroleum Corp. Class A Common Stock",{"_12":701,"_14":702},"APCX","AppTech Payments Corp.",{"_12":704,"_14":705},"APHP","American Picture House Corporation",{"_12":707,"_14":708},"API","Agora, Inc.",{"_12":710,"_14":711},"APLE","Apple Hospitality REIT, Inc.",{"_12":713,"_14":714},"APLM","Apollomics Inc.",{"_12":716,"_14":-5},"APMC",{"_12":718,"_14":719},"APMD","Apnimed, Inc.",{"_12":721,"_14":-5},"APP-ADS.TXT",{"_12":723,"_14":-5},"APPL",{"_12":725,"_14":726},"APPN","Appian Corporation",{"_12":728,"_14":729},"APT","Alpha Pro Tech, Ltd.",{"_12":731,"_14":732},"APTV","Aptiv PLC",{"_12":734,"_14":-5},"APUR",{"_12":736,"_14":737},"ARBE","Arbe Robotics Ltd.",{"_12":739,"_14":740},"ARDC","Ares Dynamic Credit Allocation Fund, Inc.",{"_12":742,"_14":743},"ARDT","Ardent Health Partners, LLC",{"_12":745,"_14":746},"ARE","Alexandria Real Estate Equities, Inc.",{"_12":748,"_14":749},"ARKO","Arko Corp.",{"_12":751,"_14":752},"ARKR","Ark Restaurants Corp.",{"_12":754,"_14":755},"ARLO","Arlo Technologies, Inc.",{"_12":757,"_14":758},"ARLP","Alliance Resource Partners, L.P.",{"_12":760,"_14":761},"ARM","Arm Holdings plc American Depositary Shares",{"_12":763,"_14":764},"ARQ","Arq, Inc.",{"_12":766,"_14":767},"ARQQ","Arqit Quantum Inc.",{"_12":769,"_14":770},"ARQT","Arcutis Biotherapeutics, Inc.",{"_12":772,"_14":773},"ARTNA","Artesian Resources Corporation",{"_12":775,"_14":776},"ARTV","Artiva Biotherapeutics, Inc.",{"_12":778,"_14":779},"ARVN","Arvinas, Inc.",{"_12":781,"_14":782},"ARXS","Arxis, Inc. Class A Common Stock",{"_12":784,"_14":785},"AS","Amer Sports, Inc.",{"_12":787,"_14":788},"ASAN","Asana, Inc.",{"_12":790,"_14":791},"ASG","Liberty All-Star Growth Fund, Inc.",{"_12":793,"_14":794},"ASIC","Ategrity Specialty Holdings LLC",{"_12":796,"_14":797},"ASLE","AerSale Corporation",{"_12":799,"_14":800},"ASND","Ascendis Pharma A/S",{"_12":802,"_14":803},"ASPI","ASP Isotopes Inc. Common Stock",{"_12":805,"_14":806},"ASPN","Aspen Aerogels, Inc.",{"_12":808,"_14":809},"ASPS","Altisource Portfolio Solutions S.A.",{"_12":811,"_14":812},"ASRV","AmeriServ Financial, Inc.",{"_12":814,"_14":815},"ASST","Strive, Inc.",{"_12":817,"_14":818},"ASTS","AST SpaceMobile, Inc.",{"_12":820,"_14":821},"ASX","ASE Technology Holding Co., Ltd.",{"_12":823,"_14":824},"ASYS","Amtech Systems, Inc.",{"_12":826,"_14":827},"ATCH","AtlasClear Holdings, Inc.",{"_12":829,"_14":830},"ATEC","Alphatec Holdings, Inc.",{"_12":832,"_14":833},"ATEX","Anterix Inc.",{"_12":835,"_14":836},"ATHM","Autohome Inc.",{"_12":838,"_14":839},"ATI","ATI Inc.",{"_12":841,"_14":842},"ATLO","Ames National Corporation",{"_12":844,"_14":845},"ATMU","Atmus Filtration Technologies Inc.",{"_12":847,"_14":848},"ATNI","ATN International, Inc.",{"_12":850,"_14":851},"ATO","Atmos Energy Corporation",{"_12":853,"_14":854},"ATRA","Atara Biotherapeutics, Inc.",{"_12":856,"_14":857},"ATRC","AtriCure, Inc.",{"_12":859,"_14":860},"ATTO","Attovia Therapeutics, Inc.",{"_12":862,"_14":863},"ATXG","Addentax Group Corp.",{"_12":865,"_14":866},"ATYR","aTyr Pharma, Inc.",{"_12":868,"_14":869},"AUB","Atlantic Union Bankshares Corporation",{"_12":871,"_14":872},"AUBN","Auburn National Bancorporation, Inc.",{"_12":874,"_14":875},"AUGO","Aura Minerals",{"_12":877,"_14":878},"AUID","authID Inc.",{"_12":880,"_14":881},"AUNA","Auna S.A.",{"_12":883,"_14":884},"AUPH","Aurinia Pharmaceuticals Inc.",{"_12":886,"_14":887},"AUR","Aurora Innovation, Inc.",{"_12":889,"_14":890},"AVAV","AeroVironment, Inc.",{"_12":892,"_14":893},"AVBC","Avidia Bancorp, Inc.",{"_12":895,"_14":896},"AVD","American Vanguard Corporation",{"_12":898,"_14":899},"AVEX","Aevex Corp.",{"_12":901,"_14":902},"AVGO","Broadcom Inc.",{"_12":904,"_14":905},"AVIR","Atea Pharmaceuticals, Inc.",{"_12":907,"_14":908},"AVLN","Avalyn Pharma Inc. Common Stock",{"_12":910,"_14":911},"AVO","Mission Produce, Inc.",{"_12":913,"_14":914},"AVPT","AvePoint, Inc.",{"_12":916,"_14":917},"AVR","Anteris Technologies Global Corp.",{"_12":919,"_14":920},"AVTR","Avantor, Inc.",{"_12":922,"_14":923},"AVTX","Avalo Therapeutics, Inc.",{"_12":925,"_14":926},"AWF","AllianceBernstein Global High Income Fund",{"_12":928,"_14":-5},"AWHL",{"_12":930,"_14":931},"AWI","Armstrong World Industries, Inc.",{"_12":933,"_14":934},"AWR","American States Water Company",{"_12":936,"_14":937},"AWRE","Aware, Inc.",{"_12":939,"_14":-5},"AXIA3",{"_12":941,"_14":942},"AXP","American Express Company",{"_12":944,"_14":945},"AXR","AMREP Corporation",{"_12":947,"_14":948},"AYI","Acuity Brands, Inc.",{"_12":950,"_14":951},"AZIO","Azio AI Holdings, Inc.",{"_12":953,"_14":954},"AZO","AutoZone, Inc.",{"_12":956,"_14":957},"AZTA","Azenta, Inc.",{"_12":959,"_14":960},"BA","The Boeing Company",{"_12":962,"_14":963},"BABA","Alibaba Group Holding Limited",{"_12":965,"_14":966},"BACC","Blue Acquisition Corp.",{"_12":968,"_14":-5},"BACKEND",{"_12":970,"_14":971},"BAER","Bridger Aerospace Group Holdings, Inc. Common Stock",{"_12":973,"_14":974},"BALL","Ball Corporation",{"_12":976,"_14":977},"BAND","Bandwidth Inc.",{"_12":979,"_14":980},"BANX","ArrowMark Financial Corp.",{"_12":982,"_14":983},"BATL","Battalion Oil Corporation",{"_12":985,"_14":986},"BATRK","Atlanta Braves Holdings, Inc.",{"_12":988,"_14":989},"BB","BlackBerry Limited",{"_12":991,"_14":-5},"BBASX",{"_12":993,"_14":994},"BBBY","Bed Bath & Beyond Inc.",{"_12":996,"_14":997},"BBD","Banco Bradesco S.A.",{"_12":999,"_14":1000},"BBDC","Barings BDC, Inc.",{"_12":1002,"_14":1003},"BBIO","BridgeBio Pharma, Inc.",{"_12":1005,"_14":1006},"BBNX","Beta Bionics, Inc.",{"_12":1008,"_14":1009},"BBSI","Barrett Business Services, Inc.",{"_12":1011,"_14":1012},"BBY","Best Buy Co., Inc.",{"_12":1014,"_14":1015},"BCAX","Bicara Therapeutics Inc. Common Stock",{"_12":1017,"_14":1018},"BCBP","BCB Bancorp, Inc.",{"_12":1020,"_14":1021},"BCDA","BioCardia, Inc.",{"_12":1023,"_14":1024},"BCG","Binah Capital Group, Inc.",{"_12":1026,"_14":1027},"BCHT","Birchtech Corp.",{"_12":1029,"_14":1030},"BCIC","BCP Investment Corporation",{"_12":1032,"_14":1033},"BCML","BayCom Corp",{"_12":1035,"_14":1036},"BCSF","Bain Capital Specialty Finance, Inc.",{"_12":1038,"_14":1039},"BDC","Belden Inc.",{"_12":1041,"_14":1042},"BDCO","Blue Dolphin Energy Company",{"_12":1044,"_14":1045},"BDL","Flanigan's Enterprises, Inc.",{"_12":1047,"_14":1048},"BDN","Brandywine Realty Trust",{"_12":1050,"_14":1051},"BDSX","Biodesix, Inc.",{"_12":1053,"_14":1054},"BE","Bloom Energy Corporation",{"_12":1056,"_14":1057},"BEAT","HeartBeam, Inc.",{"_12":1059,"_14":1060},"BEKE","KE Holdings Inc.",{"_12":1062,"_14":1063},"BETA","BETA Technologies, Inc.",{"_12":1065,"_14":1066},"BETR","Better Home & Finance Holding Company",{"_12":1068,"_14":1069},"BFC","Bank First Corporation",{"_12":1071,"_14":1072},"BFH","Bread Financial Holdings, Inc.",{"_12":1074,"_14":1075},"BFLY","Butterfly Network, Inc.",{"_12":1077,"_14":1078},"BFRG","Bullfrog AI Holdings, Inc. Common Stock",{"_12":1080,"_14":1081},"BFS","Saul Centers, Inc.",{"_12":1083,"_14":1084},"BFST","Business First Bancshares, Inc.",{"_12":1086,"_14":1087},"BG","Bunge Global S.A.",{"_12":1089,"_14":1090},"BGDE","Big Digital Energy, Inc.",{"_12":1092,"_14":1093},"BH","Biglari Holdings Inc.",{"_12":1095,"_14":1096},"BHAV","BHAV Acquisition Corp Class A Ordinary Shares",{"_12":1098,"_14":1099},"BHB","Bar Harbor Bankshares",{"_12":1101,"_14":1102},"BHM","Bluerock Homes Trust, Inc.",{"_12":1104,"_14":1105},"BHRB","Burke & Herbert Financial Services Corp.",{"_12":1107,"_14":1108},"BHVN","Biohaven Ltd.",{"_12":1110,"_14":-5},"BID",{"_12":1112,"_14":1113},"BIOE","Bio Essence Corporation",{"_12":1115,"_14":1116},"BIP","Brookfield Infrastructure Partners L.P.",{"_12":1118,"_14":1119},"BIRD","Smartbird, Inc",{"_12":1121,"_14":1122},"BIVI","BioVie Inc.",{"_12":1124,"_14":1125},"BJ","BJ's Wholesale Club Holdings, Inc.",{"_12":1127,"_14":1128},"BJDX","Bluejay Diagnostics, Inc.",{"_12":1130,"_14":1131},"BJRI","BJ's Restaurants, Inc.",{"_12":1133,"_14":1134},"BKKT","Bakkt Holdings, Inc.",{"_12":1136,"_14":1137},"BKSY","BlackSky Technology Inc.",{"_12":1139,"_14":1140},"BKV","BKV Corporation",{"_12":1142,"_14":1143},"BLBD","Blue Bird Corporation",{"_12":1145,"_14":1146},"BLCO","Bausch + Lomb Corporation",{"_12":1148,"_14":1149},"BLDR","Builders FirstSource, Inc.",{"_12":1151,"_14":1152},"BLLN","BillionToOne, Inc.",{"_12":1154,"_14":1155},"BLMN","Bloomin' Brands, Inc.",{"_12":1157,"_14":1158},"BLND","Blend Labs, Inc.",{"_12":1160,"_14":1161},"BLNE","Beeline Holdings, Inc.",{"_12":1163,"_14":1164},"BLSH","Bullish",{"_12":1166,"_14":1167},"BLSM","BlossomHill Therapeutics, Inc.",{"_12":1169,"_14":1170},"BLTE","Belite Bio, Inc",{"_12":1172,"_14":1173},"BLX","Bladex, Inc.",{"_12":1175,"_14":1176},"BMA","Banco Macro S.A.",{"_12":1178,"_14":1179},"BMBL","Bumble Inc.",{"_12":1181,"_14":1182},"BMI","Badger Meter, Inc.",{"_12":1184,"_14":1185},"BMNM","Bimini Capital Management, Inc.",{"_12":1187,"_14":1188},"BMNR","Bitmine Immersion Technologies, Inc.",{"_12":1190,"_14":1191},"BMR","Beamr Imaging Ltd.",{"_12":1193,"_14":1194},"BMRA","Biomerica, Inc.",{"_12":1196,"_14":1197},"BMRC","Bank of Marin Bancorp",{"_12":1199,"_14":1200},"BNED","Barnes & Noble Education, Inc.",{"_12":1202,"_14":1203},"BNKK","Bonk, Inc.",{"_12":1205,"_14":1206},"BNL","Broadstone Net Lease, Inc.",{"_12":1208,"_14":1209},"BNR","Burning Rock Biotech Limited",{"_12":1211,"_14":1212},"BNTX","BioNTech SE",{"_12":1214,"_14":1215},"BNY","Bank of New York Mellon Corp",{"_12":1217,"_14":1218},"BOBS","Bob's Discount Furniture, Inc.",{"_12":1220,"_14":1221},"BOC","Boston Omaha Corporation",{"_12":1223,"_14":1224},"BOF","BranchOut Food Inc.",{"_12":1226,"_14":1227},"BOLD","Boundless Bio, Inc.",{"_12":1229,"_14":1230},"BOLT","Bolt Biotherapeutics, Inc.",{"_12":1232,"_14":1233},"BORR","Borr Drilling Limited",{"_12":1235,"_14":1236},"BOSC","B.O.S. Better Online Solutions Ltd.",{"_12":1238,"_14":1239},"BOT","RoboStrategy, Inc. Common Stock",{"_12":1241,"_14":1242},"BOTJ","Bank of the James Financial Group, Inc.",{"_12":1244,"_14":1245},"BOX","Box, Inc.",{"_12":1247,"_14":1248},"BPRE","Bluerock Private Real Estate Fund",{"_12":1250,"_14":1251},"BPRN","Princeton Bancorp, Inc.",{"_12":1253,"_14":1254},"BR","Broadridge Financial Solutions, Inc.",{"_12":1256,"_14":1257},"BRBR","BellRing Brands, Inc.",{"_12":1259,"_14":1260},"BRC","Brady Corporation",{"_12":1262,"_14":1263},"BRCB","Black Rock Coffee Bar, Inc. Class A Common Stock",{"_12":1265,"_14":1266},"BRCC","BRC Inc.",{"_12":1268,"_14":1269},"BREZ","Breeze Holdings Acquisition Corp.",{"_12":1271,"_14":1272},"BRFH","Barfresh Food Group Inc.",{"_12":1274,"_14":1275},"BRID","Bridgford Foods Corporation",{"_12":1277,"_14":-5},"BRK.A",{"_12":1279,"_14":-5},"BRK.B",{"_12":1281,"_14":1282},"BRKH","Burtech Acquisition Corp.",{"_12":1284,"_14":1285},"BRO","Brown & Brown, Inc.",{"_12":1287,"_14":1288},"BROS","Dutch Bros Inc.",{"_12":1290,"_14":1291},"BRTMU","B&R Technology Merger Corp.",{"_12":1293,"_14":1294},"BRVE","Braveheart Bio, Inc.",{"_12":1296,"_14":1297},"BSBR","Banco Santander (Brasil) S.A.",{"_12":1299,"_14":1300},"BSM","Black Stone Minerals, L.P.",{"_12":1302,"_14":1303},"BSX","Boston Scientific Corporation",{"_12":1305,"_14":1306},"BTDR","Bitdeer Technologies Group",{"_12":1308,"_14":1309},"BTMD","biote Corp.",{"_12":1311,"_14":1312},"BTO","John Hancock Financial Opportunities Fund",{"_12":1314,"_14":1315},"BUKS","Butler National Corporation",{"_12":1317,"_14":1318},"BULL","Webull Corporation Class A Ordinary Shares",{"_12":1320,"_14":1321},"BURL","Burlington Stores, Inc.",{"_12":1323,"_14":1324},"BURU","Nuburu, Inc.",{"_12":1326,"_14":1327},"BUSE","First Busey Corporation",{"_12":1329,"_14":1330},"BV","BrightView Holdings, Inc.",{"_12":1332,"_14":1333},"BW","Babcock & Wilcox Enterprises, Inc.",{"_12":1335,"_14":1336},"BWA","BorgWarner Inc.",{"_12":1338,"_14":1339},"BWB","Bridgewater Bancshares, Inc.",{"_12":1341,"_14":1342},"BWFG","Bankwell Financial Group, Inc.",{"_12":1344,"_14":1345},"BWIN","The Baldwin Insurance Group, Inc.",{"_12":1347,"_14":-5},"BWIV",{"_12":1349,"_14":1350},"BWMN","Bowman Consulting Group Ltd.",{"_12":1352,"_14":1353},"BWMX","Betterware de México, S.A.P.I. de C.V.",{"_12":1355,"_14":1356},"BX","Blackstone Inc.",{"_12":1358,"_14":1359},"BXDC","Blackstone Digital Infrastructure Trust Inc.",{"_12":1361,"_14":1362},"BXMT","Blackstone Mortgage Trust, Inc.",{"_12":1364,"_14":1365},"BXSL","Blackstone Secured Lending Fund",{"_12":1367,"_14":-5},"BXSY",{"_12":1369,"_14":1370},"BY","Byline Bancorp, Inc.",{"_12":1372,"_14":1373},"BYRN","Byrna Technologies Inc.",{"_12":1375,"_14":1376},"BZ","Kanzhun Limited",{"_12":1378,"_14":1379},"BZFD","BuzzFeed, Inc.",{"_12":1381,"_14":1382},"BZUN","Baozun Inc.",{"_12":1384,"_14":1385},"CABO","Cable One, Inc.",{"_12":1387,"_14":1388},"CADEX","Cion Ares Diversified Credit Fund",{"_12":1390,"_14":1391},"CADL","Candel Therapeutics, Inc.",{"_12":1393,"_14":1394},"CAES","Cantor Equity Partners Vii Inc.",{"_12":1396,"_14":1397},"CAG","Conagra Brands, Inc.",{"_12":1399,"_14":1400},"CAI","Caris Life Sciences, Inc.",{"_12":1402,"_14":1403},"CALC","CalciMedica, Inc.",{"_12":1405,"_14":1406},"CAMP","CAMP4 Therapeutics Corporation",{"_12":1408,"_14":1409},"CAPS","Capstone Holding Corp.",{"_12":1411,"_14":1412},"CAQ","Cambridge Acquisition Corp. Class A Ordinary Shares",{"_12":1414,"_14":1415},"CARE","Carter Bankshares, Inc.",{"_12":1417,"_14":1418},"CARG","CarGurus, Inc.",{"_12":1420,"_14":1421},"CARL","Carlsmed, Inc.",{"_12":1423,"_14":1424},"CARS","Cars.com Inc.",{"_12":1426,"_14":1427},"CART","Maplebear Inc.",{"_12":1429,"_14":1430},"CASY","Casey's General Stores, Inc.",{"_12":1432,"_14":1433},"CAT","Caterpillar Inc.",{"_12":1435,"_14":1436},"CATLU","Catalyst Acquisition Corp. Units",{"_12":1438,"_14":1439},"CAVA","CAVA Group, Inc.",{"_12":1441,"_14":1442},"CBAN","Colony Bankcorp, Inc.",{"_12":1444,"_14":1445},"CBIO","Crescent Biopharma, Inc.",{"_12":1447,"_14":1448},"CBK","Commercial Bancgroup, Inc. Common Stock",{"_12":1450,"_14":1451},"CBKM","Consumers Bancorp, Inc.",{"_12":1453,"_14":1454},"CBL","CBL & Associates Properties, Inc.",{"_12":1456,"_14":1457},"CBLL","CeriBell, Inc.",{"_12":1459,"_14":1460},"CBNA","Chain Bridge Bancorp, Inc.",{"_12":1462,"_14":1463},"CBRL","Cracker Barrel Old Country Store",{"_12":1465,"_14":1466},"CBRS","Cerebras Systems Inc.",{"_12":1468,"_14":1469},"CBSH","Commerce Bancshares, Inc.",{"_12":1471,"_14":1472},"CBU","Community Bank System, Inc.",{"_12":1474,"_14":1475},"CBZ","CBIZ, Inc.",{"_12":1477,"_14":1478},"CC","The Chemours Company",{"_12":1480,"_14":1481},"CCAP","Crescent Capital BDC, Inc.",{"_12":1483,"_14":1484},"CCB","Coastal Financial Corporation",{"_12":1486,"_14":1487},"CCCTU","Columbus Circle Capital Corp III",{"_12":1489,"_14":1490},"CCD","Calamos Dynamic Convertible and Income Fund",{"_12":1492,"_14":1493},"CCFN","Muncy Columbia Financial Corporation",{"_12":1495,"_14":1496},"CCHH","CCH Holdings Ltd Ordinary Shares",{"_12":1498,"_14":1499},"CCI","Crown Castle Inc.",{"_12":1501,"_14":1502},"CCIF","Carlyle Credit Income Fund",{"_12":1504,"_14":1505},"CCLFX","Cliffwater Corporate Lending Fund",{"_12":1507,"_14":1508},"CCNE","CNB Financial Corporation",{"_12":1510,"_14":1511},"CDE","Coeur Mining, Inc.",{"_12":1513,"_14":1514},"CDLX","Cardlytics, Inc.",{"_12":1516,"_14":1517},"CDNL","Cardinal Infrastructure Group Inc.",{"_12":1519,"_14":1520},"CDNS","Cadence Design Systems, Inc.",{"_12":1522,"_14":1523},"CDW","CDW Corporation",{"_12":1525,"_14":1526},"CDZI","Cadiz Inc.",{"_12":1528,"_14":1529},"CE","Celanese Corporation",{"_12":1531,"_14":1532},"CECO","CECO Environmental Corp.",{"_12":1534,"_14":1535},"CEG","Constellation Energy Corporation",{"_12":1537,"_14":1538},"CELFX","Cliffwater Enhanced Lending Fund",{"_12":1540,"_14":1541},"CELH","Celsius Holdings, Inc.",{"_12":1543,"_14":1544},"CET","Central Securities Corp.",{"_12":1546,"_14":-5},"CFND",{"_12":1548,"_14":-5},"CFTR-PRA",{"_12":1550,"_14":1551},"CGBD","Carlyle Secured Lending, Inc.",{"_12":1553,"_14":1554},"CGCT","Cartesian Growth Corporation III",{"_12":1556,"_14":1557},"CGON","CG Oncology Inc.",{"_12":1559,"_14":1560},"CGTX","Cognition Therapeutics, Inc.",{"_12":1562,"_14":1563},"CHCO","City Holding Company",{"_12":1565,"_14":1566},"CHCT","Community Healthcare Trust Incorporated",{"_12":1568,"_14":1569},"CHE","Chemed Corporation",{"_12":1571,"_14":1572},"CHI","Calamos Convertible Opportunities and Income Fund",{"_12":1574,"_14":1575},"CHMG","Chemung Financial Corporation",{"_12":1577,"_14":1578},"CHPT","ChargePoint Holdings, Inc.",{"_12":1580,"_14":1581},"CHTR","Charter Communications, Inc.",{"_12":1583,"_14":1584},"CHW","Calamos Global Dynamic Income Fund",{"_12":1586,"_14":1587},"CHY","Calamos Convertible and High Income Fund",{"_12":1589,"_14":1590},"CHYM","Chime Financial, Inc. Class A Common Stock",{"_12":1592,"_14":1593},"CIA","Citizens, Inc.",{"_12":1595,"_14":1596},"CIEN","Ciena Corporation",{"_12":1598,"_14":1599},"CINF","Cincinnati Financial Corporation",{"_12":1601,"_14":1602},"CING","Cingulate Inc.",{"_12":1604,"_14":1605},"CINT","CI&T Inc",{"_12":1607,"_14":1608},"CJMB","Callan JMB Inc. ",{"_12":1610,"_14":1611},"CLB","Core Laboratories N.V.",{"_12":1613,"_14":1614},"CLBK","Columbia Financial, Inc.",{"_12":1616,"_14":1617},"CLH","Clean Harbors, Inc.",{"_12":1619,"_14":1620},"CLIK","Click Holdings Limited",{"_12":1622,"_14":1623},"CLIR","ClearSign Technologies Corporation",{"_12":1625,"_14":1626},"CLMB","Climb Global Solutions, Inc.",{"_12":1628,"_14":1629},"CLNE","Clean Energy Fuels Corp.",{"_12":1631,"_14":-5},"CLOO",{"_12":1633,"_14":1634},"CLOV","Clover Health Investments, Corp.",{"_12":1636,"_14":1637},"CLPR","Clipper Realty Inc.",{"_12":1639,"_14":1640},"CLRB","Cellectar Biosciences, Inc.",{"_12":1642,"_14":1643},"CLRO","ClearOne, Inc.",{"_12":1645,"_14":1646},"CLS","Celestica Inc.",{"_12":1648,"_14":1649},"CLSK","CleanSpark, Inc.",{"_12":1651,"_14":1652},"CLST","Catalyst Bancorp, Inc.",{"_12":1654,"_14":1655},"CLVT","Clarivate Plc",{"_12":1657,"_14":1658},"CLX","The Clorox Company",{"_12":1660,"_14":1661},"CLYM","Climb Bio, Inc.",{"_12":1663,"_14":1664},"CMC","Commercial Metals Company",{"_12":1666,"_14":1667},"CMCL","Caledonia Mining Corporation Plc",{"_12":1669,"_14":1670},"CMCO","Columbus McKinnon Corporation",{"_12":1672,"_14":1673},"CMDB","Costamare Bulkers Holdings Ltd",{"_12":1675,"_14":1676},"CME","CME Group Inc.",{"_12":1678,"_14":1679},"CMMB","Chemomab Therapeutics Ltd.",{"_12":1681,"_14":1682},"CMND","Clearmind Medicine Inc.",{"_12":1684,"_14":1685},"CMPX","Compass Therapeutics, Inc.",{"_12":1687,"_14":1688},"CMS","CMS Energy Corporation",{"_12":1690,"_14":1691},"CMT","Core Molding Technologies, Inc.",{"_12":1693,"_14":1694},"CMTG","Claros Mortgage Trust, Inc.",{"_12":1696,"_14":1697},"CMTV","Community Bancorp",{"_12":1699,"_14":1700},"CNM","Core & Main, Inc.",{"_12":1702,"_14":1703},"CNOB","ConnectOne Bancorp, Inc.",{"_12":1705,"_14":1706},"CNP","CenterPoint Energy, Inc.",{"_12":1708,"_14":1709},"CNSP","CNS Pharmaceuticals, Inc.",{"_12":1711,"_14":1712},"CNTB","Connect Biopharma Holdings Limited",{"_12":1714,"_14":1715},"CNTM","ConnectM Technology Solutions, Inc.",{"_12":1717,"_14":1718},"CNXC","Concentrix Corporation",{"_12":1720,"_14":1721},"CNXN","PC Connection, Inc.",{"_12":1723,"_14":1724},"CNXU","Conexeu Sciences Inc.",{"_12":1726,"_14":1727},"COAG","Hemab Therapeutics Holdings, Inc. Common Stock",{"_12":1729,"_14":1730},"COCP","Cocrystal Pharma, Inc.",{"_12":1732,"_14":1733},"CODI","Compass Diversified",{"_12":1735,"_14":1736},"COE","51Talk Online Education Group",{"_12":1738,"_14":1739},"COF","Capital One Financial Corporation",{"_12":1741,"_14":1742},"COFS","ChoiceOne Financial Services, Inc.",{"_12":1744,"_14":1745},"COHU","Cohu, Inc.",{"_12":1747,"_14":1748},"COIN","Coinbase Global, Inc.",{"_12":1750,"_14":1751},"COLB","Columbia Banking System, Inc.",{"_12":1753,"_14":-5},"CONFIG",{"_12":1755,"_14":1756},"COO","The Cooper Companies, Inc.",{"_12":1758,"_14":1759},"COR","Cencora, Inc.",{"_12":1761,"_14":1762},"CORT","Corcept Therapeutics Incorporated",{"_12":1764,"_14":1765},"CORZ","Core Scientific, Inc.",{"_12":1767,"_14":1768},"COSM","Cosmos Health Inc.",{"_12":1770,"_14":1771},"COST","Costco Wholesale Corporation",{"_12":1773,"_14":1774},"COTY","Coty Inc.",{"_12":1776,"_14":1777},"COUR","Coursera, Inc.",{"_12":1779,"_14":1780},"CPB","Campbell Soup Company",{"_12":1782,"_14":-5},"CPEFX",{"_12":1784,"_14":1785},"CPNG","Coupang, Inc.",{"_12":1787,"_14":1788},"CPRI","Capri Holdings Limited",{"_12":1790,"_14":1791},"CPS","Cooper-Standard Holdings Inc.",{"_12":1793,"_14":1794},"CPSH","CPS Technologies Corporation",{"_12":1796,"_14":1797},"CR","Crane Company",{"_12":1799,"_14":-5},"CRAFX",{"_12":1801,"_14":1802},"CRBG","Corebridge Financial, Inc.",{"_12":1804,"_14":1805},"CRBP","Corbus Pharmaceuticals Holdings, Inc.",{"_12":1807,"_14":1808},"CRC","California Resources Corp",{"_12":1810,"_14":1811},"CRCL","Circle Internet Group",{"_12":1813,"_14":1814},"CRCT","Cricut, Inc.",{"_12":1816,"_14":1817},"CRCW","The Crypto Company",{"_12":1819,"_14":1820},"CRDF","Cardiff Oncology, Inc.",{"_12":1822,"_14":1823},"CRDO","Credo Technology Group Holding Ltd",{"_12":1825,"_14":1826},"CRESY","Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria",{"_12":1828,"_14":1829},"CREX","Creative Realities, Inc.",{"_12":1831,"_14":1832},"CRH","CRH plc",{"_12":1834,"_14":1835},"CRIS","Curis, Inc.",{"_12":1837,"_14":1838},"CRL","Charles River Laboratories International, Inc.",{"_12":1840,"_14":1841},"CRM","Salesforce, Inc.",{"_12":1843,"_14":1844},"CRNC","Cerence Inc.",{"_12":1846,"_14":1847},"CROX","Crocs, Inc.",{"_12":1849,"_14":1850},"CRSP","CRISPR Therapeutics AG",{"_12":1852,"_14":1853},"CRT","Cross Timbers Royalty Trust",{"_12":1855,"_14":1856},"CRTO","Criteo S.A.",{"_12":1858,"_14":1859},"CRUS","Cirrus Logic, Inc.",{"_12":1861,"_14":1862},"CRVO","CervoMed Inc.",{"_12":1864,"_14":1865},"CRVS","Corvus Pharmaceuticals, Inc.",{"_12":1867,"_14":1868},"CRWD","CrowdStrike Holdings, Inc.",{"_12":1870,"_14":1871},"CRWV","CoreWeave, Inc. Class A Common Stock",{"_12":1873,"_14":1874},"CSAN","Cosan S.A.",{"_12":1876,"_14":-5},"CSAN3",{"_12":1878,"_14":1879},"CSBB","CSB Bancorp, Inc.",{"_12":1881,"_14":1882},"CSGP","CoStar Group, Inc.",{"_12":1884,"_14":1885},"CSHR","CoinShares PLC Ordinary Shares",{"_12":1887,"_14":1888},"CSPI","CSP Inc.",{"_12":1890,"_14":1891},"CSR","Centerspace",{"_12":1893,"_14":1894},"CSTL","Castle Biosciences, Inc.",{"_12":1896,"_14":1897},"CSTM","Constellium SE",{"_12":1899,"_14":1900},"CSW","CSW Industrials, Inc.",{"_12":1902,"_14":1903},"CSWC","Capital Southwest Corporation",{"_12":1905,"_14":1906},"CSX","CSX Corporation",{"_12":1908,"_14":1909},"CTBI","Community Trust Bancorp, Inc.",{"_12":1911,"_14":1912},"CTEV","Claritev Corporation",{"_12":1914,"_14":1915},"CTGO","Contango Ore, Inc.",{"_12":1917,"_14":1918},"CTKYY","CooTek (Cayman) Inc.",{"_12":1920,"_14":1921},"CTM","Castellum, Inc.",{"_12":1923,"_14":1924},"CTNT","Cheetah Net Supply Chain Service Inc.",{"_12":1926,"_14":1927},"CTRI","Centuri Holdings, Inc.",{"_12":1929,"_14":1930},"CTRN","Citi Trends, Inc.",{"_12":1932,"_14":1933},"CTSH","Cognizant Technology Solutions Corporation",{"_12":1935,"_14":1936},"CTSO","Cytosorbents Corporation",{"_12":1938,"_14":1939},"CTTH","CTT Pharmaceutical Holdings, Inc.",{"_12":1941,"_14":1942},"CUBI","Customers Bancorp, Inc.",{"_12":1944,"_14":1945},"CUE","Cue Biopharma, Inc.",{"_12":1947,"_14":1948},"CUEN","Cuentas Inc.",{"_12":1950,"_14":1951},"CULP","Culp, Inc.",{"_12":1953,"_14":1954},"CURI","CuriosityStream Inc.",{"_12":1956,"_14":1957},"CV","CapsoVision, Inc.",{"_12":1959,"_14":1960},"CVBF","CVB Financial Corp.",{"_12":1962,"_14":1963},"CVM","CEL-SCI Corporation",{"_12":1965,"_14":1966},"CVNA","Carvana Co.",{"_12":1968,"_14":1969},"CVR","Chicago Rivet & Machine Co.",{"_12":1971,"_14":1972},"CVRX","CVRx, Inc.",{"_12":1974,"_14":1975},"CVSA","Covista Inc.",{"_12":1977,"_14":1978},"CVSI","CV Sciences, Inc.",{"_12":1980,"_14":1981},"CW","Curtiss-Wright Corporation",{"_12":1983,"_14":1984},"CWBC","Community West Bancshares",{"_12":1986,"_14":1987},"CWBHF","Charlotte's Web Holdings, Inc.",{"_12":1989,"_14":1990},"CWCO","Consolidated Water Co. Ltd.",{"_12":1992,"_14":1993},"CWGL","Crimson Wine Group, Ltd.",{"_12":1995,"_14":1996},"CX","CEMEX, S.A.B. de C.V.",{"_12":1998,"_14":1999},"CXDO","Crexendo, Inc.",{"_12":2001,"_14":2002},"CXIIU","Churchill Capital Corp XII Units",{"_12":2004,"_14":2005},"CXM","Sprinklr, Inc.",{"_12":2007,"_14":-5},"CXNU",{"_12":2009,"_14":2010},"CXT","Crane NXT, Co.",{"_12":2012,"_14":2013},"CXW","CoreCivic, Inc.",{"_12":2015,"_14":2016},"CYAB","Cyabra, Inc. Common Stock",{"_12":2018,"_14":2019},"CYBN","Cybin Inc.",{"_12":2021,"_14":2022},"CYPH","Cypherpunk Technologies Inc.",{"_12":2024,"_14":2025},"CYTK","Cytokinetics, Incorporated",{"_12":2027,"_14":2028},"CZFS","Citizens Financial Services, Inc.",{"_12":2030,"_14":2031},"CZNC","Citizens & Northern Corporation",{"_12":2033,"_14":2034},"CZR","Caesars Entertainment, Inc.",{"_12":2036,"_14":2037},"CZWI","Citizens Community Bancorp, Inc.",{"_12":2039,"_14":2040},"DAKT","Daktronics, Inc.",{"_12":2042,"_14":2043},"DAR","Darling Ingredients Inc.",{"_12":2045,"_14":2046},"DASH","DoorDash, Inc.",{"_12":2048,"_14":-5},"DASHBOARD",{"_12":2050,"_14":2051},"DBD","Diebold Nixdorf, Incorporated",{"_12":2053,"_14":2054},"DBGI","Digital Brands Group, Inc.",{"_12":2056,"_14":2057},"DBI","Designer Brands Inc.",{"_12":2059,"_14":2060},"DBX","Dropbox, Inc.",{"_12":2062,"_14":2063},"DC","Dakota Gold Corp.",{"_12":2065,"_14":2066},"DCH","Dauch Corporation",{"_12":2068,"_14":2069},"DCTH","Delcath Systems, Inc.",{"_12":2071,"_14":2072},"DCX","Digital Currency X Technology Inc.",{"_12":2074,"_14":2075},"DDD","3D Systems Corporation",{"_12":2077,"_14":2078},"DDOG","Datadog, Inc.",{"_12":2080,"_14":2081},"DELL","Dell Technologies Inc.",{"_12":2083,"_14":2084},"DFDV","DeFi Development Corp.",{"_12":2086,"_14":2087},"DFH","Dream Finders Homes, Inc.",{"_12":2089,"_14":2090},"DFIN","Donnelley Financial Solutions, Inc.",{"_12":2092,"_14":2093},"DFTX","Definium Therapeutics, Inc.",{"_12":2095,"_14":2096},"DGAC","Disciplined Growth Acquisition Corp",{"_12":2098,"_14":2099},"DGICA","Donegal Group Inc.",{"_12":2101,"_14":2102},"DGNX","Diginex Limited",{"_12":2104,"_14":2105},"DGXX","Digi Power X Inc.",{"_12":2107,"_14":2108},"DHF","BNY Mellon High Yield Strategies Fund",{"_12":2110,"_14":2111},"DHT","DHT Holdings, Inc.",{"_12":2113,"_14":2114},"DHY","Credit Suisse High Yield Bond Fund, Inc.",{"_12":2116,"_14":2117},"DIBS","1stdibs.Com, Inc.",{"_12":2119,"_14":2120},"DIN","Dine Brands Global, Inc.",{"_12":2122,"_14":2123},"DINO","HF Sinclair Corporation",{"_12":2125,"_14":2126},"DIS","The Walt Disney Company",{"_12":2128,"_14":2129},"DKI","DarkIris Inc. Class A Ordinary Shares",{"_12":2131,"_14":2132},"DKL","Delek Logistics Partners, LP",{"_12":2134,"_14":2135},"DKS","DICK'S Sporting Goods, Inc.",{"_12":2137,"_14":2138},"DLB","Dolby Laboratories, Inc.",{"_12":2140,"_14":2141},"DLHC","DLH Holdings Corp.",{"_12":2143,"_14":2144},"DLO","DLocal Limited",{"_12":2146,"_14":2147},"DLPN","Dolphin Entertainment, Inc.",{"_12":2149,"_14":2150},"DLY","DoubleLine Yield Opportunities Fund",{"_12":2152,"_14":2153},"DMC","Del Monte Corporation",{"_12":2155,"_14":2156},"DMLP","Dorchester Minerals, L.P.",{"_12":2158,"_14":2159},"DMRA","Damora Therapeutics, Inc.",{"_12":2161,"_14":2162},"DNA","Ginkgo Bioworks Holdings, Inc.",{"_12":2164,"_14":2165},"DNTH","Dianthus Therapeutics, Inc.",{"_12":2167,"_14":2168},"DNUT","Krispy Kreme, Inc.",{"_12":2170,"_14":2171},"DOCN","DigitalOcean Holdings, Inc.",{"_12":2173,"_14":2174},"DOCS","Doximity, Inc.",{"_12":2176,"_14":2177},"DOCU","DocuSign, Inc.",{"_12":2179,"_14":2180},"DOLE","Dole plc",{"_12":2182,"_14":2183},"DOMH","Dominari Holdings Inc.",{"_12":2185,"_14":2186},"DOMO","Domo, Inc.",{"_12":2188,"_14":2189},"DPC","DPC Holdings Ltd.",{"_12":2191,"_14":2192},"DRH","DiamondRock Hospitality Company",{"_12":2194,"_14":2195},"DRI","Darden Restaurants, Inc.",{"_12":2197,"_14":2198},"DRIO","DarioHealth Corp.",{"_12":2200,"_14":2201},"DRMA","Dermata Therapeutics, Inc.",{"_12":2203,"_14":2204},"DRS","Leonardo DRS, Inc.",{"_12":2206,"_14":2207},"DSGR","Distribution Solutions Group, Inc.",{"_12":2209,"_14":2210},"DSM","BNY Mellon Strategic Municipal Bond Fund, Inc.",{"_12":2212,"_14":2213},"DSP","Viant Technology Inc.",{"_12":2215,"_14":-5},"DS_STORE",{"_12":2217,"_14":2218},"DT","Dynatrace, Inc.",{"_12":2220,"_14":2221},"DTCX","Datacentrex, Inc.",{"_12":2223,"_14":2224},"DTM","DT Midstream, Inc.",{"_12":2226,"_14":2227},"DUOL","Duolingo, Inc.",{"_12":2229,"_14":2230},"DUOT","Duos Technologies Group, Inc.",{"_12":2232,"_14":2233},"DVN","Devon Energy Corporation",{"_12":2235,"_14":2236},"DX","Dynex Capital, Inc.",{"_12":2238,"_14":2239},"DXC","DXC Technology Company",{"_12":2241,"_14":2242},"DXCM","DexCom, Inc.",{"_12":2244,"_14":2245},"DXR","Daxor Corporation",{"_12":2247,"_14":2248},"DXST","Decent Holding Inc.",{"_12":2250,"_14":2251},"DXYZ","Destiny Tech100 Inc.",{"_12":2253,"_14":2254},"DY","Dycom Industries, Inc.",{"_12":2256,"_14":2257},"DYN","Dyne Therapeutics, Inc.",{"_12":2259,"_14":2260},"EBAY","eBay Inc.",{"_12":2262,"_14":2263},"EBC","Eastern Bankshares, Inc.",{"_12":2265,"_14":2266},"EBS","Emergent BioSolutions Inc.",{"_12":2268,"_14":2269},"ECAT","BlackRock ESG Capital Allocation Trust",{"_12":2271,"_14":2272},"ECBK","ECB Bancorp, Inc.",{"_12":2274,"_14":2275},"ECC","Eagle Point Credit Company Inc.",{"_12":2277,"_14":2278},"ECF","Ellsworth Growth and Income Fund Ltd.",{"_12":2280,"_14":2281},"ECG","Everus Construction Group, Inc.",{"_12":2283,"_14":2284},"ECIA","Encision Inc.",{"_12":2286,"_14":2287},"ECL","Ecolab Inc.",{"_12":2289,"_14":-5},"ECLO",{"_12":2291,"_14":2292},"ECOR","electroCore, Inc.",{"_12":2294,"_14":2295},"ECVT","Ecovyst Inc.",{"_12":2297,"_14":2298},"ED","Consolidated Edison, Inc.",{"_12":2300,"_14":2301},"EDAP","Edap Tms S.a.",{"_12":2303,"_14":2304},"EDBL","Edible Garden AG Incorporated",{"_12":2306,"_14":2307},"EDRY","EuroDry Ltd.",{"_12":2309,"_14":2310},"EDSA","Edesa Biotech, Inc.",{"_12":2312,"_14":2313},"EEFT","Euronet Worldwide, Inc.",{"_12":2315,"_14":2316},"EFOR","Everforth, Inc.",{"_12":2318,"_14":2319},"EFSI","Eagle Financial Services, Inc.",{"_12":2321,"_14":2322},"EGAN","eGain Corporation",{"_12":2324,"_14":-5},"EHSI",{"_12":2326,"_14":2327},"EHTH","eHealth, Inc.",{"_12":2329,"_14":2330},"EIKN","Eikon Therapeutics, Inc. Common Stock",{"_12":2332,"_14":2333},"EIM","Eaton Vance Municipal Bond Fund",{"_12":2335,"_14":2336},"EIX","Edison International",{"_12":2338,"_14":2339},"EJH","E-Home Household Service Holdings Limited",{"_12":2341,"_14":2342},"EKSO","Ekso Bionics Holdings, Inc.",{"_12":2344,"_14":2345},"ELA","Envela Corporation",{"_12":2347,"_14":2348},"ELAN","Elanco Animal Health Incorporated",{"_12":2350,"_14":2351},"ELF","e.l.f. Beauty, Inc.",{"_12":2353,"_14":2354},"ELMT","Elmet Group Co.",{"_12":2356,"_14":2357},"ELOG","Eastern International Ltd. Ordinary Shares",{"_12":2359,"_14":2360},"ELTK","Eltek Ltd.",{"_12":2362,"_14":2363},"ELV","Elevance Health Inc.",{"_12":2365,"_14":2366},"ELVN","Enliven Therapeutics, Inc.",{"_12":2368,"_14":2369},"EMBC","Embecta Corp.",{"_12":2371,"_14":2372},"EML","The Eastern Company",{"_12":2374,"_14":2375},"EMPD","Empery Digital Inc.",{"_12":2377,"_14":2378},"EMYB","Embassy Bancorp, Inc.",{"_12":2380,"_14":2381},"ENBP","ENB Financial Corp",{"_12":2383,"_14":2384},"ENHA","Enhanced Group Inc. Class A",{"_12":2386,"_14":2387},"ENLT","Enlight Renewable Energy Ltd",{"_12":2389,"_14":2390},"ENOV","Enovis Corporation",{"_12":2392,"_14":2393},"ENPH","Enphase Energy, Inc.",{"_12":2395,"_14":2396},"ENR","Energizer Holdings, Inc.",{"_12":2398,"_14":2399},"ENS","EnerSys",{"_12":2401,"_14":2402},"ENSC","Ensysce Biosciences, Inc.",{"_12":2404,"_14":2405},"ENTX","Entera Bio Ltd.",{"_12":2407,"_14":2408},"ENVA","Enova International, Inc.",{"_12":2410,"_14":2411},"EOG","EOG Resources, Inc.",{"_12":2413,"_14":2414},"EOI","Eaton Vance Enhanced Equity Income Fund",{"_12":2416,"_14":2417},"EOS","Eaton Vance Enhanced Equity Income Fund II",{"_12":2419,"_14":2420},"EOSE","Eos Energy Enterprises, Inc.",{"_12":2422,"_14":2423},"EP","Empire Petroleum Corporation",{"_12":2425,"_14":2426},"EPAM","EPAM Systems, Inc.",{"_12":2428,"_14":2429},"EPD","Enterprise Products Partners L.P.",{"_12":2431,"_14":2432},"EPSN","Epsilon Energy Ltd.",{"_12":2434,"_14":2435},"EQBK","Equity Bancshares, Inc.",{"_12":2437,"_14":2438},"EQH","Equitable Holdings, Inc.",{"_12":2440,"_14":2441},"EQPT","EquipmentShare.com Inc.",{"_12":2443,"_14":2444},"ERIE","Erie Indemnity Company",{"_12":2446,"_14":2447},"ERII","Energy Recovery, Inc.",{"_12":2449,"_14":2450},"EROK","EagleRock Land LLC",{"_12":2452,"_14":2453},"ES","Eversource Energy",{"_12":2455,"_14":2456},"ESEA","Euroseas Ltd.",{"_12":2458,"_14":2459},"ESLA","Estrella Immunopharma, Inc.",{"_12":2461,"_14":2462},"ESNT","Essent Group Ltd.",{"_12":2464,"_14":2465},"ESOA","Energy Services of America Corporation",{"_12":2467,"_14":2468},"ESQ","Esquire Financial Holdings, Inc.",{"_12":2470,"_14":2471},"ESTC","Elastic N.V.",{"_12":2473,"_14":2474},"ET","Energy Transfer LP",{"_12":2476,"_14":2477},"ETD","Ethan Allen Interiors Inc.",{"_12":2479,"_14":2480},"ETN","Eaton Corporation plc",{"_12":2482,"_14":2483},"ETON","Eton Pharmaceuticals, Inc.",{"_12":2485,"_14":2486},"ETR","Entergy Corporation",{"_12":2488,"_14":2489},"ETRA","Electra Therapeutics Inc.",{"_12":2491,"_14":2492},"ETSY","Etsy, Inc.",{"_12":2494,"_14":2495},"EU","enCore Energy Corp.",{"_12":2497,"_14":2498},"EVCM","EverCommerce Inc.",{"_12":2500,"_14":2501},"EVER","EverQuote, Inc.",{"_12":2503,"_14":2504},"EVGN","Evogene Ltd.",{"_12":2506,"_14":2507},"EVLV","Evolv Technologies Holdings, Inc.",{"_12":2509,"_14":2510},"EVMN","Evommune, Inc.",{"_12":2512,"_14":2513},"EVR","Evercore Inc.",{"_12":2515,"_14":2516},"EVRG","Evergy, Inc.",{"_12":2518,"_14":2519},"EVTC","EVERTEC, Inc.",{"_12":2521,"_14":2522},"EW","Edwards Lifesciences Corporation",{"_12":2524,"_14":-5},"EWAV",{"_12":2526,"_14":-5},"EWSB",{"_12":2528,"_14":2529},"EXE","Expand Energy Corporation",{"_12":2531,"_14":2532},"EXFY","Expensify, Inc.",{"_12":2534,"_14":2535},"EXLS","ExlService Holdings, Inc.",{"_12":2537,"_14":2538},"EXOD","Exodus Movement, Inc.",{"_12":2540,"_14":2541},"EXTR","Extreme Networks, Inc.",{"_12":2543,"_14":2544},"EYE","National Vision Holdings, Inc.",{"_12":2546,"_14":2547},"EYPT","EyePoint Pharmaceuticals, Inc.",{"_12":2549,"_14":2550},"EZRA","Reliance Global Group Inc.",{"_12":2552,"_14":2553},"F","Ford Motor Company",{"_12":2555,"_14":2556},"FA","First Advantage Corporation",{"_12":2558,"_14":2559},"FANG","Diamondback Energy, Inc.",{"_12":2561,"_14":2562},"FATN","FatPipe, Inc. Common Stock",{"_12":2564,"_14":-5},"FAVICON.ICO",{"_12":2566,"_14":2567},"FBDT","First Breach Inc.",{"_12":2569,"_14":2570},"FBIN","Fortune Brands Innovations, Inc.",{"_12":2572,"_14":2573},"FBLA","FB Bancorp, Inc. Common Stock",{"_12":2575,"_14":2576},"FBLG","FibroBiologics, Inc. Common Stock",{"_12":2578,"_14":2579},"FBNC","First Bancorp",{"_12":2581,"_14":2582},"FBRT","Franklin BSP Realty Trust, Inc.",{"_12":2584,"_14":2585},"FCBM","First Carolina Financial Services",{"_12":2587,"_14":2588},"FCCO","First Community Corporation",{"_12":2590,"_14":2591},"FCEL","FuelCell Energy, Inc.",{"_12":2593,"_14":2594},"FCF","First Commonwealth Financial Corporation",{"_12":2596,"_14":2597},"FCHL","Fitness Champs Holdings Limited Common Stock",{"_12":2599,"_14":2600},"FCN","FTI Consulting, Inc.",{"_12":2602,"_14":2603},"FCNCA","First Citizens BancShares, Inc.",{"_12":2605,"_14":2606},"FCPT","Four Corners Property Trust, Inc.",{"_12":2608,"_14":2609},"FDBC","Fidelity D & D Bancorp, Inc.",{"_12":2611,"_14":2612},"FDMT","4D Molecular Therapeutics, Inc.",{"_12":2614,"_14":2615},"FDP","Fresh Del Monte Produce Inc.",{"_12":2617,"_14":2618},"FDSB","Fifth District Savings Bank",{"_12":2620,"_14":2621},"FEAM","5E Advanced Materials Inc.",{"_12":2623,"_14":2624},"FEED","ENvue Medical, Inc.",{"_12":2626,"_14":2627},"FEMY","Femasys Inc.",{"_12":2629,"_14":2630},"FERG","Ferguson plc",{"_12":2632,"_14":-5},"FERLX",{"_12":2634,"_14":2635},"FF","FutureFuel Corp.",{"_12":2637,"_14":2638},"FFAI","Faraday Future Intelligent Electric Inc.",{"_12":2640,"_14":2641},"FFIN","First Financial Bankshares, Inc.",{"_12":2643,"_14":2644},"FG","F&G Annuities & Life, Inc.",{"_12":2646,"_14":2647},"FGBI","First Guaranty Bancshares, Inc.",{"_12":2649,"_14":2650},"FGL","Founder Group Limited",{"_12":2652,"_14":2653},"FIG","Figma, Inc.",{"_12":2655,"_14":2656},"FIP","FTAI Infrastructure Inc.",{"_12":2658,"_14":2659},"FIS","Fidelity National Information Services, Inc.",{"_12":2661,"_14":2662},"FISI","Financial Institutions, Inc.",{"_12":2664,"_14":2665},"FISV","Fiserv, Inc.",{"_12":2667,"_14":2668},"FIVE","Five Below, Inc.",{"_12":2670,"_14":2671},"FIVN","Five9, Inc.",{"_12":2673,"_14":2674},"FIZZ","National Beverage Corp.",{"_12":2676,"_14":2677},"FKYS","First Keystone Corporation",{"_12":2679,"_14":2680},"FLD","Fold Holdings Inc",{"_12":2682,"_14":2683},"FLNA","Filana Therapeutics, Inc.",{"_12":2685,"_14":2686},"FLNC","Fluence Energy, Inc.",{"_12":2688,"_14":2689},"FLNT","Fluent, Inc.",{"_12":2691,"_14":2692},"FLO","Flowers Foods, Inc.",{"_12":2694,"_14":2695},"FLS","Flowserve Corporation",{"_12":2697,"_14":2698},"FLUT","Flutter Entertainment plc",{"_12":2700,"_14":2701},"FLXS","Flexsteel Industries, Inc.",{"_12":2703,"_14":2704},"FLYX","flyExclusive, Inc.",{"_12":2706,"_14":2707},"FMAC","FirstMark Horizon Acquisition Corp.",{"_12":2709,"_14":2710},"FMAO","Farmers & Merchants Bancorp, Inc.",{"_12":2712,"_14":2713},"FMBM","F & M Bank Corp.",{"_12":2715,"_14":2716},"FMC","FMC Corporation",{"_12":2718,"_14":2719},"FMNB","Farmers National Banc Corp.",{"_12":2721,"_14":2722},"FMX","Fomento Económico Mexicano, S.A.B. de C.V.",{"_12":2724,"_14":2725},"FND","Floor & Decor Holdings, Inc.",{"_12":2727,"_14":2728},"FNGR","FingerMotion, Inc.",{"_12":2730,"_14":2731},"FNKO","Funko, Inc.",{"_12":2733,"_14":2734},"FNLC","The First Bancorp, Inc.",{"_12":2736,"_14":2737},"FNRN","First Northern Community Bancorp",{"_12":2739,"_14":2740},"FNWD","Finward Bancorp",{"_12":2742,"_14":2743},"FOA","Finance Of America Companies Inc.",{"_12":2745,"_14":2746},"FOCL","EDAP TMS S.A. American Depositary Shares",{"_12":2748,"_14":2749},"FONR","FONAR Corporation",{"_12":2751,"_14":2752},"FORM","FormFactor, Inc.",{"_12":2754,"_14":2755},"FOSL","Fossil Group, Inc.",{"_12":2757,"_14":2758},"FOUR","Shift4 Payments, Inc.",{"_12":2760,"_14":2761},"FOX","Fox Corporation",{"_12":2763,"_14":2764},"FPI","Farmland Partners Inc.",{"_12":2766,"_14":2767},"FRAF","Franklin Financial Services Corporation",{"_12":2769,"_14":2770},"FRBBX","Flat Rock Enhanced Income Fund",{"_12":2772,"_14":2773},"FRD","Friedman Industries, Incorporated",{"_12":2775,"_14":2776},"FRHC","Freedom Holding Corp.",{"_12":2778,"_14":2779},"FROG","JFrog Ltd.",{"_12":2781,"_14":2782},"FROPX","Flat Rock Opportunity Fund",{"_12":2784,"_14":2785},"FRPH","FRP Holdings, Inc.",{"_12":2787,"_14":2788},"FRPT","Freshpet, Inc.",{"_12":2790,"_14":2791},"FRSH","Freshworks Inc.",{"_12":2793,"_14":2794},"FRST","Primis Financial Corp.",{"_12":2796,"_14":2797},"FRT","Federal Realty Investment Trust",{"_12":2799,"_14":2800},"FSBC","Five Star Bancorp",{"_12":2802,"_14":2803},"FSCO","FS Credit Opportunities Corp.",{"_12":2805,"_14":2806},"FSK","FS KKR Capital Corp.",{"_12":2808,"_14":2809},"FSLR","First Solar, Inc.",{"_12":2811,"_14":2812},"FSLY","Fastly, Inc.",{"_12":2814,"_14":2815},"FSS","Federal Signal Corporation",{"_12":2817,"_14":-5},"FSSL",{"_12":2819,"_14":2820},"FSUN","FirstSun Capital Bancorp",{"_12":2822,"_14":2823},"FTAI","FTAI Aviation Ltd.",{"_12":2825,"_14":2826},"FTCI","FTC Solar, Inc.",{"_12":2828,"_14":-5},"FTEAX",{"_12":2830,"_14":-5},"FTECX",{"_12":2832,"_14":2833},"FTH","Faeth Therapeutics, Inc.",{"_12":2835,"_14":-5},"FTHA",{"_12":2837,"_14":2838},"FTHY","First Trust High Yield Opportunities 2027 Term Fund",{"_12":2840,"_14":2841},"FTI","TechnipFMC plc",{"_12":2843,"_14":2844},"FTK","Flotek Industries, Inc.",{"_12":2846,"_14":2847},"FTLF","FitLife Brands, Inc.",{"_12":2849,"_14":2850},"FTS","Fortis Inc.",{"_12":2852,"_14":2853},"FUL","H.B. Fuller Company",{"_12":2855,"_14":2856},"FULC","Fulcrum Therapeutics, Inc.",{"_12":2858,"_14":2859},"FUN","Six Flags Entertainment Corporation",{"_12":2861,"_14":2862},"FUNC","First United Corporation",{"_12":2864,"_14":2865},"FUND","Sprott Focus Trust, Inc.",{"_12":2867,"_14":2868},"FUSB","First US Bancshares, Inc.",{"_12":2870,"_14":2871},"FVRR","Fiverr International Ltd.",{"_12":2873,"_14":2874},"FWDI","Forward Industries, Inc.",{"_12":2876,"_14":2877},"FXNC","First National Corporation",{"_12":2879,"_14":2880},"GABC","German American Bancorp, Inc.",{"_12":2882,"_14":2883},"GAIA","Gaia, Inc.",{"_12":2885,"_14":2886},"GAIN","Gladstone Investment Corporation",{"_12":2888,"_14":2889},"GAM","General American Investors Company, Inc.",{"_12":2891,"_14":2892},"GAMB","Gambling.com Group Limited",{"_12":2894,"_14":2895},"GAME","GameSquare Holdings, Inc.",{"_12":2897,"_14":2898},"GAP","The Gap, Inc.",{"_12":2900,"_14":2901},"GBCI","Glacier Bancorp, Inc.",{"_12":2903,"_14":2904},"GBFH","GBank Financial Holdings Inc.",{"_12":2906,"_14":2907},"GBLI","Global Indemnity Group, LLC",{"_12":2909,"_14":2910},"GBR","New Concept Energy, Inc.",{"_12":2912,"_14":2913},"GCBC","Greene County Bancorp, Inc.",{"_12":2915,"_14":2916},"GCO","Genesco Inc.",{"_12":2918,"_14":2919},"GCT","GigaCloud Technology Inc.",{"_12":2921,"_14":2922},"GD","General Dynamics Corporation",{"_12":2924,"_14":2925},"GDC","GD Culture Group Limited",{"_12":2927,"_14":2928},"GDDY","GoDaddy Inc.",{"_12":2930,"_14":2931},"GDEV","GDEV Inc.",{"_12":2933,"_14":2934},"GDTC","CytoMed Therapeutics Limited",{"_12":2936,"_14":2937},"GDV","The Gabelli Dividend & Income Trust",{"_12":2939,"_14":2940},"GDYN","Grid Dynamics Holdings, Inc.",{"_12":2942,"_14":2943},"GEHC","GE HealthCare Technologies Inc.",{"_12":2945,"_14":2946},"GEL","Genesis Energy, L.P.",{"_12":2948,"_14":2949},"GEN","Gen Digital Inc.",{"_12":2951,"_14":2952},"GENB","Generate Biomedicines, Inc.",{"_12":2954,"_14":2955},"GENI","Genius Sports Limited",{"_12":2957,"_14":2958},"GEVO","Gevo, Inc.",{"_12":2960,"_14":2961},"GF","The New Germany Fund, Inc.",{"_12":2963,"_14":2964},"GFF","Griffon Corporation",{"_12":2966,"_14":2967},"GFI","Gold Fields Limited",{"_12":2969,"_14":2970},"GFS","GLOBALFOUNDRIES Inc.",{"_12":2972,"_14":2973},"GGAL","Grupo Financiero Galicia S.A.",{"_12":2975,"_14":2976},"GGB","Gerdau S.A.",{"_12":2978,"_14":2979},"GGG","Graco Inc.",{"_12":2981,"_14":2982},"GGR","Gogoro Inc.",{"_12":2984,"_14":2985},"GGROU","Golden Growers Cooperative",{"_12":2987,"_14":2988},"GGT","The Gabelli Multimedia Trust Inc.",{"_12":2990,"_14":2991},"GH","Guardant Health, Inc.",{"_12":2993,"_14":2994},"GHM","Graham Corporation",{"_12":2996,"_14":2997},"GIII","G-III Apparel Group, Ltd.",{"_12":2999,"_14":3000},"GILD","Gilead Sciences, Inc.",{"_12":3002,"_14":3003},"GIPL","Global Innovative Platforms Inc.",{"_12":3005,"_14":3006},"GIS","General Mills, Inc.",{"_12":3008,"_14":3009},"GKOS","Glaukos Corporation",{"_12":3011,"_14":3012},"GL","Globe Life Inc.",{"_12":3014,"_14":3015},"GLBE","Global-e Online Ltd.",{"_12":3017,"_14":3018},"GLBS","Globus Maritime Limited",{"_12":3020,"_14":3021},"GLIBK","GCI Liberty, Inc.",{"_12":3023,"_14":3024},"GLND","Greenland Energy Company Common Stock",{"_12":3026,"_14":3027},"GLOB","Globant S.A.",{"_12":3029,"_14":3030},"GLOO","Gloo Holdings, Inc.",{"_12":3032,"_14":3033},"GLP","Global Partners LP",{"_12":3035,"_14":3036},"GLPI","Gaming and Leisure Properties, Inc.",{"_12":3038,"_14":3039},"GLRE","Greenlight Capital Re, Ltd.",{"_12":3041,"_14":3042},"GLSI","Greenwich LifeSciences, Inc.",{"_12":3044,"_14":3045},"GLXY","Galaxy Digital",{"_12":3047,"_14":3048},"GME","GameStop Corp.",{"_12":3050,"_14":3051},"GMEX","GMEX Robotics Corp.",{"_12":3053,"_14":3054},"GMRS","GMR Solutions Inc.",{"_12":3056,"_14":3057},"GNRC","Generac Holdings Inc.",{"_12":3059,"_14":3060},"GO","Grocery Outlet Holding Corp.",{"_12":3062,"_14":3063},"GOAI","Eva Live, Inc.",{"_12":3065,"_14":3066},"GOF","Guggenheim Strategic Opportunities Fund",{"_12":3068,"_14":3069},"GOGO","Gogo Inc.",{"_12":3071,"_14":3072},"GOLD","Gold.com, Inc.",{"_12":3074,"_14":3075},"GOOD","Gladstone Commercial Corporation",{"_12":3077,"_14":3078},"GOOGL","Alphabet Inc.",{"_12":3080,"_14":3081},"GOTU","Gaotu Techedu Inc.",{"_12":3083,"_14":3084},"GOVB","Gouverneur Bancorp, Inc.",{"_12":3086,"_14":3087},"GPGI","GPGI, Inc.",{"_12":3089,"_14":3090},"GPI","Group 1 Automotive, Inc.",{"_12":3092,"_14":3093},"GPK","Graphic Packaging Holding Company",{"_12":3095,"_14":3096},"GPOR","Gulfport Energy Corp",{"_12":3098,"_14":3099},"GPRE","Green Plains Inc.",{"_12":3101,"_14":3102},"GPUS","Hyperscale Data, Inc.",{"_12":3104,"_14":3105},"GRAB","Grab Holdings Limited",{"_12":3107,"_14":3108},"GRAL","GRAIL Inc.",{"_12":3110,"_14":3111},"GRCE","Grace Therapeutics, Inc.",{"_12":3113,"_14":3114},"GREE","Greenidge Generation Holdings Inc.",{"_12":3116,"_14":3117},"GRF","Eagle Capital Growth Fund, Inc.",{"_12":3119,"_14":3120},"GRML","Greenland Mines Ltd.",{"_12":3122,"_14":3123},"GRND","Grindr Inc.",{"_12":3125,"_14":3126},"GRNQ","Greenpro Capital Corp.",{"_12":3128,"_14":3129},"GRNT","Granite Ridge Resources, Inc",{"_12":3131,"_14":3132},"GROV","Grove Collaborative Holdings, Inc.",{"_12":3134,"_14":3135},"GROW","U.S. Global Investors, Inc.",{"_12":3137,"_14":3138},"GRWG","GrowGeneration Corp.",{"_12":3140,"_14":3141},"GRX","The Gabelli Healthcare & Wellness Trust",{"_12":3143,"_14":3144},"GSAT","Globalstar, Inc.",{"_12":3146,"_14":3147},"GSBD","Goldman Sachs BDC, Inc.",{"_12":3149,"_14":3150},"GSHD","Goosehead Insurance, Inc",{"_12":3152,"_14":3153},"GSL","Global Ship Lease, Inc.",{"_12":3155,"_14":3156},"GSM","Ferroglobe PLC",{"_12":3158,"_14":3159},"GTE","Gran Tierra Energy Inc.",{"_12":3161,"_14":3162},"GTLB","GitLab Inc.",{"_12":3164,"_14":3165},"GTM","ZoomInfo Technologies Inc.",{"_12":3167,"_14":3168},"GUER","Guerrilla RF, Inc.",{"_12":3170,"_14":3171},"GUTS","Fractyl Health, Inc. Common Stock",{"_12":3173,"_14":3174},"GVA","Granite Construction Incorporated",{"_12":3176,"_14":3177},"GVH","Globavend Holdings Limited",{"_12":3179,"_14":3180},"GWAV","Greenwave Technology Solutions, Inc.",{"_12":3182,"_14":3183},"GWH","ESS Tech, Inc.",{"_12":3185,"_14":3186},"GWRE","Guidewire Software, Inc.",{"_12":3188,"_14":3189},"GWRS","Global Water Resources, Inc.",{"_12":3191,"_14":3192},"GYGY","Game Your Game Inc.",{"_12":3194,"_14":3195},"HALO","Halozyme Therapeutics, Inc.",{"_12":3197,"_14":3198},"HAO","Haoxi Health Technology Limited",{"_12":3200,"_14":3201},"HAPN","Happen, Inc. Common Stock",{"_12":3203,"_14":3204},"HAWK","HawkEye 360, Inc.",{"_12":3206,"_14":3207},"HAYW","Hayward Holdings, Inc.",{"_12":3209,"_14":3210},"HBAN","Huntington Bancshares Incorporated",{"_12":3212,"_14":-5},"HBIA.PK",{"_12":3214,"_14":3215},"HBIO","Harvard Bioscience, Inc.",{"_12":3217,"_14":3218},"HBNC","Horizon Bancorp, Inc.",{"_12":3220,"_14":3221},"HBT","HBT Financial, Inc.",{"_12":3223,"_14":3224},"HCAT","Health Catalyst, Inc.",{"_12":3226,"_14":3227},"HCWB","HCW Biologics Inc.",{"_12":3229,"_14":3230},"HDSN","Hudson Technologies, Inc.",{"_12":60,"_14":61},{"_12":3233,"_14":3234},"HEPA","Hepion Pharmaceuticals, Inc.",{"_12":3236,"_14":3237},"HEQ","John Hancock Hedged Equity & Income Fund",{"_12":3239,"_14":3240},"HERZ","Herzfeld Credit Income Fund, Inc.",{"_12":3242,"_14":3243},"HFFG","HF Foods Group Inc.",{"_12":3245,"_14":3246},"HFRO","Highland Funds I - Highland Income Fund",{"_12":3248,"_14":3249},"HG","Hamilton Insurance Group, Ltd.",{"_12":3251,"_14":3252},"HGBL","Heritage Global Inc.",{"_12":3254,"_14":3255},"HGTY","Hagerty, Inc.",{"_12":3257,"_14":3258},"HHH","Howard Hughes Holdings Inc.",{"_12":3260,"_14":3261},"HIMS","Hims & Hers Health, Inc.",{"_12":3263,"_14":3264},"HIPO","Hippo Holdings Inc.",{"_12":3266,"_14":3267},"HIVE","HIVE Digital Technologies Ltd.",{"_12":3269,"_14":3270},"HKHC","Horizon Kinetics Holding Corporation",{"_12":3272,"_14":3273},"HKIT","Hitek Global Inc.",{"_12":3275,"_14":3276},"HLF","Herbalife Nutrition Ltd.",{"_12":3278,"_14":3279},"HLI","Houlihan Lokey, Inc.",{"_12":3281,"_14":3282},"HLMN","Hillman Solutions Corp.",{"_12":3284,"_14":3285},"HLNE","Hamilton Lane Incorporated",{"_12":3287,"_14":3288},"HMH","HMH Holding Inc. Class A Common Stock",{"_12":3290,"_14":3291},"HMMR","Hammer Technology Holdings Corp.",{"_12":3293,"_14":3294},"HMN","Horace Mann Educators Corporation",{"_12":3296,"_14":3297},"HNGE","Hinge Health, Inc.",{"_12":3299,"_14":3300},"HNNA","Hennessy Advisors, Inc.",{"_12":3302,"_14":3303},"HNRG","Hallador Energy Company",{"_12":3305,"_14":3306},"HNST","The Honest Company, Inc.",{"_12":3308,"_14":3309},"HNVR","Hanover Bancorp, Inc.",{"_12":3311,"_14":3312},"HOG","Harley-Davidson, Inc.",{"_12":3314,"_14":3315},"HOMB","Home Bancshares, Inc.",{"_12":3317,"_14":3318},"HONA","Honeywell Aerospace Inc",{"_12":3320,"_14":3321},"HOOD","Robinhood Markets, Inc.",{"_12":3323,"_14":3324},"HPE","Hewlett Packard Enterprise Company",{"_12":3326,"_14":3327},"HPF","John Hancock Preferred Income Fund II",{"_12":3329,"_14":3330},"HPI","John Hancock Preferred Income Fund",{"_12":3332,"_14":3333},"HPP","Hudson Pacific Properties, Inc.",{"_12":3335,"_14":3336},"HPQ","HP Inc.",{"_12":3338,"_14":3339},"HPS","John Hancock Preferred Income Fund III",{"_12":3341,"_14":3342},"HQ","Horizon Quantum Holdings Ltd. Class A Ordinary Shares",{"_12":3344,"_14":3345},"HQH","Abrdn Healthcare Investors",{"_12":3347,"_14":3348},"HQI","HireQuest, Inc.",{"_12":3350,"_14":3351},"HQL","Tekla Life Sciences Investors",{"_12":3353,"_14":3354},"HR","Healthcare Realty Trust Incorporated",{"_12":3356,"_14":3357},"HRB","H&R Block, Inc.",{"_12":3359,"_14":3360},"HRGN","Harvard Apparatus Regenerative Technology Inc.",{"_12":3362,"_14":3363},"HRI","Herc Holdings Inc.",{"_12":3365,"_14":3366},"HRL","Hormel Foods Corporation",{"_12":3368,"_14":3369},"HRMY","Harmony Biosciences Holdings, Inc.",{"_12":3371,"_14":3372},"HROW","Harrow Health, Inc.",{"_12":3374,"_14":3375},"HRTG","Heritage Insurance Holdings, Inc.",{"_12":3377,"_14":3378},"HRZN","Horizon Technology Finance Corporation",{"_12":3380,"_14":3381},"HSBC","HSBC Holdings plc",{"_12":3383,"_14":3384},"HSHP","Himalaya Shipping Ltd.",{"_12":3386,"_14":3387},"HSIC","Henry Schein, Inc.",{"_12":3389,"_14":3390},"HSY","The Hershey Company",{"_12":3392,"_14":3393},"HTD","John Hancock Tax-Advantaged Dividend Income Fund",{"_12":3395,"_14":3396},"HTFL","Heartflow, Inc. Common Stock",{"_12":3398,"_14":3399},"HTGC","Hercules Capital, Inc.",{"_12":3401,"_14":3402},"HTLD","Heartland Express, Inc.",{"_12":3404,"_14":3405},"HTO","H2O America",{"_12":3407,"_14":3408},"HUBC","HUB Cyber Security Ltd.",{"_12":3410,"_14":3411},"HUBS","HubSpot, Inc.",{"_12":3413,"_14":3414},"HUIZ","Huize Holding Limited",{"_12":3416,"_14":3417},"HUM","Humana Inc.",{"_12":3419,"_14":3420},"HUMA","Humacyte, Inc.",{"_12":3422,"_14":3423},"HUN","Huntsman Corporation",{"_12":3425,"_14":3426},"HUT","Hut 8 Corp.",{"_12":3428,"_14":3429},"HWH","HWH International Inc.",{"_12":3431,"_14":3432},"HWKN","Hawkins, Inc.",{"_12":3434,"_14":3435},"HYLN","Hyliion Holdings Corp.",{"_12":3437,"_14":3438},"HYMC","Hycroft Mining Holding Corporation",{"_12":3440,"_14":3441},"HYNE","Hoyne Bancorp, Inc. Common Stock",{"_12":3443,"_14":3444},"HYPD","Hyperion DeFi, Inc.",{"_12":3446,"_14":3447},"IAUX","i-80 Gold Corp.",{"_12":3449,"_14":3450},"IBATF","International Battery Metals Ltd.",{"_12":3452,"_14":3453},"IBCP","Independent Bank Corporation",{"_12":3455,"_14":3456},"IBEX","IBEX Limited",{"_12":3458,"_14":3459},"IBIO","iBio, Inc.",{"_12":3461,"_14":3462},"IBKR","Interactive Brokers Group, Inc.",{"_12":3464,"_14":3465},"IBM","International Business Machines Corporation",{"_12":3467,"_14":3468},"IBP","Installed Building Products, Inc.",{"_12":3470,"_14":3471},"IBRX","ImmunityBio, Inc.",{"_12":3473,"_14":3474},"IBTA","Ibotta, Inc.",{"_12":3476,"_14":3477},"ICCC","ImmuCell Corporation",{"_12":3479,"_14":3480},"ICFI","ICF International, Inc.",{"_12":3482,"_14":3483},"ICHR","Ichor Holdings, Ltd.",{"_12":3485,"_14":3486},"ICLR","ICON Public Limited Company",{"_12":3488,"_14":3489},"IDAI","T Stamp Inc.",{"_12":3491,"_14":3492},"IDCC","InterDigital, Inc.",{"_12":3494,"_14":3495},"IDT","IDT Corporation",{"_12":3497,"_14":3498},"IDYA","IDEAYA Biosciences, Inc.",{"_12":3500,"_14":3501},"IFF","International Flavors & Fragrances Inc.",{"_12":3503,"_14":3504},"IGR","CBRE Global Real Estate Income Fund",{"_12":3506,"_14":3507},"IHRT","iHeartMedia, Inc.",{"_12":3509,"_14":3510},"IHT","InnSuites Hospitality Trust",{"_12":3512,"_14":3513},"IIIV","i3 Verticals, Inc.",{"_12":3515,"_14":3516},"IIPR","Innovative Industrial Properties, Inc.",{"_12":3518,"_14":3519},"ILPT","Industrial Logistics Properties Trust",{"_12":3521,"_14":3522},"IMDX","Insight Molecular Diagnostics Inc.",{"_12":3524,"_14":3525},"IMKTA","Ingles Markets, Incorporated",{"_12":3527,"_14":3528},"IMMR","Immersion Corporation",{"_12":3530,"_14":3531},"IMNM","Immunome, Inc.",{"_12":3533,"_14":3534},"IMRX","Immuneering Corporation",{"_12":3536,"_14":3537},"IMSR","Terrestrial Energy Inc.",{"_12":3539,"_14":3540},"IMTX","Immatics N.V.",{"_12":3542,"_14":3543},"IMVT","Immunovant, Inc.",{"_12":3545,"_14":3546},"INBX","Inhibrx Biosciences Inc.",{"_12":3548,"_14":3549},"INCY","Incyte Corporation",{"_12":3551,"_14":3552},"INDI","indie Semiconductor, Inc.",{"_12":3554,"_14":3555},"INDV","Indivior Pharmaceuticals Inc",{"_12":3557,"_14":3558},"INFQ","Infleqtion Inc",{"_12":3560,"_14":3561},"INFU","InfuSystem Holdings, Inc.",{"_12":3563,"_14":3564},"INGM","Ingram Micro Holding Corporation",{"_12":3566,"_14":3567},"INIO","INNIO N.V. Ordinary Shares",{"_12":3569,"_14":3570},"INKT","MiNK Therapeutics, Inc.",{"_12":3572,"_14":3573},"INLF","INLIF Limited",{"_12":3575,"_14":3576},"INM","InMed Pharmaceuticals Inc.",{"_12":3578,"_14":3579},"INNV","Innovage Holding Corp.",{"_12":3581,"_14":3582},"INR","Infinity Natural Resources, Inc.",{"_12":3584,"_14":3585},"INSE","Inspired Entertainment, Inc.",{"_12":3587,"_14":3588},"INTA","Intapp, Inc.",{"_12":3590,"_14":3591},"INTC","Intel Corp.",{"_12":3593,"_14":3594},"INTG","The InterGroup Corporation",{"_12":3596,"_14":3597},"INTU","Intuit Inc.",{"_12":3599,"_14":3600},"INTZ","Intrusion Inc.",{"_12":3602,"_14":3603},"INV","Innventure, Inc.",{"_12":3605,"_14":3606},"IONQ","IonQ, Inc.",{"_12":3608,"_14":3609},"IONR","ioneer Ltd",{"_12":3611,"_14":3612},"IONS","Ionis Pharmaceuticals, Inc.",{"_12":3614,"_14":3615},"IOR","Income Opportunity Realty Investors, Inc.",{"_12":3617,"_14":3618},"IOT","Samsara Inc.",{"_12":3620,"_14":3621},"IP","International Paper Company",{"_12":3623,"_14":3624},"IPGP","IPG Photonics Corporation",{"_12":3626,"_14":3627},"IPM","Intelligent Protection Management Corp.",{"_12":3629,"_14":3630},"IPVVU","InterPrivate Investment Partners V, Inc. Units",{"_12":3632,"_14":3633},"IPW","iPower Inc.",{"_12":3635,"_14":3636},"IPWR","Ideal Power Inc.",{"_12":3638,"_14":3639},"IPX","IperionX Limited",{"_12":3641,"_14":3642},"IQI","Invesco Quality Municipal Income Trust",{"_12":3644,"_14":3645},"IR","Ingersoll Rand Inc.",{"_12":3647,"_14":3648},"IRD","Opus Genetics, Inc.",{"_12":3650,"_14":3651},"IRIX","IRIDEX Corporation",{"_12":3653,"_14":3654},"IRM","Iron Mountain Incorporated",{"_12":3656,"_14":3657},"IRTC","iRhythm Technologies, Inc.",{"_12":3659,"_14":3660},"ISBA","Isabella Bank Corporation",{"_12":3662,"_14":3663},"ISTR","Investar Holding Corporation",{"_12":3665,"_14":3666},"ITG","ITG Inc.",{"_12":3668,"_14":3669},"ITIC","Investors Title Company",{"_12":3671,"_14":3672},"ITT","ITT Inc.",{"_12":3674,"_14":3675},"ITW","Illinois Tool Works Inc.",{"_12":3677,"_14":3678},"IVR","Invesco Mortgage Capital Inc.",{"_12":3680,"_14":-5},"IVYIX",{"_12":3682,"_14":3683},"IX","ORIX Corporation",{"_12":3685,"_14":3686},"J","Jacobs Solutions Inc.",{"_12":3688,"_14":3689},"JACK","Jack in the Box Inc.",{"_12":3691,"_14":3692},"JAGU","Jaguar Uranium Corp. Class A",{"_12":3694,"_14":3695},"JAN","Janus Living, Inc.",{"_12":3697,"_14":3698},"JANL","Janel Corporation",{"_12":3700,"_14":3701},"JATT","JATT Acquisition Corp",{"_12":3703,"_14":3704},"JAZZ","Jazz Pharmaceuticals plc",{"_12":3706,"_14":3707},"JBHT","J.B. Hunt Transport Services, Inc.",{"_12":3709,"_14":3710},"JBL","Jabil Inc.",{"_12":3712,"_14":3713},"JCTC","Jewett-Cameron Trading Company Ltd.",{"_12":3715,"_14":3716},"JEF","Jefferies Financial Group Inc.",{"_12":3718,"_14":3719},"JEM","707 Cayman Holdings Limited Ordinary Shares",{"_12":3721,"_14":3722},"JFR","Nuveen Floating Rate Income Fund",{"_12":3724,"_14":3725},"JHI","John Hancock Investors Trust",{"_12":3727,"_14":3728},"JHS","John Hancock Income Securities Trust",{"_12":3730,"_14":3731},"JHX","James Hardie Industries plc",{"_12":3733,"_14":3734},"JILL","J.Jill, Inc.",{"_12":3736,"_14":3737},"JKHY","Jack Henry & Associates, Inc.",{"_12":3739,"_14":3740},"JKS","JinkoSolar Holding Co., Ltd.",{"_12":3742,"_14":3743},"JLS","Nuveen Mortgage and Income Fund",{"_12":3745,"_14":3746},"JMKE","Jersey Mike's Subs Inc.",{"_12":3748,"_14":3749},"JMSB","John Marshall Bancorp, Inc.",{"_12":3751,"_14":3752},"JOBY","Joby Aviation, Inc.",{"_12":3754,"_14":3755},"JQC","Nuveen Credit Strategies Income Fund",{"_12":3757,"_14":3758},"JSDA","Jones Soda Co.",{"_12":3760,"_14":3761},"JTTT","JATT III Acquisition Corp",{"_12":3763,"_14":-5},"JUSH",{"_12":3765,"_14":3766},"JUVF","Juniata Valley Financial Corp.",{"_12":3768,"_14":3769},"JYNT","The Joint Corp.",{"_12":3771,"_14":3772},"KARD","Kardigan, Inc.",{"_12":3774,"_14":3775},"KBDC","Kayne Anderson BDC, Inc.",{"_12":3777,"_14":3778},"KBR","KBR, Inc.",{"_12":3780,"_14":3781},"KDOZF","Kidoz Inc.",{"_12":3783,"_14":3784},"KDP","Keurig Dr Pepper Inc.",{"_12":3786,"_14":3787},"KEEL","Keel Infrastructure Corp.",{"_12":3789,"_14":3790},"KELYA","Kelly Services, Inc.",{"_12":3792,"_14":3793},"KEYS","Keysight Technologies, Inc.",{"_12":3795,"_14":3796},"KFS","Kingsway Financial Services Inc.",{"_12":3798,"_14":3799},"KFY","Korn Ferry",{"_12":3801,"_14":3802},"KGS","Kodiak Gas Services, Inc.",{"_12":3804,"_14":3805},"KHC","The Kraft Heinz Company",{"_12":3807,"_14":3808},"KINS","Kingstone Companies, Inc.",{"_12":3810,"_14":3811},"KKR","KKR & Co. Inc.",{"_12":3813,"_14":3814},"KLAR","Klarna Group plc",{"_12":3816,"_14":3817},"KLC","KinderCare Learning Companies, Inc.",{"_12":3819,"_14":3820},"KLNG","Koil Energy Solutions, Inc.",{"_12":3822,"_14":3823},"KLRA","Kailera Therapeutics, Inc.",{"_12":3825,"_14":3826},"KLRS","Kalaris Therapeutics Inc",{"_12":3828,"_14":3829},"KLTR","Kaltura, Inc.",{"_12":3831,"_14":3832},"KMDA","Kamada Ltd.",{"_12":3834,"_14":3835},"KMI","Kinder Morgan, Inc.",{"_12":3837,"_14":3838},"KMPR","Kemper Corporation",{"_12":3840,"_14":3841},"KMT","Kennametal Inc.",{"_12":3843,"_14":3844},"KMTS","Kestra Medical Technologies, Ltd.",{"_12":3846,"_14":3847},"KMX","CarMax, Inc.",{"_12":3849,"_14":3850},"KNOP","KNOT Offshore Partners LP",{"_12":3852,"_14":3853},"KNSL","Kinsale Capital Group, Inc.",{"_12":3855,"_14":3856},"KNTK","Kinetik Holdings Inc.",{"_12":3858,"_14":3859},"KOD","Kodiak Sciences Inc.",{"_12":3861,"_14":3862},"KODK","Eastman Kodak Company",{"_12":3864,"_14":3865},"KOS","Kosmos Energy Ltd.",{"_12":3867,"_14":-5},"KPET",{"_12":3869,"_14":3870},"KR","The Kroger Co.",{"_12":3872,"_14":3873},"KREF","KKR Real Estate Finance Trust Inc.",{"_12":3875,"_14":3876},"KRMD","KORU Medical Systems, Inc.",{"_12":3878,"_14":3879},"KRMN","Karman Holdings Inc.",{"_12":3881,"_14":3882},"KRNT","Kornit Digital Ltd.",{"_12":3884,"_14":3885},"KRNY","Kearny Financial Corp.",{"_12":3887,"_14":3888},"KRO","Kronos Worldwide, Inc.",{"_12":3890,"_14":3891},"KROS","Keros Therapeutics, Inc.",{"_12":3893,"_14":3894},"KRRO","Korro Bio, Inc.",{"_12":3896,"_14":3897},"KTOS","Kratos Defense & Security Solutions, Inc.",{"_12":3899,"_14":3900},"KTTA","Pasithea Therapeutics Corp.",{"_12":3902,"_14":3903},"KURA","Kura Oncology, Inc.",{"_12":3905,"_14":3906},"KUST","Kustom Entertainment, Inc.",{"_12":3908,"_14":3909},"KVYO","Klaviyo, Inc.",{"_12":3911,"_14":3912},"KWY","Kingsway Corporation",{"_12":3914,"_14":3915},"KYMR","Kymera Therapeutics, Inc.",{"_12":3917,"_14":3918},"KYN","Kayne Anderson Energy Infrastructure Fund, Inc.",{"_12":3920,"_14":3921},"KYNB","Kyntra Bio, Inc.",{"_12":3923,"_14":3924},"L","Loews Corporation",{"_12":3926,"_14":3927},"LAC","Lithium Americas Corp.",{"_12":3929,"_14":3930},"LAES","SEALSQ Corp",{"_12":3932,"_14":3933},"LARK","Landmark Bancorp, Inc.",{"_12":3935,"_14":3936},"LASE","Laser Photonics Corporation",{"_12":3938,"_14":3939},"LASR","nLIGHT, Inc.",{"_12":3941,"_14":3942},"LAW","CS Disco, Inc.",{"_12":3944,"_14":3945},"LBGJ","Li Bang International Corporation Inc. Ordinary Shares",{"_12":3947,"_14":-5},"LBRA",{"_12":3949,"_14":3950},"LBRT","Liberty Energy Inc.",{"_12":3952,"_14":3953},"LCFY","Locafy Limited",{"_12":3955,"_14":3956},"LCNB","LCNB Corp.",{"_12":3958,"_14":3959},"LCRDX","Lord Abbett Credit Opportunities Fund",{"_12":3961,"_14":3962},"LCTC","Lifeloc Technologies, Inc.",{"_12":3964,"_14":3965},"LCTX","Lineage Cell Therapeutics, Inc.",{"_12":3967,"_14":3968},"LDI","loanDepot, Inc.",{"_12":3970,"_14":3971},"LE","Lands' End, Inc.",{"_12":3973,"_14":3974},"LEE","Lee Enterprises, Incorporated",{"_12":3976,"_14":3977},"LEEEF","Leef Brands Inc.",{"_12":3979,"_14":3980},"LEGN","Legend Biotech Corporation",{"_12":3982,"_14":3983},"LEGO","Legato Merger Corp. IV",{"_12":3985,"_14":3986},"LEN","Lennar Corporation",{"_12":3988,"_14":3989},"LENZ","LENZ Therapeutics, Inc.",{"_12":3991,"_14":3992},"LFT","Lument Finance Trust, Inc.",{"_12":3994,"_14":3995},"LFTO","Liftoff Mobile, Inc. Common Stock",{"_12":3997,"_14":3998},"LFVN","LifeVantage Corporation",{"_12":4000,"_14":4001},"LGCY","Legacy Education Inc.",{"_12":4003,"_14":4004},"LGHL","Lion Group Holding Ltd.",{"_12":4006,"_14":4007},"LGN","Legence Corp. Class A Common stock",{"_12":4009,"_14":4010},"LGND","Ligand Pharmaceuticals Incorporated",{"_12":4012,"_14":4013},"LHAI","Linkhome Holdings Inc.",{"_12":4015,"_14":-5},"LICENSE.TXT",{"_12":4017,"_14":4018},"LIEN","Chicago Atlantic BDC, Inc.",{"_12":4020,"_14":4021},"LIF","Life360, Inc.",{"_12":4023,"_14":4024},"LIFE","Ethos Technologies Inc.",{"_12":4026,"_14":4027},"LILA","Liberty Latin America Ltd.",{"_12":4029,"_14":4030},"LIME","Neutron Holdings Inc.",{"_12":4032,"_14":4033},"LIN","Linde plc",{"_12":4035,"_14":4036},"LINE","Lineage, Inc.",{"_12":4038,"_14":4039},"LION","Lionsgate Studios Corp.",{"_12":4041,"_14":4042},"LIQT","LiqTech International, Inc.",{"_12":4044,"_14":4045},"LITB","LightInTheBox Holding Co., Ltd.",{"_12":4047,"_14":4048},"LITE","Lumentum Holdings Inc.",{"_12":4050,"_14":4051},"LITS","Lite Strategy, Inc.",{"_12":4053,"_14":4054},"LIVE","Live Ventures Incorporated",{"_12":4056,"_14":4057},"LKFN","Lakeland Financial Corporation",{"_12":4059,"_14":4060},"LLYVK","Liberty Live Group",{"_12":4062,"_14":4063},"LMB","Limbach Holdings, Inc.",{"_12":4065,"_14":4066},"LMFA","LM Funding America, Inc.",{"_12":4068,"_14":4069},"LMND","Lemonade, Inc.",{"_12":4071,"_14":4072},"LMRI","Lumexa Imaging Holdings, Inc. Common Stock",{"_12":4074,"_14":-5},"LNBIX",{"_12":4076,"_14":4077},"LNC","Lincoln National Corporation",{"_12":4079,"_14":4080},"LND","BrasilAgro - Companhia Brasileira de Propriedades Agrícolas",{"_12":4082,"_14":4083},"LNKS","Linkers Industries Limited",{"_12":4085,"_14":-5},"LNPIX",{"_12":4087,"_14":4088},"LOAN","Manhattan Bridge Capital, Inc.",{"_12":4090,"_14":4091},"LOAR","Loar Holdings Inc.",{"_12":4093,"_14":4094},"LOCL","Local Bounti Corporation",{"_12":4096,"_14":4097},"LODE","Comstock Inc.",{"_12":4099,"_14":-5},"LOG-IN",{"_12":4101,"_14":4102},"LOGC","ContextLogic Inc.",{"_12":4104,"_14":-5},"LOGIN",{"_12":4106,"_14":-5},"LOGIN_UP.PHP",{"_12":4108,"_14":4109},"LOOP","Loop Industries, Inc.",{"_12":4111,"_14":4112},"LOVE","The Lovesac Company",{"_12":4114,"_14":4115},"LPCN","Lipocine Inc.",{"_12":4117,"_14":4118},"LPG","Dorian LPG Ltd.",{"_12":4120,"_14":4121},"LPTH","LightPath Technologies, Inc.",{"_12":4123,"_14":4124},"LQDA","Liquidia Corporation",{"_12":4126,"_14":4127},"LRMR","Larimar Therapeutics, Inc.",{"_12":4129,"_14":4130},"LSAK","Lesaka Technologies, Inc.",{"_12":4132,"_14":4133},"LSF","Laird Superfood, Inc.",{"_12":4135,"_14":4136},"LTC","LTC Properties, Inc.",{"_12":4138,"_14":4139},"LTGO","Latigo Biotherapeutics Inc.",{"_12":4141,"_14":4142},"LTH","Life Time Group Holdings, Inc.",{"_12":4144,"_14":4145},"LTRN","Lantern Pharma Inc.",{"_12":4147,"_14":4148},"LTRX","Lantronix, Inc.",{"_12":4150,"_14":4151},"LUCD","Lucid Diagnostics Inc.",{"_12":4153,"_14":4154},"LUCK","Lucky Strike Entertainment Corporation",{"_12":4156,"_14":4157},"LULU","Lululemon Athletica Inc.",{"_12":4159,"_14":4160},"LUMN","Lumen Technologies, Inc.",{"_12":4162,"_14":4163},"LUNR","Intuitive Machines, Inc.",{"_12":4165,"_14":4166},"LUXE","LuxExperience B.V.",{"_12":4168,"_14":4169},"LW","Lamb Weston Holdings, Inc.",{"_12":4171,"_14":4172},"LWAY","Lifeway Foods, Inc.",{"_12":4174,"_14":4175},"LXRX","Lexicon Pharmaceuticals, Inc.",{"_12":4177,"_14":4178},"LYEL","Lyell Immunopharma, Inc.",{"_12":4180,"_14":4181},"LYFT","Lyft, Inc.",{"_12":4183,"_14":4184},"LYTS","LSI Industries Inc.",{"_12":4186,"_14":4187},"LZ","LegalZoom.com, Inc.",{"_12":4189,"_14":4190},"MA","Mastercard Incorporated",{"_12":4192,"_14":4193},"MAA","Mid-America Apartment Communities, Inc.",{"_12":4195,"_14":4196},"MAIA","MAIA Biotechnology, Inc.",{"_12":4198,"_14":4199},"MAIN","Main Street Capital Corporation",{"_12":4201,"_14":4202},"MAIR","Madison Air Solutions Corporation",{"_12":4204,"_14":4205},"MAMA","Mama's Creations, Inc.",{"_12":4207,"_14":4208},"MANE","Veradermics, Incorporated",{"_12":4210,"_14":4211},"MAR","Marriott International, Inc.",{"_12":4213,"_14":4214},"MARA","Marathon Digital Holdings, Inc.",{"_12":4216,"_14":4217},"MASS","908 Devices Inc.",{"_12":4219,"_14":4220},"MATW","Matthews International Corporation",{"_12":4222,"_14":4223},"MATX","Matson, Inc.",{"_12":4225,"_14":4226},"MAX","MediaAlpha, Inc.",{"_12":4228,"_14":4229},"MAZE","Maze Therapeutics, Inc.",{"_12":4231,"_14":4232},"MBBC","Marathon Bancorp, Inc.",{"_12":4234,"_14":4235},"MBC","MasterBrand, Inc.",{"_12":4237,"_14":4238},"MBGL","Mobility Global Inc",{"_12":4240,"_14":4241},"MBLY","Mobileye Global Inc.",{"_12":4243,"_14":4244},"MBRX","Moleculin Biotech, Inc.",{"_12":4246,"_14":4247},"MBX","MBX Biosciences, Inc. Common Stock",{"_12":4249,"_14":-5},"MCAH",{"_12":4251,"_14":4252},"MCB","Metropolitan Bank Holding Corp.",{"_12":4254,"_14":4255},"MCFT","MasterCraft Boat Holdings, Inc.",{"_12":4257,"_14":4258},"MCO","Moody's Corporation",{"_12":4260,"_14":4261},"MCRI","Monarch Casino & Resort, Inc.",{"_12":4263,"_14":4264},"MCS","The Marcus Corporation",{"_12":4266,"_14":4267},"MDB","MongoDB, Inc.",{"_12":4269,"_14":4270},"MDLN","Medline Inc.",{"_12":4272,"_14":4273},"MDRR","Medalist Diversified REIT, Inc.",{"_12":4275,"_14":4276},"MDT","Medtronic plc",{"_12":4278,"_14":4279},"MDV","Modiv Inc.",{"_12":4281,"_14":4282},"MDWD","MediWound Ltd.",{"_12":4284,"_14":4285},"MDXH","MDxHealth S.A.",{"_12":4287,"_14":4288},"MED","Medifast, Inc.",{"_12":4290,"_14":4291},"MEDP","Medpace Holdings, Inc.",{"_12":4293,"_14":4294},"MEGI","NYLI CBRE Global Infrastructure Megatrends Term Fund",{"_12":4296,"_14":4297},"MELI","MercadoLibre, Inc.",{"_12":4299,"_14":4300},"MERC","Mercer International Inc.",{"_12":4302,"_14":4303},"MESO","Mesoblast Limited",{"_12":4305,"_14":4306},"META","Meta Platforms, Inc.",{"_12":4308,"_14":-5},"MFJ",{"_12":4310,"_14":4311},"MFP","Midera Food Processing, Inc.",{"_12":4313,"_14":4314},"MGEE","MGE Energy, Inc.",{"_12":4316,"_14":4317},"MGF","Aberdeen Government Markets Income Fund",{"_12":4319,"_14":4320},"MGM","MGM Resorts International",{"_12":4322,"_14":4323},"MGNI","Magnite, Inc.",{"_12":4325,"_14":4326},"MGPI","MGP Ingredients, Inc.",{"_12":4328,"_14":4329},"MGRC","McGrath RentCorp",{"_12":4331,"_14":4332},"MGTI","MGT Capital Investments, Inc.",{"_12":4334,"_14":4335},"MGTX","MeiraGTx Holdings plc",{"_12":4337,"_14":4338},"MGY","Magnolia Oil & Gas Corporation",{"_12":4340,"_14":4341},"MH","McGraw Hill, Inc.",{"_12":4343,"_14":4344},"MHH","Mastech Digital, Inc.",{"_12":4346,"_14":4347},"MHK","Mohawk Industries, Inc.",{"_12":4349,"_14":4350},"MIAX","Miami International Holdings, Inc. ",{"_12":4352,"_14":4353},"MIMI","Mint Incorporation Limited",{"_12":4355,"_14":4356},"MIN","Aberdeen Intermediate Income Fund",{"_12":4358,"_14":4359},"MIR","Mirion Technologies, Inc.",{"_12":4361,"_14":4362},"MKC","McCormick & Company, Incorporated",{"_12":4364,"_14":4365},"MKL","Markel Corporation",{"_12":4367,"_14":4368},"MKTW","MarketWise, Inc.",{"_12":4370,"_14":4371},"MKZR","MacKenzie Realty Capital, Inc.",{"_12":4373,"_14":4374},"MLAB","Mesa Laboratories, Inc.",{"_12":4376,"_14":4377},"MLCI","Mount Logan Capital Inc. Common Stock",{"_12":4379,"_14":4380},"MLP","Maui Land & Pineapple Company, Inc.",{"_12":4382,"_14":-5},"MLPT",{"_12":4384,"_14":4385},"MLYS","Mineralys Therapeutics, Inc.",{"_12":4387,"_14":4388},"MMI","Marcus & Millichap, Inc.",{"_12":4390,"_14":4391},"MMM","3M Company",{"_12":4393,"_14":4394},"MMS","Maximus, Inc.",{"_12":4396,"_14":4397},"MMSI","Merit Medical Systems, Inc.",{"_12":4399,"_14":4400},"MMT","Aberdeen Multi-Market Income Fund",{"_12":4402,"_14":4403},"MNKD","MannKind Corporation",{"_12":4405,"_14":4406},"MNOV","MediciNova, Inc.",{"_12":4408,"_14":4409},"MNPR","Monopar Therapeutics Inc.",{"_12":4411,"_14":4412},"MNR","Mach Natural Resources LP",{"_12":4414,"_14":4415},"MNSO","MINISO Group Holding Limited",{"_12":4417,"_14":4418},"MNTK","Montauk Renewables, Inc.",{"_12":4420,"_14":4421},"MNTR","Mentor Capital, Inc.",{"_12":4423,"_14":4424},"MNTS","Momentus Inc.",{"_12":4426,"_14":4427},"MO","Altria Group, Inc.",{"_12":4429,"_14":-5},"MOALX",{"_12":4431,"_14":4432},"MOBI","Mobia Medical, Inc. Common Stock",{"_12":4434,"_14":4435},"MOGU","MOGU Inc.",{"_12":4437,"_14":4438},"MONIX","Monachil Credit Income Fund",{"_12":4440,"_14":4441},"MORN","Morningstar, Inc.",{"_12":4443,"_14":4444},"MP","MP Materials Corp.",{"_12":4446,"_14":4447},"MPB","Mid Penn Bancorp, Inc.",{"_12":4449,"_14":4450},"MPLT","MapLight Therapeutics, Inc.",{"_12":4452,"_14":4453},"MPWR","Monolithic Power Systems, Inc.",{"_12":4455,"_14":4456},"MQ","Marqeta, Inc.",{"_12":4458,"_14":4459},"MRAI","Marpai, Inc.",{"_12":4461,"_14":4462},"MRAM","Everspin Technologies, Inc.",{"_12":4464,"_14":4465},"MRBK","Meridian Corporation",{"_12":4467,"_14":4468},"MRCY","Mercury Systems, Inc.",{"_12":4470,"_14":4471},"MRMD","MariMed Inc.",{"_12":4473,"_14":4474},"MRP","Millrose Properties, Inc.",{"_12":4476,"_14":4477},"MRT","Marti Technologies, Inc.",{"_12":4479,"_14":4480},"MRVL","Marvell Technology, Inc.",{"_12":4482,"_14":4483},"MRX","Marex Group Limited",{"_12":4485,"_14":4486},"MSA","MSA Safety Incorporated",{"_12":4488,"_14":4489},"MSBI","Midland States Bancorp, Inc.",{"_12":4491,"_14":4492},"MSC","Studio City International Holdings Limited",{"_12":4494,"_14":4495},"MSCI","MSCI Inc.",{"_12":4497,"_14":4498},"MSDL","Morgan Stanley Direct Lending Fund",{"_12":4500,"_14":4501},"MSEX","Middlesex Water Company",{"_12":4503,"_14":4504},"MSFT","Microsoft Corporation",{"_12":4506,"_14":4507},"MSGM","Motorsport Games Inc.",{"_12":4509,"_14":4510},"MSGS","Madison Square Garden Sports Corp.",{"_12":4512,"_14":4513},"MSIF","MSC Income Fund, Inc.",{"_12":4515,"_14":4516},"MSS","Maison Solutions Inc. Class A Common Stock",{"_12":4518,"_14":4519},"MSTR","Strategy Inc",{"_12":4521,"_14":-5},"MTAK",{"_12":4523,"_14":4524},"MTCH","Match Group, Inc.",{"_12":4526,"_14":4527},"MTDR","Matador Resources Company",{"_12":4529,"_14":4530},"MTEN","Mingteng International Corporation Inc.",{"_12":4532,"_14":4533},"MTEX","Mannatech, Incorporated",{"_12":4535,"_14":4536},"MTG","MGIC Investment Corporation",{"_12":4538,"_14":4539},"MTN","Vail Resorts, Inc.",{"_12":4541,"_14":-5},"MTNE",{"_12":4543,"_14":4544},"MTSI","MACOM Technology Solutions Holdings, Inc.",{"_12":4546,"_14":4547},"MTUS","Metallus Inc.",{"_12":4549,"_14":-5},"MUNEX",{"_12":4551,"_14":4552},"MUX","McEwen Mining Inc.",{"_12":4554,"_14":4555},"MVBF","MVB Financial Corp.",{"_12":4557,"_14":4558},"MWA","Mueller Water Products, Inc.",{"_12":4560,"_14":4561},"MX","Magnachip Semiconductor Corporation",{"_12":4563,"_14":4564},"MXF","The Mexico Fund, Inc.",{"_12":4566,"_14":-5},"MY-ACCOUNT",{"_12":4568,"_14":4569},"MYGN","Myriad Genetics, Inc.",{"_12":4571,"_14":4572},"MYN","BlackRock MuniYield New York Quality Fund, Inc.",{"_12":4574,"_14":4575},"MYO","Myomo, Inc.",{"_12":4577,"_14":4578},"MZTI","The Marzetti Company",{"_12":4580,"_14":-5},"N.A.",{"_12":4582,"_14":4583},"NA","Nano Labs Ltd",{"_12":4585,"_14":4586},"NAIFX","Nomura Alternative Income Fund",{"_12":4588,"_14":4589},"NAKA","Nakamoto Inc.",{"_12":4591,"_14":4592},"NAMS","NewAmsterdam Pharma Company N.V.",{"_12":4594,"_14":4595},"NAN","Nuveen New York Quality Municipal Income Fund",{"_12":4597,"_14":4598},"NATR","Nature's Sunshine Products, Inc.",{"_12":4600,"_14":4601},"NAUT","Nautilus Biotechnology, Inc.",{"_12":4603,"_14":4604},"NAVN","Navan, Inc.",{"_12":4606,"_14":4607},"NBBK","NB Bancorp, Inc. Common Stock",{"_12":4609,"_14":4610},"NBH","Neuberger Municipal Fund Inc.",{"_12":4612,"_14":4613},"NBIS","Nebius Group N.V.",{"_12":4615,"_14":4616},"NBP","NovaBridge Biosciences",{"_12":4618,"_14":4619},"NBTB","NBT Bancorp Inc.",{"_12":4621,"_14":4622},"NCDL","Nuveen Churchill Direct Lending Corp.",{"_12":4624,"_14":4625},"NCEL","NewcelX Ltd.",{"_12":4627,"_14":4628},"NCLH","Norwegian Cruise Line Holdings Ltd.",{"_12":4630,"_14":4631},"NCMI","National CineMedia, Inc.",{"_12":4633,"_14":4634},"NCNO","nCino, Inc.",{"_12":4636,"_14":-5},"NCO",{"_12":4638,"_14":4639},"NCRA","Nocera, Inc.",{"_12":4641,"_14":4642},"NCT","Intercont (Cayman) Limited Ordinary shares",{"_12":4644,"_14":4645},"NDAQ","Nasdaq, Inc.",{"_12":4647,"_14":4648},"NDSN","Nordson Corporation",{"_12":4650,"_14":4651},"NEA","Nuveen AMT-Free Quality Municipal Income Fund",{"_12":4653,"_14":4654},"NEGG","Newegg Commerce, Inc.",{"_12":4656,"_14":4657},"NEM","Newmont Corporation",{"_12":4659,"_14":4660},"NEOG","Neogen Corporation",{"_12":4662,"_14":4663},"NEOV","NeoVolta Inc.",{"_12":4665,"_14":4666},"NET","Cloudflare, Inc.",{"_12":4668,"_14":4669},"NEU","NewMarket Corporation",{"_12":4671,"_14":4672},"NEWT","NewtekOne, Inc.",{"_12":4674,"_14":4675},"NEXT","NextDecade Corporation",{"_12":4677,"_14":4678},"NFBK","Northfield Bancorp, Inc.",{"_12":4680,"_14":4681},"NFJ","Virtus Dividend, Interest & Premium Strategy Fund",{"_12":4683,"_14":4684},"NFRX","Harrison Street Infrastructure Active ETF",{"_12":4686,"_14":4687},"NGL","NGL Energy Partners LP",{"_12":4689,"_14":4690},"NGTF","Nightfood Holdings, Inc.",{"_12":4692,"_14":4693},"NHC","National HealthCare Corporation",{"_12":4695,"_14":4696},"NHI","National Health Investors, Inc.",{"_12":4698,"_14":4699},"NIQ","NIQ Global Intelligence Plc",{"_12":4701,"_14":4702},"NIVF","NewGenIvf Group Limited",{"_12":4704,"_14":4705},"NIXX","Nixxy, Inc.",{"_12":4707,"_14":4708},"NKE","NIKE, Inc.",{"_12":4710,"_14":4711},"NKSH","National Bankshares, Inc.",{"_12":4713,"_14":4714},"NLCP","NewLake Capital Partners, Inc.",{"_12":4716,"_14":4717},"NMAX","Newsmax, Inc.",{"_12":4719,"_14":4720},"NMCO","Nuveen Municipal Credit Opportunities Fund",{"_12":4722,"_14":4723},"NMFC","New Mountain Finance Corporation",{"_12":4725,"_14":4726},"NMM","Navios Maritime Partners L.P.",{"_12":4728,"_14":4729},"NMR","Nomura Holdings, Inc.",{"_12":4731,"_14":4732},"NMTC","NeuroOne Medical Technologies Corporation",{"_12":4734,"_14":4735},"NMZ","Nuveen Municipal High Income Opportunity Fund",{"_12":4737,"_14":4738},"NN","NextNav Inc.",{"_12":4740,"_14":4741},"NNOX","Nano-X Imaging Ltd.",{"_12":4743,"_14":4744},"NOAH","Noah Holdings Limited",{"_12":4746,"_14":4747},"NOMA","Nomadar Corp.",{"_12":4749,"_14":4750},"NOMD","Nomad Foods Limited",{"_12":4752,"_14":-5},"NONE",{"_12":4754,"_14":4755},"NOW","ServiceNow, Inc.",{"_12":4757,"_14":4758},"NP","Neptune Insurance Holdings Inc.",{"_12":4760,"_14":4761},"NPB","Northpointe Bancshares, Inc.",{"_12":4763,"_14":4764},"NRDY","Nerdy, Inc.",{"_12":4766,"_14":4767},"NRGV","Energy Vault Holdings, Inc.",{"_12":4769,"_14":4770},"NRIM","Northrim BanCorp, Inc.",{"_12":4772,"_14":4773},"NRIX","Nurix Therapeutics, Inc.",{"_12":4775,"_14":4776},"NRP","Natural Resource Partners L.P.",{"_12":4778,"_14":4779},"NRSN","NeuroSense Therapeutics Ltd.",{"_12":4781,"_14":4782},"NRXS","NeurAxis, Inc.",{"_12":4784,"_14":4785},"NSIT","Insight Enterprises, Inc.",{"_12":4787,"_14":4788},"NSLR","Neostellar Capital Corp.",{"_12":4790,"_14":4791},"NSP","Insperity, Inc.",{"_12":4793,"_14":4794},"NSPR","InspireMD, Inc.",{"_12":4796,"_14":4797},"NSRX","Nasus Pharma Ltd.",{"_12":4799,"_14":4800},"NTAP","NetApp, Inc.",{"_12":4802,"_14":4803},"NTB","The Bank of N.T. Butterfield & Son Limited",{"_12":4805,"_14":4806},"NTHI","NEONC TECHNOLOGIES HOLDINGS, INC.",{"_12":4808,"_14":4809},"NTNX","Nutanix, Inc.",{"_12":4811,"_14":4812},"NTRA","Natera, Inc.",{"_12":4814,"_14":4815},"NTRP","NextTrip, Inc.",{"_12":4817,"_14":4818},"NTRS","Northern Trust Corporation",{"_12":4820,"_14":4821},"NTSK","Netskope, Inc. Class A Common Stock",{"_12":4823,"_14":4824},"NTST","NETSTREIT Corp.",{"_12":4826,"_14":4827},"NTWK","NetSol Technologies, Inc.",{"_12":4829,"_14":4830},"NU","Nu Holdings Ltd.",{"_12":4832,"_14":4833},"NUAI","New Era Energy & Digital, Inc.",{"_12":4835,"_14":4836},"NUTX","Nutex Health, Inc.",{"_12":4838,"_14":4839},"NUVB","Nuvation Bio Inc.",{"_12":4841,"_14":4842},"NVA","Nova Minerals Corp",{"_12":4844,"_14":4845},"NVCT","Nuvectis Pharma, Inc.",{"_12":4847,"_14":4848},"NVDA","NVIDIA Corporation",{"_12":4850,"_14":4851},"NVMI","Nova Ltd.",{"_12":4853,"_14":4854},"NVR","NVR, Inc.",{"_12":44,"_14":45},{"_12":4857,"_14":4858},"NWAX","New America Acquisition I Corp.",{"_12":4860,"_14":4861},"NWBI","Northwest Bancshares, Inc.",{"_12":4863,"_14":4864},"NWFL","Norwood Financial Corp.",{"_12":4866,"_14":4867},"NWGL","CL Workshop Group Limited",{"_12":4869,"_14":4870},"NWN","Northwest Natural Holding Company",{"_12":4872,"_14":4873},"NWPP","New Peoples Bankshares, Inc.",{"_12":4875,"_14":4876},"NWPX","NWPX Infrastructure, Inc.",{"_12":4878,"_14":-5},"NWWP",{"_12":4880,"_14":4881},"NXDR","Nextdoor Holdings, Inc.",{"_12":4883,"_14":4884},"NXDT","NexPoint Diversified Real Estate Trust",{"_12":4886,"_14":4887},"NXG","NXG NextGen Infrastructure Income Fund",{"_12":4889,"_14":4890},"NXH","Neighborhood Intelligence, Inc. Common Stock",{"_12":4892,"_14":4893},"NXPI","NXP Semiconductors N.V.",{"_12":4895,"_14":4896},"NXRT","NexPoint Residential Trust, Inc.",{"_12":4898,"_14":4899},"NXST","Nexstar Media Group, Inc.",{"_12":4901,"_14":4902},"NXTC","NextCure, Inc.",{"_12":4904,"_14":4905},"NYAX","Nayax Ltd.",{"_12":4907,"_14":4908},"NYC","American Strategic Investment Co.",{"_12":4910,"_14":4911},"OAK-PA","Oaktree Capital Group, LLC 6.625% PFD UT A",{"_12":4913,"_14":4914},"OBDC","Blue Owl Capital Corporation",{"_12":4916,"_14":4917},"OBIO","Orchestra BioMed Holdings, Inc.",{"_12":4919,"_14":4920},"OBK","Origin Bancorp, Inc.",{"_12":4922,"_14":4923},"OBT","Orange County Bancorp, Inc.",{"_12":4925,"_14":4926},"OCCI","OFS Credit Company, Inc.",{"_12":4928,"_14":4929},"OCFC","OceanFirst Financial Corp.",{"_12":4931,"_14":4932},"OCGN","Ocugen, Inc.",{"_12":4934,"_14":4935},"OCSL","Oaktree Specialty Lending Corporation",{"_12":4937,"_14":4938},"OCUL","Ocular Therapeutix, Inc.",{"_12":4940,"_14":4941},"ODTX","Odyssey Therapeutics, Inc.",{"_12":4943,"_14":4944},"ODYS","Odysight.ai Inc.",{"_12":4946,"_14":4947},"OESX","Orion Energy Systems, Inc.",{"_12":4949,"_14":4950},"OFIX","Orthofix Medical Inc.",{"_12":4952,"_14":4953},"OFLX","Omega Flex, Inc.",{"_12":4955,"_14":4956},"OGN","Organon & Co.",{"_12":4958,"_14":4959},"OI","O-I Glass, Inc.",{"_12":4961,"_14":4962},"OII","Oceaneering International, Inc.",{"_12":4964,"_14":4965},"OKLO","Oklo Inc.",{"_12":4967,"_14":4968},"OKTA","Okta, Inc.",{"_12":4970,"_14":4971},"OKYO","OKYO Pharma Limited",{"_12":4973,"_14":4974},"OLED","Universal Display Corporation",{"_12":4976,"_14":4977},"OM","Outset Medical, Inc.",{"_12":4979,"_14":4980},"OMDA","Omada Health",{"_12":4982,"_14":4983},"OMER","Omeros Corporation",{"_12":4985,"_14":4986},"ON","ON Semiconductor Corporation",{"_12":4988,"_14":4989},"ONC","BeOne Medicines AG",{"_12":4991,"_14":4992},"ONCO","Onconetix, Inc.",{"_12":4994,"_14":4995},"ONCY","Oncolytics Biotech Inc.",{"_12":4997,"_14":4998},"ONDS","Ondas Holdings Inc.",{"_12":5000,"_14":5001},"ONEW","OneWater Marine Inc.",{"_12":5003,"_14":5004},"ONMD","OneMedNet Corporation",{"_12":5006,"_14":5007},"ONON","On Holding AG",{"_12":5009,"_14":5010},"ONT","Onterris, Inc.",{"_12":5012,"_14":5013},"ONTO","Onto Innovation Inc.",{"_12":5015,"_14":5016},"OOMA","Ooma, Inc.",{"_12":5018,"_14":5019},"OPAD","Offerpad Solutions Inc.",{"_12":5021,"_14":5022},"OPAL","OPAL Fuels Inc.",{"_12":5024,"_14":5025},"OPCH","Option Care Health, Inc.",{"_12":5027,"_14":5028},"OPEN","Opendoor Technologies Inc.",{"_12":5030,"_14":5031},"OPFI","OppFi Inc.",{"_12":5033,"_14":5034},"OPK","OPKO Health, Inc.",{"_12":5036,"_14":5037},"OPLN","OPENLANE, Inc.",{"_12":5039,"_14":5040},"OPTU","Optimum Communications, Inc.",{"_12":5042,"_14":5043},"OPTX","Syntec Optics Holdings, Inc.",{"_12":5045,"_14":5046},"ORBS","Eightco Holdings Inc.",{"_12":5048,"_14":5049},"ORCL","Oracle Corporation",{"_12":5051,"_14":5052},"ORGO","Organogenesis Holdings Inc.",{"_12":5054,"_14":5055},"ORI","Old Republic International Corporation",{"_12":5057,"_14":5058},"ORIC","ORIC Pharmaceuticals, Inc.",{"_12":5060,"_14":5061},"ORKA","Oruka Therapeutics, Inc.",{"_12":5063,"_14":5064},"ORMP","Oramed Pharmaceuticals Inc.",{"_12":5066,"_14":5067},"ORN","Orion Group Holdings, Inc.",{"_12":5069,"_14":5070},"ORRF","Orrstown Financial Services, Inc.",{"_12":5072,"_14":5073},"OSBC","Old Second Bancorp, Inc.",{"_12":5075,"_14":5076},"OSCR","Oscar Health, Inc.",{"_12":5078,"_14":5079},"OSPN","OneSpan Inc.",{"_12":5081,"_14":5082},"OSUR","OraSure Technologies, Inc.",{"_12":5084,"_14":-5},"OTAI",{"_12":5086,"_14":5087},"OTF","Blue Owl Technology Finance Corp.",{"_12":5089,"_14":5090},"OTH","Off The Hook YS Inc.",{"_12":5092,"_14":5093},"OTLC","Oncotelic Therapeutics, Inc.",{"_12":5095,"_14":5096},"OTLK","Outlook Therapeutics, Inc.",{"_12":5098,"_14":5099},"OUST","Ouster, Inc.",{"_12":5101,"_14":5102},"OUT","Outfront Media Inc.",{"_12":5104,"_14":5105},"OVBC","Ohio Valley Banc Corp.",{"_12":5107,"_14":5108},"OVLY","Oak Valley Bancorp",{"_12":5110,"_14":5111},"OWLS","OBOOK Holdings Inc.",{"_12":5113,"_14":5114},"OXM","Oxford Industries, Inc.",{"_12":5116,"_14":5117},"OXSQ","Oxford Square Capital Corp.",{"_12":5119,"_14":5120},"OXY","Occidental Petroleum Corporation",{"_12":5122,"_14":5123},"P","Everpure, Inc.",{"_12":5125,"_14":5126},"PACB","Pacific Biosciences of California, Inc.",{"_12":5128,"_14":5129},"PACS","PACS Group, Inc.",{"_12":5131,"_14":5132},"PAGS","PagSeguro Digital Ltd.",{"_12":5134,"_14":5135},"PAHC","Phibro Animal Health Corporation",{"_12":5137,"_14":5138},"PAL","Proficient Auto Logistics, Inc. Common Stock",{"_12":5140,"_14":5141},"PALI","Palisade Bio, Inc.",{"_12":5143,"_14":5144},"PAM","Pampa Energía S.A.",{"_12":5146,"_14":5147},"PAMT","Pamt Corp.",{"_12":5149,"_14":-5},"PANEL",{"_12":5151,"_14":5152},"PANW","Palo Alto Networks, Inc.",{"_12":5154,"_14":5155},"PAR","PAR Technology Corporation",{"_12":5157,"_14":5158},"PASG","Passage Bio, Inc.",{"_12":5160,"_14":5161},"PATH","UiPath Inc.",{"_12":5163,"_14":5164},"PATK","Patrick Industries, Inc.",{"_12":5166,"_14":5167},"PAX","Patria Investments Limited",{"_12":5169,"_14":-5},"PAYIX",{"_12":5171,"_14":5172},"PAYS","Paysign, Inc.",{"_12":5174,"_14":5175},"PB","Prosperity Bancshares, Inc.",{"_12":5177,"_14":5178},"PBF","PBF Energy Inc.",{"_12":5180,"_14":5181},"PBHC","Pathfinder Bancorp, Inc.",{"_12":5183,"_14":5184},"PBI","Pitney Bowes Inc.",{"_12":5186,"_14":5187},"PBLS","Parabilis Medicines, Inc.",{"_12":5189,"_14":-5},"PBLSX",{"_12":5191,"_14":5192},"PBR","Petróleo Brasileiro S.A. - Petrobras",{"_12":5194,"_14":5195},"PCB","PCB Bancorp",{"_12":5197,"_14":5198},"PCF","High Income Securities Fund",{"_12":5200,"_14":5201},"PCG","PG&E Corporation",{"_12":5203,"_14":5204},"PCOR","Procore Technologies, Inc.",{"_12":5206,"_14":5207},"PCRX","Pacira BioSciences, Inc.",{"_12":5209,"_14":5210},"PCSA","Processa Pharmaceuticals, Inc.",{"_12":5212,"_14":-5},"PCSZX",{"_12":5214,"_14":5215},"PCT","PureCycle Technologies, Inc.",{"_12":5217,"_14":5218},"PCVX","Vaxcyte, Inc.",{"_12":5220,"_14":5221},"PD","PagerDuty, Inc.",{"_12":5223,"_14":5224},"PDC","Perpetuals.com Ltd",{"_12":5226,"_14":5227},"PDI","PIMCO Dynamic Income Fund",{"_12":5229,"_14":5230},"PDM","Piedmont Office Realty Trust, Inc.",{"_12":5232,"_14":5233},"PDT","John Hancock Premium Dividend Fund",{"_12":5235,"_14":5236},"PDX","PIMCO Dynamic Income Strategy Fund",{"_12":5238,"_14":5239},"PDYN","Palladyne AI Corp.",{"_12":5241,"_14":5242},"PEB","Pebblebrook Hotel Trust",{"_12":5244,"_14":5245},"PEBO","Peoples Bancorp Inc.",{"_12":5247,"_14":5248},"PED","PEDEVCO Corp.",{"_12":5250,"_14":5251},"PEG","Public Service Enterprise Group Incorporated",{"_12":5253,"_14":5254},"PEGA","Pegasystems Inc.",{"_12":5256,"_14":5257},"PENN","PENN Entertainment, Inc.",{"_12":5259,"_14":5260},"PERI","Perion Network Ltd.",{"_12":5262,"_14":5263},"PETS","PetMed Express, Inc.",{"_12":5265,"_14":5266},"PETV","PetVivo Holdings, Inc.",{"_12":5268,"_14":5269},"PETZ","TDH Holdings, Inc.",{"_12":5271,"_14":5272},"PFBX","Peoples Financial Corporation",{"_12":5274,"_14":5275},"PFE","Pfizer Inc.",{"_12":5277,"_14":5278},"PFG","Principal Financial Group, Inc.",{"_12":5280,"_14":5281},"PFGC","Performance Food Group Co",{"_12":5283,"_14":5284},"PFHO","Pacific Health Care Organization, Inc.",{"_12":5286,"_14":5287},"PFLEX","PIMCO Flexible Credit Income Fund",{"_12":5289,"_14":5290},"PFLT","PennantPark Floating Rate Capital Ltd.",{"_12":5292,"_14":5293},"PFSA","Profusa, Inc. Common Stock",{"_12":5295,"_14":5296},"PFX","PhenixFIN Corporation",{"_12":5298,"_14":5299},"PG","The Procter & Gamble Company",{"_12":5301,"_14":5302},"PGC","Peapack-Gladstone Financial Corporation",{"_12":5304,"_14":5305},"PGNY","Progyny, Inc.",{"_12":5307,"_14":5308},"PGR","The Progressive Corporation",{"_12":5310,"_14":5311},"PGY","Pagaya Technologies Ltd.",{"_12":5313,"_14":5314},"PHIN","PHINIA Inc.",{"_12":5316,"_14":5317},"PHIO","Phio Pharmaceuticals Corp.",{"_12":5319,"_14":5320},"PHK","PIMCO High Income Fund",{"_12":5322,"_14":5323},"PHR","Phreesia, Inc.",{"_12":5325,"_14":5326},"PHVS","Pharvaris N.V.",{"_12":5328,"_14":5329},"PI","Impinj, Inc.",{"_12":5331,"_14":5332},"PICS","PicS N.V.",{"_12":5334,"_14":-5},"PIIVX",{"_12":5336,"_14":5337},"PINS","Pinterest, Inc.",{"_12":5339,"_14":5340},"PKBK","Parke Bancorp, Inc.",{"_12":5342,"_14":5343},"PKOH","Park-Ohio Holdings Corp.",{"_12":5345,"_14":5346},"PL","Planet Labs PBC",{"_12":5348,"_14":5349},"PLAB","Photronics, Inc.",{"_12":5351,"_14":5352},"PLAY","Dave & Buster's Entertainment, Inc.",{"_12":5354,"_14":5355},"PLBC","Plumas Bancorp",{"_12":5357,"_14":5358},"PLD","Prologis, Inc.",{"_12":5360,"_14":5361},"PLMR","Palomar Holdings, Inc.",{"_12":5363,"_14":5364},"PLNT","Planet Fitness, Inc.",{"_12":5366,"_14":5367},"PLSE","Pulse Biosciences, Inc.",{"_12":5369,"_14":5370},"PLTR","Palantir Technologies Inc.",{"_12":5372,"_14":5373},"PLUG","Plug Power Inc.",{"_12":5375,"_14":5376},"PLUS","ePlus inc.",{"_12":5378,"_14":5379},"PLXS","Plexus Corp.",{"_12":5381,"_14":5382},"PLYX","Polaryx Therapeutics, Inc. Common Stock",{"_12":5384,"_14":5385},"PMA","Ming Shing Group Holdings Limited",{"_12":5387,"_14":5388},"PMEC","Primech Holdings Ltd. Ordinary Shares",{"_12":5390,"_14":5391},"PML","PIMCO Municipal Income Fund II",{"_12":5393,"_14":5394},"PMM","Putnam Managed Municipal Income Trust",{"_12":5396,"_14":5397},"PMN","ProMIS Neurosciences, Inc.",{"_12":5399,"_14":5400},"PMO","Putnam Municipal Opportunities Trust",{"_12":5402,"_14":5403},"PMPEX","Primark Private Equity Investments Fund",{"_12":5405,"_14":5406},"PMTS","CPI Card Group Inc.",{"_12":5408,"_14":-5},"PNAQ",{"_12":5410,"_14":5411},"PNBK","Patriot National Bancorp, Inc.",{"_12":5413,"_14":5414},"PNFP","Pinnacle Financial Partners, Inc.",{"_12":5416,"_14":5417},"PNNT","PennantPark Investment Corporation",{"_12":5419,"_14":5420},"PNRG","PrimeEnergy Resources Corporation",{"_12":5422,"_14":5423},"POCI","Precision Optics Corporation, Inc.",{"_12":5425,"_14":5426},"PODC","PodcastOne, Inc.",{"_12":5428,"_14":5429},"PODD","Insulet Corporation",{"_12":5431,"_14":5432},"PONO","Pono Capital Corp.",{"_12":5434,"_14":5435},"PONY","Pony AI Inc. American Depositary Shares",{"_12":5437,"_14":5438},"POOL","Pool Corporation",{"_12":5440,"_14":5441},"POR","Portland General Electric Company",{"_12":5443,"_14":-5},"PORT.U",{"_12":5445,"_14":5446},"POWL","Powell Industries, Inc.",{"_12":5448,"_14":5449},"PPG","PPG Industries, Inc.",{"_12":5451,"_14":5452},"PPHC","Public Policy Holding Company, Inc. Common Stock",{"_12":5454,"_14":5455},"PPRUX","PGIM Private Real Estate Fund, Inc. - Class I",{"_12":5457,"_14":5458},"PRCH","Porch Group, Inc.",{"_12":5460,"_14":5461},"PRCT","PROCEPT BioRobotics Corporation",{"_12":5463,"_14":5464},"PRDO","Perdoceo Education Corporation",{"_12":5466,"_14":5467},"PRE","Prenetics Global Ltd",{"_12":5469,"_14":5470},"PRGS","Progress Software Corporation",{"_12":5472,"_14":5473},"PRHI","Presurance Holdings, Inc.",{"_12":5475,"_14":5476},"PRIM","Primoris Services Corporation",{"_12":5478,"_14":5479},"PRKS","United Parks & Resorts Inc.",{"_12":5481,"_14":5482},"PRLB","Proto Labs, Inc.",{"_12":5484,"_14":5485},"PRLD","Prelude Therapeutics Incorporated",{"_12":5487,"_14":5488},"PRMB","Primo Brands Corporation",{"_12":5490,"_14":5491},"PROP","Prairie Operating Co.",{"_12":5493,"_14":5494},"PRPL","Purple Innovation, Inc.",{"_12":5496,"_14":5497},"PRPO","Precipio, Inc.",{"_12":5499,"_14":5500},"PRQR","ProQR Therapeutics N.V.",{"_12":5502,"_14":5503},"PRTA","Prothena Corporation plc",{"_12":5505,"_14":5506},"PRTS","CarParts.com, Inc.",{"_12":5508,"_14":5509},"PS","Pershing Square Inc.",{"_12":5511,"_14":5512},"PSBD","Palmer Square Capital BDC Inc.",{"_12":5514,"_14":5515},"PSEC","Prospect Capital Corporation",{"_12":5517,"_14":5518},"PSN","Parsons Corporation",{"_12":5520,"_14":5521},"PSNL","Personalis, Inc.",{"_12":5523,"_14":5524},"PSNY","Polestar Automotive Holding UK PLC",{"_12":5526,"_14":5527},"PSQH","PSQ Holdings, Inc.",{"_12":5529,"_14":5530},"PSUS","Pershing Square USA, Ltd.",{"_12":5532,"_14":5533},"PSX","Phillips 66",{"_12":5535,"_14":5536},"PTC","PTC Inc.",{"_12":5538,"_14":5539},"PTCT","PTC Therapeutics, Inc.",{"_12":5541,"_14":5542},"PTEN","Patterson-UTI Energy, Inc.",{"_12":5544,"_14":5545},"PTGX","Protagonist Therapeutics, Inc.",{"_12":5547,"_14":5548},"PTHS","Pelthos Therapeutics Inc.",{"_12":5550,"_14":5551},"PTIX","Protagenic Therapeutics, Inc.",{"_12":5553,"_14":5554},"PTLO","Portillo's Inc.",{"_12":5556,"_14":5557},"PUBM","PubMatic, Inc.",{"_12":5559,"_14":5560},"PVH","PVH Corp.",{"_12":5562,"_14":5563},"PVLA","Palvella Therapeutics, Inc.",{"_12":5565,"_14":5566},"PWRL","Powerlaw Corp. Common Stock",{"_12":5568,"_14":5569},"PXED","Phoenix Education Partners, Inc",{"_12":5571,"_14":5572},"PYPL","PayPal Holdings, Inc.",{"_12":5574,"_14":5575},"Q","Qnity Electronics, Inc.",{"_12":5577,"_14":5578},"QCLS","Q/C Technologies, Inc.",{"_12":5580,"_14":5581},"QCOM","QUALCOMM Incorporated",{"_12":5583,"_14":5584},"QCRH","QCR Holdings, Inc.",{"_12":5586,"_14":5587},"QFIN","Qfin Holdings, Inc.",{"_12":5589,"_14":5590},"QLYS","Qualys, Inc.",{"_12":5592,"_14":5593},"QNBC","QNB Corp.",{"_12":5595,"_14":5596},"QNRX","Quoin Pharmaceuticals, Ltd.",{"_12":5598,"_14":5599},"QNT","Quantinuum Inc. Class A Common Stock",{"_12":5601,"_14":5602},"QNTO","Quaint Oak Bancorp, Inc.",{"_12":5604,"_14":5605},"QRHC","Quest Resource Holding Corporation",{"_12":5607,"_14":5608},"QS","QuantumScape Corporation",{"_12":5610,"_14":5611},"QSI","Quantum-Si incorporated",{"_12":5613,"_14":5614},"QTEX","QTREX Quantum Ltd.",{"_12":5616,"_14":5617},"QTRX","Quanterix Corporation",{"_12":5619,"_14":5620},"QTTB","Q32 Bio Inc.",{"_12":5622,"_14":5623},"QUIK","QuickLogic Corporation",{"_12":5625,"_14":5626},"QVCG","QVC Group, Inc.",{"_12":5628,"_14":5629},"QVCGP","QVC Group Inc.",{"_12":5631,"_14":5632},"RAIN","Rain Enhancement Technologies Holdco Inc",{"_12":5634,"_14":5635},"RAKR","Rainmaker Worldwide Inc",{"_12":5637,"_14":-5},"RANGER",{"_12":5639,"_14":5640},"RANI","Rani Therapeutics Holdings, Inc.",{"_12":5642,"_14":5643},"RAPP","Rapport Therapeutics, Inc. Common Stock",{"_12":5645,"_14":5646},"RBA","RB Global, Inc.",{"_12":5648,"_14":5649},"RBKB","Rhinebeck Bancorp, Inc.",{"_12":5651,"_14":5652},"RBLX","Roblox Corporation",{"_12":5654,"_14":5655},"RBRK","Rubrik, Inc.",{"_12":5657,"_14":5658},"RC","Ready Capital Corporation",{"_12":5660,"_14":5661},"RCAT","Red Cat Holdings, Inc.",{"_12":5663,"_14":5664},"RCEL","AVITA Medical, Inc.",{"_12":5666,"_14":5667},"RCG","RENN Fund, Inc.",{"_12":5669,"_14":5670},"RCKY","Rocky Brands, Inc.",{"_12":5672,"_14":5673},"RCT","RedCloud Holdings plc",{"_12":5675,"_14":5676},"RDDT","Reddit, Inc.",{"_12":5678,"_14":5679},"RDGL","Vivos Inc.",{"_12":5681,"_14":5682},"RDGT","Ridgetech Inc.",{"_12":5684,"_14":5685},"RDN","Radian Group Inc.",{"_12":5687,"_14":5688},"RDVT","Red Violet, Inc.",{"_12":5690,"_14":5691},"RDW","Redwire Corp",{"_12":5693,"_14":5694},"RDWR","Radware Ltd.",{"_12":5696,"_14":5697},"RDZN","Roadzen, Inc.",{"_12":5699,"_14":-5},"README.HTML",{"_12":5701,"_14":5702},"REAX","The Real Brokerage Inc.",{"_12":5704,"_14":5705},"REEMF","Rare Element Resources Ltd.",{"_12":5707,"_14":5708},"REF","Reformation Inc. (California)",{"_12":5710,"_14":5711},"REFI","Chicago Atlantic Real Estate Finance, Inc.",{"_12":5713,"_14":5714},"REFLX","PIMCO Flexible Real Estate Income Fund - Institutional",{"_12":67,"_14":68},{"_12":5717,"_14":5718},"RELY","Remitly Global, Inc.",{"_12":5720,"_14":5721},"RENT","Rent the Runway, Inc.",{"_12":5723,"_14":5724},"REX","REX American Resources Corporation",{"_12":5726,"_14":5727},"REXR","Rexford Industrial Realty, Inc.",{"_12":5729,"_14":5730},"REYN","Reynolds Consumer Products Inc.",{"_12":5732,"_14":5733},"REZI","Resideo Technologies, Inc.",{"_12":5735,"_14":5736},"RGCO","RGC Resources, Inc.",{"_12":5738,"_14":5739},"RGEN","Repligen Corporation",{"_12":5741,"_14":5742},"RGLD","Royal Gold, Inc.",{"_12":5744,"_14":5745},"RGNX","REGENXBIO Inc.",{"_12":5747,"_14":5748},"RGR","Sturm, Ruger & Company, Inc.",{"_12":5750,"_14":5751},"RH","Rh",{"_12":5753,"_14":5754},"RHEP","Regional Health Properties, Inc.",{"_12":5756,"_14":5757},"RHLD","Resolute Holdings Management, Inc.",{"_12":5759,"_14":5760},"RHP","Ryman Hospitality Properties, Inc.",{"_12":5762,"_14":-5},"RIAEX",{"_12":5764,"_14":5765},"RICK","RCI Hospitality Holdings, Inc.",{"_12":5767,"_14":5768},"RIG","Transocean Ltd.",{"_12":5770,"_14":5771},"RITE","MineralRite Corporation",{"_12":5773,"_14":5774},"RIVN","Rivian Automotive, Inc.",{"_12":5776,"_14":5777},"RKLB","Rocket Lab USA, Inc.",{"_12":5779,"_14":5780},"RKT","Rocket Companies, Inc.",{"_12":5782,"_14":5783},"RLAY","Relay Therapeutics, Inc.",{"_12":5785,"_14":5786},"RLI","RLI Corp.",{"_12":53,"_14":54},{"_12":5789,"_14":5790},"RLYB","Rallybio Corporation",{"_12":5792,"_14":5793},"RM","Regional Management Corp.",{"_12":5795,"_14":5796},"RMBI","Richmond Mutual Bancorporation, Inc.",{"_12":5798,"_14":5799},"RMBS","Rambus Inc.",{"_12":5801,"_14":5802},"RMD","ResMed Inc.",{"_12":5804,"_14":5805},"RMT","Royce Micro-Cap Trust, Inc.",{"_12":5807,"_14":-5},"RNAQ",{"_12":5809,"_14":5810},"RNG","RingCentral, Inc.",{"_12":5812,"_14":5813},"RNTX","Rein Therapeutics Inc.",{"_12":5815,"_14":5816},"RNXT","RenovoRx, Inc.",{"_12":5818,"_14":-5},"ROBOTS.TXT",{"_12":5820,"_14":5821},"ROC","Rank One Computing Corp.",{"_12":178,"_14":199},{"_12":5824,"_14":5825},"ROIV","Roivant Sciences Ltd.",{"_12":5827,"_14":5828},"ROKU","Roku, Inc.",{"_12":5830,"_14":5831},"ROLR","High Roller Technologies, Inc.",{"_12":5833,"_14":5834},"RPAY","Repay Holdings Corporation",{"_12":5836,"_14":5837},"RPC","Ridgepost Capital, Inc.",{"_12":5839,"_14":5840},"RPGL","Republic Power Group Limited Class A Ordinary Shares",{"_12":5842,"_14":-5},"RPLRT",{"_12":5844,"_14":5845},"RPRX","Royalty Pharma plc",{"_12":5847,"_14":5848},"RRBI","Red River Bancshares, Inc.",{"_12":5850,"_14":5851},"RSG","Republic Services, Inc.",{"_12":5853,"_14":5854},"RSI","Rush Street Interactive, Inc.",{"_12":5856,"_14":5857},"RSKD","Riskified Ltd.",{"_12":5859,"_14":5860},"RTB","RTB Digital Inc",{"_12":5862,"_14":5863},"RTSN","Retension Pharmaceuticals Inc.",{"_12":5865,"_14":5866},"RUBI","Rubico Inc.",{"_12":5868,"_14":5869},"RUN","Sunrun Inc.",{"_12":5871,"_14":5872},"RVI","Robinhood Ventures Fund I",{"_12":5874,"_14":5875},"RVMD","Revolution Medicines, Inc.",{"_12":5877,"_14":5878},"RVSB","Riverview Bancorp, Inc.",{"_12":5880,"_14":5881},"RVT","Royce Value Trust Inc.",{"_12":5883,"_14":5884},"RVTY","Revvity, Inc.",{"_12":5886,"_14":5887},"RWAY","Runway Growth Finance Corp.",{"_12":5889,"_14":5890},"RWT","Redwood Trust, Inc.",{"_12":5892,"_14":5893},"RXRX","Recursion Pharmaceuticals, Inc.",{"_12":5895,"_14":5896},"RYAN","Ryan Specialty Holdings, Inc.",{"_12":5898,"_14":5899},"RZLT","Rezolute, Inc.",{"_12":5901,"_14":5902},"RZLV","Rezolve AI PLC",{"_12":5904,"_14":5905},"S","SentinelOne, Inc.",{"_12":5907,"_14":5908},"SABR","Sabre Corporation",{"_12":5910,"_14":-5},"SAFTX",{"_12":5912,"_14":5913},"SAGT","SAGTEC GLOBAL Ltd",{"_12":5915,"_14":-5},"SAGU",{"_12":5917,"_14":5918},"SAH","Sonic Automotive, Inc.",{"_12":5920,"_14":5921},"SAIC","Science Applications International Corporation",{"_12":5923,"_14":5924},"SAIL","SailPoint, Inc.",{"_12":5926,"_14":5927},"SAR","Saratoga Investment Corp.",{"_12":5929,"_14":5930},"SARO","StandardAero, Inc.",{"_12":5932,"_14":5933},"SATL","Satellogic Inc.",{"_12":5935,"_14":5936},"SBCF","Seacoast Banking Corporation of Florida",{"_12":5938,"_14":5939},"SBDS","Solo Brands, Inc.",{"_12":5941,"_14":5942},"SBET","Sharplink, Inc.",{"_12":5944,"_14":5945},"SBFG","SB Financial Group, Inc.",{"_12":5947,"_14":5948},"SBGI","Sinclair, Inc.",{"_12":5950,"_14":5951},"SBLK","Star Bulk Carriers Corp.",{"_12":5953,"_14":5954},"SBMT","Silver Bow Mining Corp.",{"_12":5956,"_14":5957},"SBSW","Sibanye Stillwater Limited",{"_12":5959,"_14":5960},"SBUX","Starbucks Corporation",{"_12":5962,"_14":5963},"SCHW","The Charles Schwab Corporation",{"_12":5965,"_14":-5},"SCISX",{"_12":5967,"_14":5968},"SCM","Stellus Capital Investment Corporation",{"_12":5970,"_14":5971},"SCND","Scientific Industries, Inc.",{"_12":5973,"_14":5974},"SCOR","comScore Inc.",{"_12":5976,"_14":5977},"SCTH","SecureTech Innovations, Inc.",{"_12":5979,"_14":5980},"SCTX","Scribe Therapeutics Inc.",{"_12":5982,"_14":5983},"SCVL","Shoe Carnival, Inc.",{"_12":5985,"_14":5986},"SCYX","SCYNEXIS, Inc.",{"_12":5988,"_14":5989},"SDGR","Schrödinger, Inc.",{"_12":5991,"_14":5992},"SDHC","Smith Douglas Homes Corp.",{"_12":5994,"_14":5995},"SE","Sea Limited",{"_12":5997,"_14":5998},"SEI","Solaris Energy Infrastructure, Inc.",{"_12":6000,"_14":6001},"SEIC","SEI Investments Company",{"_12":6003,"_14":6004},"SELF","Global Self Storage, Inc.",{"_12":6006,"_14":-5},"SELLERS.JSON",{"_12":6008,"_14":6009},"SENS","Senseonics Holdings, Inc.",{"_12":6011,"_14":6012},"SER","Serina Therapeutics, Inc.",{"_12":6014,"_14":6015},"SEZL","Sezzle Inc.",{"_12":6017,"_14":6018},"SFBC","Sound Financial Bancorp, Inc.",{"_12":6020,"_14":6021},"SFM","Sprouts Farmers Market, Inc.",{"_12":6023,"_14":6024},"SFST","Southern First Bancshares, Inc.",{"_12":6026,"_14":6027},"SG","Sweetgreen, Inc.",{"_12":6029,"_14":6030},"SGHT","Sight Sciences, Inc.",{"_12":6032,"_14":6033},"SGI","Somnigroup International Inc",{"_12":6035,"_14":6036},"SGRP","SPAR Group, Inc.",{"_12":6038,"_14":6039},"SGRY","Surgery Partners, Inc.",{"_12":6041,"_14":6042},"SHAK","Shake Shack Inc.",{"_12":6044,"_14":6045},"SHBI","Shore Bancshares, Inc.",{"_12":6047,"_14":6048},"SHEN","Shenandoah Telecommunications Company",{"_12":6050,"_14":6051},"SHIP","Seanergy Maritime Holdings Corp.",{"_12":6053,"_14":6054},"SHMD","SCHMID Group N.V. Class A Ordinary Shares",{"_12":6056,"_14":6057},"SHPH","Shuttle Pharmaceuticals Holdings, Inc.",{"_12":6059,"_14":6060},"SI","Shoulder Innovations, Inc.",{"_12":6062,"_14":6063},"SIBN","SI-BONE, Inc.",{"_12":6065,"_14":6066},"SIEB","Siebert Financial Corp.",{"_12":6068,"_14":-5},"SIGN-IN",{"_12":6070,"_14":-5},"SIGNIN",{"_12":6072,"_14":6073},"SION","Sionna Therapeutics, Inc.",{"_12":6075,"_14":6076},"SITE","SiteOne Landscape Supply, Inc.",{"_12":6078,"_14":-5},"SITEMAP.XML",{"_12":6080,"_14":6081},"SITM","SiTime Corporation",{"_12":6083,"_14":6084},"SJM","The J. M. Smucker Company",{"_12":6086,"_14":6087},"SKAS","Saker Aviation Services, Inc.",{"_12":6089,"_14":6090},"SKIL","Skillsoft Corp.",{"_12":6092,"_14":6093},"SKKY","Skkynet Cloud Systems, Inc.",{"_12":6095,"_14":6096},"SKWD","Skyward Specialty Insurance Group, Inc.",{"_12":6098,"_14":6099},"SKYA","SkyAI, Inc.",{"_12":6101,"_14":6102},"SKYE","Skye Bioscience, Inc.",{"_12":6104,"_14":6105},"SKYH","Sky Harbour Group Corporation",{"_12":6107,"_14":6108},"SLAI","SOLAI Limited",{"_12":6110,"_14":6111},"SLBT","SL Science Holding Ltd",{"_12":6113,"_14":6114},"SLGL","Sol-Gel Technologies Ltd.",{"_12":6116,"_14":6117},"SLMT","Brera Holdings PLC",{"_12":6119,"_14":6120},"SLND","Southland Holdings, Inc.",{"_12":6122,"_14":6123},"SLNG","Stabilis Solutions, Inc.",{"_12":6125,"_14":6126},"SLNH","Soluna Holdings, Inc.",{"_12":6128,"_14":6129},"SLRC","SLR Investment Corp.",{"_12":6131,"_14":6132},"SMBK","SmartFinancial, Inc.",{"_12":6134,"_14":6135},"SMC","Summit Midstream Corp.",{"_12":6137,"_14":6138},"SMCI","Super Micro Computer, Inc.",{"_12":6140,"_14":6141},"SMG","The Scotts Miracle-Gro Company",{"_12":6143,"_14":6144},"SMID","Smith-Midland Corporation",{"_12":6146,"_14":6147},"SMMT","Summit Therapeutics Inc.",{"_12":6149,"_14":6150},"SMPL","The Simply Good Foods Company",{"_12":6152,"_14":6153},"SMR","NuScale Power Corporation",{"_12":6155,"_14":6156},"SMRT","SmartRent, Inc.",{"_12":6158,"_14":6159},"SMTC","Semtech Corporation",{"_12":6161,"_14":6162},"SMWB","Similarweb Ltd.",{"_12":6164,"_14":6165},"SNAP","Snap Inc.",{"_12":6167,"_14":6168},"SND","Smart Sand, Inc.",{"_12":6170,"_14":6171},"SNDA","Sonida Senior Living, Inc.",{"_12":6173,"_14":6174},"SNDK","Sandisk Corporation",{"_12":6176,"_14":6177},"SNES","SenesTech, Inc.",{"_12":6179,"_14":6180},"SNEX","StoneX Group Inc.",{"_12":6182,"_14":6183},"SNOW","Snowflake Inc.",{"_12":6185,"_14":6186},"SNPS","Synopsys, Inc.",{"_12":6188,"_14":6189},"SNSE","Sensei Biotherapeutics, Inc.",{"_12":6191,"_14":6192},"SODI","Solitron Devices, Inc.",{"_12":6194,"_14":6195},"SOFI","SoFi Technologies, Inc.",{"_12":6197,"_14":6198},"SOLV","Solventum Corporation",{"_12":6200,"_14":6201},"SON","Sonoco Products Company",{"_12":6203,"_14":6204},"SONO","Sonos, Inc.",{"_12":6206,"_14":6207},"SONY","Sony Group Corporation",{"_12":6209,"_14":6210},"SOPH","SOPHiA GENETICS S.A.",{"_12":6212,"_14":6213},"SOTK","Sono-Tek Corporation",{"_12":6215,"_14":6216},"SOUN","SoundHound AI, Inc.",{"_12":6218,"_14":6219},"SPB","Spectrum Brands Holdings, Inc.",{"_12":6221,"_14":6222},"SPCE","Virgin Galactic Holdings, Inc.",{"_12":6224,"_14":6225},"SPCX","Space Exploration Technologies Corp.",{"_12":6227,"_14":6228},"SPFI","South Plains Financial, Inc.",{"_12":6230,"_14":6231},"SPFX","Standard Premium Finance Holdings, Inc.",{"_12":6233,"_14":6234},"SPG","Simon Property Group, Inc.",{"_12":6236,"_14":6237},"SPGI","S&P Global Inc.",{"_12":6239,"_14":6240},"SPIR","Spire Global, Inc.",{"_12":6242,"_14":6243},"SPOK","Spok Holdings, Inc.",{"_12":6245,"_14":6246},"SPOT","Spotify Technology S.A.",{"_12":6248,"_14":6249},"SPRU","Spruce Power Holding Corporation",{"_12":6251,"_14":6252},"SPT","Sprout Social, Inc.",{"_12":6254,"_14":6255},"SPTX","Seaport Therapeutics, Inc. Common Stock",{"_12":6257,"_14":6258},"SR","Spire Inc.",{"_12":6260,"_14":6261},"SRAD","Sportradar Group AG",{"_12":6263,"_14":6264},"SRBK","SR Bancorp, Inc. Common stock",{"_12":6266,"_14":6267},"SRE","Sempra",{"_12":6269,"_14":6270},"SRI","Stoneridge, Inc.",{"_12":6272,"_14":6273},"SRTS","Sensus Healthcare, Inc.",{"_12":6275,"_14":6276},"SRZN","Surrozen, Inc.",{"_12":6278,"_14":6279},"SSII","SS Innovations International, Inc.",{"_12":6281,"_14":6282},"SSL","Sasol Limited",{"_12":6284,"_14":6285},"SSMR","Sunshine Silver Mining & Refining Company",{"_12":6287,"_14":6288},"SSP","The E.W. Scripps Company",{"_12":6290,"_14":6291},"SSSS","SuRo Capital Corp.",{"_12":6293,"_14":6294},"SST","System1, Inc.",{"_12":6296,"_14":6297},"ST","Sensata Technologies Holding plc",{"_12":6299,"_14":6300},"STAA","STAAR Surgical Company",{"_12":6302,"_14":6303},"STC","Stewart Information Services Corporation",{"_12":6305,"_14":6306},"STCB","Starco Brands, Inc.",{"_12":6308,"_14":6309},"STDN","Standard Nuclear Inc.",{"_12":6311,"_14":6312},"STEP","StepStone Group Inc.",{"_12":6314,"_14":6315},"STEW","SRH Total Return Fund, Inc.",{"_12":6317,"_14":6318},"STEX","Streamex Corp.",{"_12":6320,"_14":6321},"STFS","Star Fashion Culture Holdings Limited",{"_12":6323,"_14":6324},"STGW","Stagwell Inc.",{"_12":6326,"_14":6327},"STI","Solidion Technology Inc.",{"_12":6329,"_14":6330},"STIM","Neuronetics, Inc.",{"_12":6332,"_14":6333},"STLN","Starling Oncology, Inc.",{"_12":6335,"_14":6336},"STNE","StoneCo Ltd.",{"_12":6338,"_14":6339},"STNG","Scorpio Tankers Inc.",{"_12":6341,"_14":6342},"STOK","Stoke Therapeutics, Inc.",{"_12":6344,"_14":-5},"STPEX",{"_12":6346,"_14":6347},"STRA","Strategic Education, Inc.",{"_12":6349,"_14":6350},"STRR","Star Equity Holdings, Inc.",{"_12":6352,"_14":6353},"STRT","Strattec Security Corporation",{"_12":6355,"_14":-5},"STRUX",{"_12":6357,"_14":6358},"STRW","Strawberry Fields REIT LLC",{"_12":6360,"_14":6361},"STRZ","Starz Entertainment Corp.",{"_12":6363,"_14":6364},"STT","State Street Corporation",{"_12":6366,"_14":6367},"STTK","Shattuck Labs, Inc.",{"_12":6369,"_14":6370},"STUB","StubHub Holdings, Inc.",{"_12":6372,"_14":6373},"STVN","Stevanato Group S.p.A.",{"_12":6375,"_14":-5},"STWI",{"_12":6377,"_14":6378},"STX","Seagate Technology Holdings plc",{"_12":6380,"_14":6381},"SUJA","Suja Life, Inc.",{"_12":6383,"_14":6384},"SUMA","SUMA Acquisition Corporation Class A Ordinary Shares",{"_12":6386,"_14":6387},"SUNE","SUNation Energy Inc.",{"_12":6389,"_14":6390},"SUNS","Sunrise Realty Trust, Inc.",{"_12":6392,"_14":6393},"SURG","SurgePays, Inc.",{"_12":6395,"_14":6396},"SVBL","Silver Bull Resources, Inc.",{"_12":6398,"_14":6399},"SVCO","Silvaco Group, Inc. Common Stock",{"_12":6401,"_14":6402},"SVRE","SaverOne 2014 Ltd",{"_12":6404,"_14":6405},"SVRN","OceanPal Inc. Common Stock",{"_12":6407,"_14":6408},"SVV","Savers Value Village, Inc.",{"_12":6410,"_14":6411},"SWIM","Latham Group, Inc.",{"_12":6413,"_14":6414},"SWMR","Swarmer, Inc Common Stock",{"_12":6416,"_14":-5},"SWPR",{"_12":6418,"_14":6419},"SWX","Southwest Gas Holdings, Inc.",{"_12":6421,"_14":6422},"SWZ","Total Return Securities, Inc.",{"_12":6424,"_14":6425},"SXC","SunCoke Energy, Inc.",{"_12":6427,"_14":6428},"SXTP","60 Degrees Pharmaceuticals, Inc.",{"_12":6430,"_14":6431},"SYM","Symbotic Inc.",{"_12":6433,"_14":6434},"SYNA","Synaptics Incorporated",{"_12":6436,"_14":6437},"SYRE","Spyre Therapeutics, Inc.",{"_12":6439,"_14":6440},"SYY","Sysco Corporation",{"_12":6442,"_14":6443},"TACT","TransAct Technologies Incorporated",{"_12":6445,"_14":6446},"TAKAX","Carlyle Tactical Private Credit Fund",{"_12":6448,"_14":6449},"TALO","Talos Energy Inc.",{"_12":6451,"_14":3639},"TAOFF",{"_12":6453,"_14":6454},"TAP","Molson Coors Beverage Company",{"_12":6456,"_14":6457},"TARS","Tarsus Pharmaceuticals, Inc.",{"_12":6459,"_14":6460},"TBBK","The Bancorp, Inc.",{"_12":6462,"_14":6463},"TBI","TrueBlue, Inc.",{"_12":6465,"_14":6466},"TBLD","Thornburg Income Builder Opportunities Trust",{"_12":6468,"_14":6469},"TBN","Tamboran Resources Corp",{"_12":6471,"_14":6472},"TBPH","Theravance Biopharma Inc",{"_12":6474,"_14":6475},"TCBI","Texas Capital Bancshares, Inc.",{"_12":6477,"_14":6478},"TCBS","Texas Community Bancshares, Inc.",{"_12":6480,"_14":-5},"TCGSX",{"_12":6482,"_14":6483},"TCPC","BlackRock TCP Capital Corp.",{"_12":6485,"_14":6486},"TDC","Teradata Corporation",{"_12":6488,"_14":6489},"TDIC","Dreamland Limited Class A Ordinary Shares",{"_12":6491,"_14":6492},"TDUP","ThredUp Inc.",{"_12":6494,"_14":6495},"TDW","Tidewater Inc.",{"_12":6497,"_14":6498},"TEAD","Teads Holding Co.",{"_12":6500,"_14":6501},"TEAM","Atlassian Corporation",{"_12":6503,"_14":6504},"TECX","Tectonic Therapeutic, Inc.",{"_12":6506,"_14":6507},"TELA","TELA Bio, Inc.",{"_12":6509,"_14":6510},"TEM","Tempus AI, Inc.",{"_12":6512,"_14":6513},"TEN","Tsakos Energy Navigation Limited",{"_12":6515,"_14":6516},"TENB","Tenable Holdings, Inc.",{"_12":6518,"_14":6519},"TENX","Tenax Therapeutics, Inc.",{"_12":6521,"_14":6522},"TEO","Telecom Argentina S.A.",{"_12":6524,"_14":6525},"TER","Teradyne, Inc.",{"_12":6527,"_14":6528},"TEVA","Teva Pharmaceutical Industries Limited",{"_12":6530,"_14":6531},"TFC","Truist Financial Corporation",{"_12":6533,"_14":6534},"TFIN","Triumph Financial, Inc.",{"_12":6536,"_14":6537},"TFSL","TFS Financial Corporation",{"_12":6539,"_14":6540},"TG","Tredegar Corporation",{"_12":6542,"_14":6543},"TGEN","Tecogen Inc.",{"_12":6545,"_14":6546},"TGLS","Tecnoglass Inc.",{"_12":6548,"_14":6549},"TGS","Transportadora de Gas del Sur S.A.",{"_12":6551,"_14":6552},"TH","Target Hospitality Corp.",{"_12":6554,"_14":6555},"THFF","First Financial Corporation",{"_12":6557,"_14":6558},"THM","International Tower Hill Mines Ltd.",{"_12":6560,"_14":6561},"THO","Thor Industries, Inc.",{"_12":6563,"_14":6564},"THQ","Abrdn Healthcare Opportunities Fund",{"_12":6566,"_14":6567},"THRY","Thryv Holdings, Inc.",{"_12":6569,"_14":6570},"THW","Abrdn World Healthcare Fund",{"_12":6572,"_14":6573},"TILE","Interface, Inc.",{"_12":6575,"_14":6576},"TIPT","Tiptree Inc.",{"_12":6578,"_14":6579},"TISI","Team, Inc.",{"_12":6581,"_14":6582},"TIVC","Tivic Health Systems, Inc.",{"_12":6584,"_14":6585},"TKLF","Tokyo Lifestyle Co., Ltd.",{"_12":6587,"_14":6588},"TKNO","Alpha Teknova, Inc.",{"_12":6590,"_14":6591},"TKO","TKO Group Holdings, Inc.",{"_12":6593,"_14":-5},"TLAC",{"_12":6595,"_14":6596},"TLPH","Talphera, Inc.",{"_12":6598,"_14":6599},"TLRY","Tilray Brands, Inc.",{"_12":6601,"_14":6602},"TLS","Telos Corporation",{"_12":6604,"_14":6605},"TLSA","Tiziana Life Sciences Ltd",{"_12":6607,"_14":6608},"TLSI","TriSalus Life Sciences, Inc.",{"_12":6610,"_14":6611},"TLX","Telix Pharmaceuticals Limited",{"_12":6613,"_14":6614},"TM","Toyota Motor Corporation",{"_12":6616,"_14":6617},"TMC","TMC the metals company inc.",{"_12":6619,"_14":6620},"TMCI","Treace Medical Concepts, Inc.",{"_12":6622,"_14":6623},"TMDX","TransMedics Group, Inc.",{"_12":6625,"_14":6626},"TMP","Tompkins Financial Corporation",{"_12":6628,"_14":6629},"TMUS","T-Mobile US, Inc.",{"_12":6631,"_14":6632},"TNC","Tennant Company",{"_12":6634,"_14":6635},"TNET","TriNet Group, Inc.",{"_12":6637,"_14":6638},"TNGX","Tango Therapeutics, Inc.",{"_12":6640,"_14":6641},"TNL","Travel + Leisure Co.",{"_12":6643,"_14":6644},"TNON","Tenon Medical, Inc.",{"_12":6646,"_14":6647},"TNXP","Tonix Pharmaceuticals Holding Corp.",{"_12":6649,"_14":6650},"TOFB","Tofutti Brands Inc.",{"_12":6652,"_14":6653},"TOI","The Oncology Institute, Inc.",{"_12":6655,"_14":6656},"TOL","Toll Brothers, Inc.",{"_12":6658,"_14":6659},"TONX","TON Strategy Co.",{"_12":6661,"_14":6662},"TORO","Toro Corp.",{"_12":6664,"_14":6665},"TOST","Toast, Inc.",{"_12":6667,"_14":6668},"TOUR","Tuniu Corporation",{"_12":6670,"_14":6671},"TPC","Tutor Perini Corporation",{"_12":6673,"_14":6674},"TPL","Texas Pacific Land Corporation",{"_12":6676,"_14":6677},"TPST","Tempest Therapeutics, Inc.",{"_12":6679,"_14":6680},"TPVG","TriplePoint Venture Growth BDC Corp.",{"_12":6682,"_14":6683},"TRAW","Traws Pharma, Inc.",{"_12":6685,"_14":6686},"TRCK","Track Group, Inc.",{"_12":6688,"_14":6689},"TRDA","Entrada Therapeutics, Inc.",{"_12":6691,"_14":6692},"TREX","Trex Company, Inc.",{"_12":6694,"_14":6695},"TRGS","TRG Latin America Acquisitions Corp. Class A Ordinary Shares",{"_12":6697,"_14":6698},"TRIN","Trinity Capital Inc.",{"_12":6700,"_14":6701},"TRMD","TORM plc",{"_12":6703,"_14":6704},"TRNS","Transcat, Inc.",{"_12":6706,"_14":6707},"TRS","TriMas Corporation",{"_12":6709,"_14":6710},"TRST","TrustCo Bank Corp NY",{"_12":6712,"_14":6713},"TRU","TransUnion",{"_12":6715,"_14":6716},"TRUP","Trupanion, Inc.",{"_12":6718,"_14":6719},"TRVI","Trevi Therapeutics, Inc.",{"_12":6721,"_14":6722},"TRXB","TRex Bio Inc.",{"_12":6724,"_14":6725},"TSCO","Tractor Supply Company",{"_12":6727,"_14":6728},"TSI","TCW Strategic Income Fund, Inc.",{"_12":6730,"_14":6731},"TSLX","Sixth Street Specialty Lending, Inc.",{"_12":6733,"_14":6734},"TSM","Taiwan Semiconductor Manufacturing Company Limited",{"_12":6736,"_14":6737},"TSN","Tyson Foods, Inc.",{"_12":6739,"_14":6740},"TSQ","Townsquare Media, Inc.",{"_12":6742,"_14":6743},"TSSI","TSS, Inc.",{"_12":6745,"_14":6746},"TT","Trane Technologies plc",{"_12":6748,"_14":6749},"TTAM","Titan America S.A.",{"_12":6751,"_14":6752},"TTAN","ServiceTitan, Inc.",{"_12":6754,"_14":6755},"TTC","The Toro Company",{"_12":6757,"_14":6758},"TTD","The Trade Desk, Inc.",{"_12":6760,"_14":6761},"TTEC","TTEC Holdings, Inc.",{"_12":6763,"_14":6764},"TTEK","Tetra Tech, Inc.",{"_12":6766,"_14":6767},"TTGT","TechTarget, Inc.",{"_12":6769,"_14":6770},"TTI","TETRA Technologies, Inc.",{"_12":6772,"_14":6773},"TTMI","TTM Technologies, Inc.",{"_12":6775,"_14":6776},"TTWO","Take-Two Interactive Software, Inc.",{"_12":6778,"_14":6779},"TURB","Turbo Energy, S.A. American Depositary Shares",{"_12":6781,"_14":6782},"TUSK","Mammoth Energy Services, Inc.",{"_12":6784,"_14":6785},"TVA","Texas Ventures Acquisition III Corp",{"_12":6787,"_14":6788},"TVTX","Travere Therapeutics, Inc.",{"_12":6790,"_14":6791},"TWFG","TWFG, Inc. Common Stock",{"_12":6793,"_14":6794},"TWLO","Twilio Inc.",{"_12":6796,"_14":6797},"TWN","The Taiwan Fund, Inc.",{"_12":6799,"_14":6800},"TWST","Twist Bioscience Corporation",{"_12":6802,"_14":6803},"TXG","10x Genomics, Inc.",{"_12":6805,"_14":6806},"TXO","TXO Partners, L.P.",{"_12":6808,"_14":6809},"TXT","Textron Inc.",{"_12":6811,"_14":6812},"TXTM","ProText Mobility, Inc.",{"_12":6814,"_14":6815},"TYG","Tortoise Energy Infrastructure Corporation",{"_12":6817,"_14":6818},"TYL","Tyler Technologies, Inc.",{"_12":6820,"_14":6821},"UA","Under Armour, Inc.",{"_12":6823,"_14":6824},"UAMY","United States Antimony Corporation",{"_12":6826,"_14":6827},"UBCP","United Bancorp, Inc.",{"_12":6829,"_14":6830},"UBER","Uber Technologies, Inc.",{"_12":6832,"_14":6833},"UCAR","U Power Limited",{"_12":6835,"_14":6836},"UCB","United Community Banks, Inc.",{"_12":6838,"_14":6839},"UCL","uCloudlink Group Inc.",{"_12":6841,"_14":6842},"UFCS","United Fire Group, Inc.",{"_12":6844,"_14":6845},"UGP","Ultrapar Participações S.A.",{"_12":6847,"_14":6848},"ULBI","Ultralife Corporation",{"_12":6850,"_14":6851},"ULS","UL Solutions Inc.",{"_12":6853,"_14":6854},"ULTA","Ulta Beauty, Inc.",{"_12":6856,"_14":6857},"UMBF","UMB Financial Corporation",{"_12":6859,"_14":6860},"UMC","United Microelectronics Corporation",{"_12":6862,"_14":6863},"UMH","UMH Properties, Inc.",{"_12":6865,"_14":6866},"UNB","Union Bankshares, Inc.",{"_12":6868,"_14":6869},"UP","Wheels Up Experience Inc.",{"_12":6871,"_14":6872},"UPBD","Upbound Group, Inc.",{"_12":6874,"_14":6875},"UPST","Upstart Holdings, Inc.",{"_12":6877,"_14":6878},"UPWK","Upwork Inc.",{"_12":6880,"_14":6881},"URBN","Urban Outfitters, Inc.",{"_12":6883,"_14":6884},"URG","Ur-Energy Inc.",{"_12":6886,"_14":6887},"URGN","UroGen Pharma Ltd.",{"_12":6889,"_14":6890},"UROY","Uranium Royalty Corp.",{"_12":6892,"_14":-5},"URSB",{"_12":6894,"_14":6895},"USA","Liberty All-Star Equity Fund",{"_12":6897,"_14":6898},"USAC","USA Compression Partners, LP",{"_12":6900,"_14":6901},"USAR","USA Rare Earth Inc",{"_12":6903,"_14":6904},"USAU","U.S. Gold Corp.",{"_12":6906,"_14":6907},"USEA","United Maritime Corporation",{"_12":6909,"_14":6910},"USEG","U.S. Energy Corp.",{"_12":6912,"_14":6913},"USLM","United States Lime & Minerals, Inc.",{"_12":6915,"_14":6916},"USO","United States Oil Fund, LP",{"_12":6918,"_14":6919},"USPH","U.S. Physical Therapy, Inc.",{"_12":6921,"_14":6922},"UTG","Reaves Utility IF",{"_12":6924,"_14":6925},"UTGN","UTG, Inc.",{"_12":6927,"_14":6928},"UTHR","United Therapeutics Corporation",{"_12":6930,"_14":6931},"UTI","Universal Technical Institute, Inc.",{"_12":6933,"_14":6934},"UUU","Universal Safety Products, Inc.",{"_12":6936,"_14":6937},"UUUU","Energy Fuels Inc.",{"_12":6939,"_14":6940},"UWHR","Uwharrie Capital Corp",{"_12":6942,"_14":6943},"UXIN","Uxin Limited",{"_12":6945,"_14":6946},"V","Visa Inc.",{"_12":6948,"_14":6949},"VAC","Marriott Vacations Worldwide Corporation",{"_12":6951,"_14":6952},"VALE","Vale S.A.",{"_12":6954,"_14":6955},"VALU","Value Line, Inc.",{"_12":113,"_14":156},{"_12":6958,"_14":6959},"VCIG","VCI Global Limited",{"_12":6961,"_14":-5},"VCRDX",{"_12":6963,"_14":6964},"VCYT","Veracyte, Inc.",{"_12":6966,"_14":-5},"VDTA",{"_12":6968,"_14":-5},"VECA",{"_12":6970,"_14":6971},"VEEE","Twin Vee Powercats Co.",{"_12":6973,"_14":6974},"VEEV","Veeva Systems Inc.",{"_12":6976,"_14":6977},"VENU","Venu Holding Corporation",{"_12":6979,"_14":6980},"VEON","VEON Ltd.",{"_12":6982,"_14":6983},"VERA","Vera Therapeutics, Inc.",{"_12":6985,"_14":6986},"VERI","Veritone, Inc.",{"_12":6988,"_14":6989},"VERO","Venus Concept Inc.",{"_12":6991,"_14":6992},"VERX","Vertex, Inc.",{"_12":6994,"_14":6995},"VFC","V.F. Corporation",{"_12":6997,"_14":6998},"VFF","Village Farms International, Inc.",{"_12":7000,"_14":7001},"VFLEX","First Trust Alternative Opportunities Fund",{"_12":7003,"_14":7004},"VG","Venture Global, Inc.",{"_12":7006,"_14":7007},"VGNT","Versigent PLC",{"_12":7009,"_14":7010},"VIA","Via Transportation, Inc.",{"_12":7012,"_14":7013},"VIAV","Viavi Solutions Inc.",{"_12":7015,"_14":7016},"VICR","Vicor Corporation",{"_12":7018,"_14":7019},"VIDA","Vidaroo Corp",{"_12":7021,"_14":7022},"VII","7GC & Co. Holdings Inc.",{"_12":7024,"_14":7025},"VINP","Vinci Compass Investments Ltd.",{"_12":7027,"_14":7028},"VIRC","Virco Mfg. Corporation",{"_12":7030,"_14":7031},"VISN","Vistance Networks, Inc.",{"_12":7033,"_14":7034},"VITL","Vital Farms, Inc.",{"_12":7036,"_14":7037},"VKI","Invesco Advantage Municipal Income Trust II",{"_12":7039,"_14":7040},"VKQ","Invesco Municipal Trust",{"_12":7042,"_14":7043},"VKTX","Viking Therapeutics, Inc.",{"_12":7045,"_14":7046},"VMAR","Vision Marine Technologies Inc.",{"_12":7048,"_14":7049},"VMI","Valmont Industries, Inc.",{"_12":7051,"_14":7052},"VNO","Vornado Realty Trust",{"_12":7054,"_14":7055},"VPLM","Voip-Pal.com Inc.",{"_12":7057,"_14":7058},"VRA","Vera Bradley, Inc.",{"_12":7060,"_14":7061},"VRCA","Verrica Pharmaceuticals Inc.",{"_12":7063,"_14":7064},"VRDN","Viridian Therapeutics, Inc.",{"_12":7066,"_14":7067},"VRM","Vroom, Inc.",{"_12":7069,"_14":7070},"VRSK","Verisk Analytics, Inc.",{"_12":7072,"_14":7073},"VRSN","VeriSign, Inc.",{"_12":7075,"_14":7076},"VRTS","Virtus Investment Partners, Inc.",{"_12":7078,"_14":7079},"VRXA","Veraxa Biotech Holding AG",{"_12":7081,"_14":7082},"VSAT","Viasat, Inc.",{"_12":7084,"_14":7085},"VSCO","Victoria's Secret & Co.",{"_12":7087,"_14":7088},"VSH","Vishay Intertechnology, Inc.",{"_12":7090,"_14":7091},"VSNT","Versant Media Group, Inc. Class A",{"_12":7093,"_14":7094},"VST","Vistra Corp.",{"_12":7096,"_14":7097},"VSTM","Verastem, Inc.",{"_12":7099,"_14":7100},"VSTS","Vestis Corporation",{"_12":7102,"_14":7103},"VSXY","Victoria's Secret & Company",{"_12":7105,"_14":7106},"VTOL","Bristow Group Inc.",{"_12":7108,"_14":7109},"VTR","Ventas, Inc.",{"_12":7111,"_14":7112},"VTS","Vitesse Energy, Inc.",{"_12":7114,"_14":7115},"VTSI","VirTra, Inc.",{"_12":7117,"_14":7118},"VVOS","Vivos Therapeutics, Inc.",{"_12":7120,"_14":7121},"VVV","Valvoline Inc.",{"_12":7123,"_14":7124},"VXRT","Vaxart, Inc.",{"_12":7126,"_14":7127},"VZ","Verizon Communications Inc.",{"_12":7129,"_14":7130},"W","Wayfair Inc.",{"_12":7132,"_14":7133},"WAB","Westinghouse Air Brake Technologies Corporation",{"_12":7135,"_14":7136},"WABC","Westamerica Bancorporation",{"_12":7138,"_14":7139},"WALD","Waldencast plc",{"_12":7141,"_14":7142},"WASH","Washington Trust Bancorp, Inc.",{"_12":7144,"_14":7145},"WAT","Waters Corporation",{"_12":7147,"_14":7148},"WATT","Energous Corporation",{"_12":7150,"_14":7151},"WAY","Waystar Holding Corp.",{"_12":7153,"_14":7154},"WBX","Wallbox N.V.",{"_12":7156,"_14":7157},"WCC","WESCO International, Inc.",{"_12":7159,"_14":7160},"WCN","Waste Connections, Inc.",{"_12":7162,"_14":7163},"WD","Walker & Dunlop, Inc.",{"_12":7165,"_14":7166},"WDAY","Workday, Inc.",{"_12":7168,"_14":7169},"WDI","Western Asset Diversified Income Fund",{"_12":7171,"_14":7172},"WELL","Welltower Inc.",{"_12":7174,"_14":7175},"WES","Western Midstream Partners, LP",{"_12":7177,"_14":7178},"WEST","Westrock Coffee Company, LLC",{"_12":7180,"_14":7181},"WEX","WEX Inc.",{"_12":7183,"_14":7184},"WGS","GeneDx Holdings Corp.",{"_12":7186,"_14":7187},"WHD","Cactus, Inc.",{"_12":7189,"_14":7190},"WHF","WhiteHorse Finance, Inc.",{"_12":7192,"_14":7193},"WHLR","Wheeler Real Estate Investment Trust, Inc.",{"_12":7195,"_14":7196},"WHR","Whirlpool Corporation",{"_12":7198,"_14":7199},"WIX","Wix.com Ltd.",{"_12":7201,"_14":7202},"WKC","World Kinect Corporation",{"_12":7204,"_14":7205},"WKSP","Worksport Ltd.",{"_12":7207,"_14":7208},"WLFC","Willis Lease Finance Corporation",{"_12":7210,"_14":7211},"WLTH","Wealthfront Corporation",{"_12":7213,"_14":7214},"WMB","The Williams Companies, Inc.",{"_12":7216,"_14":7217},"WMT","Walmart Inc.",{"_12":7219,"_14":7220},"WNW","Meiwu Technology Company Limited",{"_12":7222,"_14":7223},"WOK","WORK Medical Technology Group Ltd.",{"_12":7225,"_14":7226},"WOR","Worthington Industries, Inc.",{"_12":7228,"_14":-5},"WP-ADMIN",{"_12":7230,"_14":-5},"WP-JSON",{"_12":7232,"_14":-5},"WP-LOGIN",{"_12":7234,"_14":-5},"WP-LOGIN.PHP",{"_12":7236,"_14":7237},"WPP","WPP plc",{"_12":7239,"_14":7240},"WRAP","Wrap Technologies, Inc.",{"_12":7242,"_14":7243},"WRB","W. R. Berkley Corporation",{"_12":7245,"_14":7246},"WRBY","Warby Parker Inc.",{"_12":7248,"_14":7249},"WSBC","WesBanco, Inc.",{"_12":7251,"_14":7252},"WSBK","Winchester Bancorp, Inc. Common Stock",{"_12":7254,"_14":7255},"WSM","Williams-Sonoma, Inc.",{"_12":7257,"_14":7258},"WTW","Willis Towers Watson Public Limited Company",{"_12":7260,"_14":7261},"WULF","TeraWulf Inc.",{"_12":7263,"_14":7264},"WVE","Wave Life Sciences Ltd.",{"_12":7266,"_14":7267},"WW","WW International, Inc.",{"_12":7269,"_14":7270},"XAGE","Longevity Health Holdings Inc.",{"_12":7272,"_14":7273},"XAIR","Beyond Air, Inc.",{"_12":7275,"_14":7276},"XBP","XBP Global Holdings, Inc.",{"_12":7278,"_14":7279},"XE","X-Energy, Inc. Class A Common Stock",{"_12":7281,"_14":7282},"XENE","Xenon Pharmaceuticals Inc.",{"_12":7284,"_14":7285},"XERS","Xeris Biopharma Holdings, Inc.",{"_12":7287,"_14":7288},"XFOR","X4 Pharmaceuticals, Inc.",{"_12":7290,"_14":-5},"XHFIX",{"_12":7292,"_14":7293},"XIIIU","Churchill Capital Corp XIII Units",{"_12":7295,"_14":-5},"XIVYX",{"_12":7297,"_14":7298},"XLO","Xilio Therapeutics, Inc.",{"_12":7300,"_14":7301},"XMTR","Xometry, Inc.",{"_12":7303,"_14":7304},"XP","XP Inc.",{"_12":7306,"_14":-5},"XPEPX",{"_12":7308,"_14":7309},"XPO","XPO Logistics, Inc.",{"_12":7311,"_14":7312},"XPOF","Xponential Fitness, Inc.",{"_12":7314,"_14":7315},"XRAY","DENTSPLY SIRONA Inc.",{"_12":7317,"_14":7318},"XRN","Chiron Real Estate Inc.",{"_12":7320,"_14":7321},"XSPIX","StepStone Private Venture and Growth Fund - Class I Shares",{"_12":7323,"_14":7324},"XYL","Xylem Inc.",{"_12":7326,"_14":7327},"XYZ","Block, Inc.",{"_12":7329,"_14":7330},"XZO","Exzeo Group, Inc.",{"_12":7332,"_14":7333},"YDES","YD Bio Limited Ordinary Shares",{"_12":7335,"_14":7336},"YEXT","Yext, Inc.",{"_12":7338,"_14":7339},"YORW","The York Water Company",{"_12":7341,"_14":7342},"YPF","YPF Sociedad Anónima",{"_12":7344,"_14":7345},"YQ","17 Education & Technology Group Inc.",{"_12":7347,"_14":7348},"YUM","Yum! Brands, Inc.",{"_12":7350,"_14":7351},"YYAI","AiRWA Inc.",{"_12":7353,"_14":7354},"YYGH","YY Group Holding Limited",{"_12":7356,"_14":7357},"ZBIO","Zenas BioPharma, Inc.",{"_12":7359,"_14":7360},"ZBRA","Zebra Technologies Corporation",{"_12":7362,"_14":7363},"ZGN","Ermenegildo Zegna N.V.",{"_12":7365,"_14":7366},"ZION","Zions Bancorporation, National Association",{"_12":7368,"_14":7369},"ZIP","ZipRecruiter, Inc.",{"_12":7371,"_14":7372},"ZIVO","ZIVO Bioscience, Inc.",{"_12":7374,"_14":7375},"ZLAB","Zai Lab Limited",{"_12":7377,"_14":7378},"ZM","Zoom Communications, Inc.",{"_12":7380,"_14":7381},"ZNB","Zeta Network Group",{"_12":7383,"_14":7384},"ZNTL","Zentalis Pharmaceuticals, Inc.",{"_12":7386,"_14":-5},"ZOMDF",{"_12":7388,"_14":7389},"ZONE","Zone Frontier Inc.",{"_12":7391,"_14":7392},"ZS","Zscaler, Inc.",{"_12":7394,"_14":7395},"ZSPC","zSpace, Inc.",{"_12":7397,"_14":7398},"ZSTK","ZeroStack Corp.",{"_12":7400,"_14":7401},"ZTS","Zoetis Inc.",{"_12":7403,"_14":7404},"ZUMZ","Zumiez Inc.",{"_12":7406,"_14":7407},"ZURA","Zura Bio Limited",{"_12":7409,"_14":7410},"ZVRA","Zevra Therapeutics, Inc.",{"_12":7412,"_14":7413},"ZWS","Zurn Elkay Water Solutions Corporation",{"_12":7415,"_14":7416},"ZYME","Zymeworks Inc.","filters",{"_7419":7420,"_7421":7422,"_7423":7424,"_7425":7426,"_7427":83},"days",30,"minMkt",50000000,"maxMkt",2000000000,"minVal",25000,"minInsiders","actionData","errors"]

Tracked (6)

Clusters (3)

Pinned (2)